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CHAPTER 1 
 
 
GENERAL INTRODUCTION 
 
 
 
THE SKIN 
 
The skin is a physical barrier between an organism and its environment. As the largest organ of 
the human body it prevents the loss of water from the body and protects the internal 
environment from outside influences. In order to understand the defensive capacities of the 
skin, it is important to define the structural basics of this external surface. The skin is 
composed of two layers: the epidermis and the dermis, and rests on the subcutaneous adipose 
tissue. The epidermis is a multilayered epithelium composed of several different cell types. 
Keratinocytes (KC) are the major cell type, and represent about 95% of the epidermal cell 
mass. They are responsible for the biochemical and physical integrity of the skin via their 
production of keratin and mucopolysaccharides (Barker et al., 1991). Langerhans cells (LC) 
comprise the second most promiment cell type in the skin. LC are bone marrow-derived 
dendritic cells and represent only 2% to 5% of the epidermal population. Melanocytes form 
some 3% of the epidermal cells and by generating the pigment melanin they protect the skin 
against ultraviolet radiation. Besides its barrier function, the skin has been recognized for some 
time as an immunologically active tissue. LC are the principal antigen-presenting cells in the 
skin (Katz, 1979), and KC act as signal transducers, converting non-specific exogenous stimuli 
into the production of cytokines, chemotactic factors and adhesion molecules (Barker et al., 
1991). 
 
CONTACT HYPERSENSITIVITY  
 
Hypersensitivity reactions to drugs and industrial chemicals are relatively common in man, and 
often considered to be increasing at such a rate to become a major health problem in relation to 
environmental chemical exposures (Salvaggio, 1990; Vos et al., 1995). In the context of 
occupational and environmental health one of the most important allergic diseases caused by 
chemicals is contact hypersensitivity (CHS), also known as skin sensitization. CHS can occur 
as a result of exposure to a wide variety of chemicals and drugs (Nethercott and Holness, 
1989), cosmetics (De Groot et al., 1988; Remaut, 1992), and various metals (Nethercott and 
Holness, 1989; Picardo et al., 1990).  
CHS is not inborn, but always a consequence of earlier cutaneous contact. Individuals 
with CHS typically develop dermatitis (within a few days of exposure) in areas that were 
exposed directly to the allergen, and is characterized by perivascular inflammatory infiltration 
of mononuclear cells in the epidermis. Underlying the inflammation is vasodilatation resulting 
in redness (erythema) and increased vascular permeability with formation of oedema and 
induration. In this respect, the term dermatitis is used synonymously with eczema. 
CHS is a rather common disease and the prevalence at any given time varies between 
2-4%. Epidemiological studies comprising 20.000 individuals representing the general 
population showed a one year prevalence of hand eczema of 10% (Meding, 1990), 20% of 
which were classified as caused by contact allergy. The average duration was 12.8 years and 
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22% have had periods of sick leave. The risk of CHS as a result of repeated exposure to 
certain contact allergens (such as poison ivy) prevalent in certain areas of North and South 
America, may be higher than 20% (Weston and Bruckner, 2000). Furthermore, European and 
US studies show that children aged 0 to 14 may account for as many as 20% of cases of CHS 
(Barros et al., 1991; Goncalo et al., 1992; Hogan and Weston, 1993). These findings clearly 
show that CHS is both a common disease but also costly for society and can imply significant 
socio-economic consequences for the individual (Matthias, 1985). 
CHS is a classical type IV delayed type hypersensitivity (DTH) reaction, caused by an 
abnormal response of the skin immune system (Bos and Kapsenberg, 1986) and is 
characterised by the infiltration of T-lymphocytes into the dermis and epidermis (Krasteva, 
1993). Contact allergens are generally haptens, which are highly reactive low-molecular-weight 
(generally less than 500 Dalton), lipid-soluble molecules that by themselves are not recognized 
by the immune system. Haptens bind to proteins within the epidermis and dermis forming a 
complete antigen. The interaction between antigen and the T-lymphocyte of the cellular 
immune system is divided into two sequential phases: an initial sensitisation (induction) phase 
and a subsequent elicitation (challenge) phase.  
  
Initiation phase 
The sensitisation phase begins with the application of hapten to the skin surface. The hapten 
penetrates the epidermal barrier (stratum corneum) and binds covalently with cell surface or 
structural proteins, forming a hapten-carrier complex. This hapten-self component is effectively 
taken up by Langerhans cells (LC), specialized dendritic cells that function as the principal 
antigen presenting cells (APC) in the epidermis (Bergstresser et al., 1991). LC ingest the 
antigen, and process it to form small peptides before being expressed at the cell surface in 
association with major histocompatibility complex (MHC) molecules (Strelein and Grammer, 
1989). After uptake of the antigen LC migrate via the afferent lymphatic into the lymph node 
(LN) where they present the antigen to the T-lymphocyte. Before LC can migrate they 
undergo a variety of phenotypic and morphological changes (Picut et al., 1987; Kolde and 
Knop, 1987; Aiba and Katz, 1990). Once LC, loaded with hapten-carrier complexes, arrive in 
the paracortical T-cell areas of the LN draining the skin, they present the antigen to CD4+ T-
helper (Th) cells, which results in a clonal expansion of these cells to become antigen-specific 
effector T-cells. These primed T-cells migrate through the circulation to the skin or other sites 
and serve as a pool of (antigen-specific) memory T-cells (Knight et al., 1985a, 1985b). 
 
Elicitation phase 
Re-exposure of the skin to the same chemical will result in presentation of the hapten-peptide 
complex by Langerhans and possibly non-Langerhans antigen presenting cells to primed T-cells 
(Figure 1). This interaction results in activation of the antigen-specific T-cells and the release 
of numerous inflammatory mediators (Belsito, 1989; Bergstresser, 1990). These activated T-
cells release a variety of lymphokines (cytokines) which have a variety of effects on 
neighbouring KC, dermal cells, blood vessels and nerve endings. CHS develops within 24 
hours of antigen exposure.  
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Figure 1  
Induction and elicitation phase of contact hypersensitivity. Haptens penetrate the the upper epidermal layer, the 
stratum corneum, and bind to skin proteins. These complexes are recognized, captured, and processed by 
Langerhans cells (LC). After maturation, that is affected by keratinocyte (KC) –derived cytokines, hapten-
bearing LC migrate to the draining lymph node were they present the hapten to T-cells. This leads to activation 
and the clonal expansion of T-cells and a subsequent release of these cells in the blood circulation. Upon 
repeated skin exposure to the hapten, skin-recruited hapten-specific T cells will cause a local cytokine-mediated 
inflammation. 
 
 
CYTOKINE EXPRESSION IN THE SKIN 
 
Cytokines are small polypeptide molecules that exert their biological functions in extremely 
low (picomolar) concentrations through specific receptors expressed on the surface of immune 
as well as non-immune cells (Paul, 1988; Green, 1989). They are produced locally and 
transiently in response to exogenous stimuli to mediate cell specific effects, including cell 
growth and differentiation, migration and immune functions. CHS is to a large extent regulated 
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by the action of cytokines. For instance, upon exposure of the skin to contact sensitizing 
agents, cytokine production in the epidermis by both KC and LC is immediately upregulated, 
thereby initiating the process of LC maturation and migration. The cytokines of greatest 
importance are GM-CSF, IL-1 and TNF-α (Kimber et al., 2000). Within the epidermis, KC are 
the major source of cytokines. In addition, cytokines are produced by LC and melanocytes 
(William and Kupper, 1996). An overview of the cytokines produced by these epidermal cells 
is shown in Table 1. Some of these cytokines are described in more detail in the following 
paragraphs. 
Interleukin-1 (IL-1) was originally described as lymphocyte-activating factor and was 
thought to be produced only by monocytes. It is now well established, however, that many 
cells, including epithelial cells, endothelial cells, fibroblasts and various tumor cells, function as 
sources for IL-1 (Oppenheim et al., 1986; Kupper et al., 1986). Two distinct forms of IL-1, 
termed IL-1α and IL-1β, have been described. IL-1α was the first cytokine demonstrated to be 
produced by KC (Luger et al., 1981; Sauder et al., 1982). Epidermal KC constitutively 
synthesize IL-1α (Dinarello, 1984), and contain a large amount of preformed and biologically 
active IL-1α (Mizutani, 1991). Once the physical barrier of the upper epidermis is damaged, 
IL-1α is rapidly released so that this IL-1α reservoir represents a rapid response system for 
immune and inflammatory regulation in the skin, and IL-1α acts as a first line of defence 
against injury (Kupper, 1988). In addition, IL-1α acts as primary promoting factor in CHS 
reactions, stimulating further release of IL-1α and the production and release of other 
‘secondary’ cytokines such as IL-6, IL-8 and GM-CSF (Corsini and Galli, 2000). 
IL-18 is also abundantly expressed in the skin. Besides the epidermal KC and LC, IL-
18 is widely expressed by both leukocytic and non-leukocytic cells including macrophages and 
dendritic cells. Also IL-18 is known to be constitutively produced by keratinocytes (Stoll et al., 
1997). While recent findings have revealed that contact allergen-induced LC migration and 
dendritic cell accumulation in draining lymph nodes require IL-18 (Cumberbatch et al., 2001), 
it was first discovered as an interferon-γ inducing factor (IGIF) in sera of mice treated with 
Myobacterium bovis BCG and challenged with LPS (Nakamura et al., 1989). IL-18 acts 
synergistically with IL-12 to induce a Th1 response through induction of IFN-γ by T-cells 
(Micallef et al., 1996; Robinson et al., 1997). Also IFN-γ production by NK cells as well as the 
activation of NK cells are influenced by IL-18 (Hunter et al., 1997; Micallef et al., 1997). IL-
18 has a direct effect on TNF-α production by T helper and NK cells (Puren et al., 1998). 
Studies in the past have revealed IL-18 as a typical Th1 cytokine. However, recent reports 
show that IL-18 also induces the production of Th2 cytokines from T-cells, NK cells, 
basophils, and mast cells (Hoshino et al., 1999; Yoshimoto et al., 1999; Nakanishi et al., 
2001).  
After activation of the skin by various stimuli, IFN-γ is the first cytokine produced by 
T-cells and natural killer (NK) cells (Kasahara et al., 1983; Howie et al., 1996). IFN-γ 
activates macrophages, neutrophils and NK cells, promoting T- and B-cell differentiation and 
increasing IL-1 and IL-2 synthesis. Moreover, IFN-γ increases intercellular adhesion molecule-
1 (ICAM-1) and MHC II expression on epidermal KC (Bos, 1990), suggesting that KC may 
function as additional accesory cells in the skin able to interact with T-cells. 
IL-4 plays a major role in T-cell development. It promotes differentiation of Th cells 
into Th2 cells during an immune response (Romagnani, 1992). Activated B-cells are induced 
by IL-4 to produce IgE (Coffman et al., 1986), and IL-4 can act as a mast cell growth factor. 
Mast cells and basophils produce IL-4. It has been hypothesized that IL-4  produced by these 
cells induces the development of Th2 cells, and that these cells in turn produce IL-4.  
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It has been found that IL-10, a cytokine described originally as cytokine synthesis 
inhibitory factor, inhibits the immunostimulatory and antigen presentation functions of LC and 
the ability of dendritic cells to induce IFN-γ production by T-cells (Enk et al., 1993; Macatonia 
et al., 1993; Peguet-Navarro et al., 1994; Beissert et al., 1995), thereby stimulating a Th2 
response. IL-10 is produced by Th2 cells and keratinocytes, and is known to be upregulated in 
response to skin sensitization (Enk and Katz, 1992). IL-10 inhibits cutaneous inflammatory 
reactions (Berg et al., 1995), and may serve as a down-regulatory molecule for LC maturation 
(Kimber and Cumberbatch, 1992; Enk and Katz, 1995). 
 
 
Table 1  
Epidermal cytokines (after: William and Kupper, 1996; Corsini and Galli, 2000). 
    Epidermal cell types 
 
Cytokines 
 
Keratinocytes Langerhans cells Melanocytes 
Interleukin 1α (IL-1α)  + + + 
IL-1β + + + 
IL-3 (mouse) + - - 
IL-6 + + + 
IL-7 + - - 
IL-8 (human) + - + 
IL-10 + - + 
IL-12 + - + 
IL-15 + + - 
IL-18 + + - 
Granulocyte Colony-Stimulating Factor (G-CSF) + - + 
Granulocyte Macrophage Colony-Stimulating 
Factor (GM-CSF) 
+ - + 
Macrophage Colony-Stimulating Factor (M-CSF) + - + 
Macrophage Chemoattractant Protein 1 (MCP-1) + - + 
Macrophage Inflammatory Protein 1α (MIP-1α) - + - 
MIP-2 (mouse) + + + 
Interferon-inducible Protein 10 (IP-10) + - - 
RANTES (regulated upon activation, normal T-
cells expressed and secreted) 
+ - + 
Transforming growth factor α (TGF-α) + - + 
Transforming growth factor β (TGF-β) + + + 
Tumor necrosis factor α (TNF-α) + + + 
 
 
PRECLINICAL METHODS FOR TESTING THE CONTACT ALLERGENIC 
POTENTIAL OF CHEMICALS 
 
Effective toxicologic evaluation of skin sensitization requires that potential contact allergens 
are identified. Much of the early work designed to investigate the phenomenon of contact 
sensitivity was performed in the guinea pig (Landsteiner and Jacobs, 1935) and it was this 
species that was chosen initially for the development of predictive tests. Since the introduction 
in 1944 by Draize et al. of the first method designed specifically for the identification of 
contact allergens, a variety of guinea pig methods has been described. As the guinea pig 
maximization test (GPMT) and the Buehler test have been much more widely used compared 
to any other guinea-pig assay, only these two guinea pig tests are discussed in this thesis in 
addition to tests in the mouse. 
General introduction 
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Guinea pig maximization test 
The GPMT has been used as a method for the prediction of skin sensitizing potential for over 
30 years since it was first described (Magnusson and Kligman, 1969 and 1970). During the 
induction phase animals are exposed intradermally (day 0), in combination with Freund’s 
Complete Adjuvant (FCA), and topically with an occlusive patch (day 7) on the shaved 
scapular area. The elicitation (challenge) is performed on the shaved flank by the application of 
an occlusive patch. The control animals receive the vehicle during the induction phase and the 
tested chemical during the elicitation phase. The skin reaction is read after 24 and 48 hours as 
visual assessment of induced erythema and graded according to a semi-quantitative rating 
scale. Finally, the number of positive animals in the test group is an indication of the potency of 
the contact allergen. If ≥30% of the test animals scored positive, the chemical is considered a 
sensitizer. The GPMT is the preferred test method in the EU and >90% of the tests on new 
and existing chemicals were/are carried out using this method (Schlede and Eppler, 1995). 
 
Buehler test  
The Buehler test (Buehler, 1965; the technique has later been refined in 1994) is still the 
preferred test procedure in the USA. The main differences between the Buehler test and the 
GPMT are that both the induction and elicitation exposures are done topically, and no FCA is 
used in the Buehler test. Several experimental studies compared the Buehler test with the 
GPMT by testing strong sensitizers and found the Buehler test to be less sensitive than the 
GPMT (Marzulli and Maguire, 1982; Fahr et al., 1976; Frankild et al., 2000). Both guinea pig 
methods described above are recommended in the Organisation for Economic Cooperation and 
Development (OECD) guideline #406 (1992). 
 
Mouse ear swelling test 
More recently, different types of tests to predict the capacity of chemicals to induce contact 
allergy have been developed in mice. One is the mouse ear swelling test (MEST), where the 
activity is assessed as a function of both the degree of specific ear swelling and the percentage 
of test animals that exhibit a positive response (Gad et al., 1986). On tape-stripped abdomial 
skin, the test material is applied topically for 4 consecutive days in combination with FCA. Ten 
days following sensitization, test and control mice are challenged on one ear with the test 
material and on the other ear with the appropriate vehicle alone. Ear thickness is measured 24 
and 48 hours later. Initially, this test was considered to be very promising but failed to prove 
superior to guinea pig assays. It is actually rather less sensitive, and as expensive and time-
consuming as most guinea pig tests. 
 
Local lymph node assay 
An alternative approach based on the immunobiological events and responses that are 
provoked by contact allergens, is the murine local lymph node assay (LLNA). The LLNA is a 
predictive test that uses in vivo cell proliferation in the draining lymph nodes for assessment of 
the contact sensitization potential of chemicals (Kimber, 1986; Kimber and Weisenberger, 
1989). Here, the uptake of [3H]TdR by the local lymph node cells, as a response to the 
application of the test chemical to the mouse ear, is a measure for the immune response and 
thus is used as a measure of sensitization. A chemical proves to be positive and can be 
regarded a sensitizer, when it shows a threefold increase over vehicle control. In contrast to 
the MEST and guinea pig assays, activity is measured as a function of events occuring during 
the induction, rather than elicitation phase of contact sensitization.  
The LLNA has been evaluated extensively for its sensitivity and reliability in predicting 
the contact sensitization of chemicals through both intra- and interlaboratory validation studies 
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(Kimber et al., 1991; Kimber and Basketter, 1992; Loveless et al., 1996) and has been found 
to correlate well with guinea pig studies and human analyses (Basketter et al., 1993; 1994). 
Next, the LLNA was submitted to the Interagency Coordinating Committee on the 
Validation of Alternative Methods (ICVAMM, NIH 1999), for consideration as an alternative 
(i.e., stand-alone) test method to the guinea pig sensitization tests. It was concluded that the 
LLNA is an acceptable alternative to guinea pig test methods for the identification of potential 
contact sensitizers. Another conclusion in this evaluation was that the LLNA offers animal 
welfare advantages (exclusion of adjuvant, topical application instead of intradermal injection 
of the compound, shorter protocol) compared to the use of traditional guinea pig methods and 
reduces the total number of animals required. 
The LLNA has been developed further to discriminate skin sensitizers from respiratory 
sensitizers (Dearman et al., 1992; Vandebriel et al., 2000) based on the induction of CD4+ T 
helper subsets. Contact allergens preferentially induce a T-helper 1 (Th1) response and mediate 
type IV immediate hypersensitivity, whereas respiratory allergens preferentially induce a T-
helper 2 (Th2) response and mediate type I immediate hypersensitivity by the production of 
IgE and IgG1. These responses can be discriminated on the basis of cytokine production, such 
as IFN-γ, that is produced by Th1 cells, and IL-4 and IL-10, that are produced by Th2 cells. 
Th cells can be divided in the functional T helper subsets Th1 and Th2, according to patterns 
of lymphokine activity production (Abbas et al., 1996; O’Garra, 1998). In general, Th1 cells 
preferentially induce IL-2 and IFN-γ, whereas Th2 cells produce IL-4, IL-5, IL-6, IL-10, and 
IL-13 (Mossman et al., 1986; Openshaw et al., 1995). Cytokines also influence the type of  T-
cell subsets that are activated (Seder and Paul, 1994).  
 
RISK ASSESSMENT IN IMMUNOTOXICOLOGY 
 
Immunotoxicology is a relatively new area of toxicology. Immunotoxicology has grown, 
during the first 30 years of its existence, to a fully acknowledged subdiscipline of toxicology 
and may be defined as the scientific discipline concerned with the adverse effects resulting from 
the interaction of xenobiotics with the immune system. It includes the consequences of an 
action (i.e. either suppression or enhancement) by a substance (or its metabolite) on the 
immune system, as well as the immunological response to such a substance (IPCS, 1996; 
1999).  
Risk assessment has become a more structured activity during the past 50 years and is 
increasingly being used to form a basis for policy decisions. A fundamental goal of risk 
assessment is to establish a safe level of human exposure to chemicals. Unfortunately, for most 
compounds there is a general lack of basic toxicokinetic and mechanistic data, so that 
estimation of risk inevitably relies on a number of uncertainties, assumptions, and 
rationalisations. Initially, immunotoxicologists focused their efforts only on the identification of 
hazard and dose-response assessment and no attention was paid to risk assessment. 
Fortunately, immunotoxicologists increasingly turned to assessing the risk in relation to 
immunotoxic effects (Trizio et al., 1988; Luster et al., 1994; Selgrade et al., 1995; ILSI, 1995; 
Van Loveren et al., 1997 Descotes), and risk assessment is now emerging as a new and 
important field for immunotoxicology. 
For contact allergy, the assessment of risk is still limited to hazard identification, and 
risk management is restricted to labeling. A next step in the risk assessment process should be 
determination of the relative potency of the substance in relation to that of other known 
contact allergens, which is one of the focuses in this thesis. In general, traditional test methods 
are not well suited for relative potency evaluation because they lack the possibility of dose-
response assessment, and therefore much remains to be done for designing appropriate 
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quantitative experimental models useful for risk assessment of sensitization. The LLNA offers 
an opportunity to obtain an objective and quantitative assessment of potency as this test 
includes dose-response assessment. An important issue in relation to the assessment of dose-
response relationships is the identification of a threshold (Kimber et al., 1999; Boukhman and 
Maibach, 2001). The threshold for sensitization can be defined as the highest level of exposure 
that fails to induce sensitization or fails to elicit an allergic reaction in a previously sensitized 
subject. Threshold data may provide information on safe exposure levels for humans. Exposure 
is determined by a combination of factors (i.e. duration, magnitude, frequency of exposure), 
and is usually the most neglected aspect of the risk assessment process. The final step of the 
process is immunotoxicity risk characterization. Unfortunately, the current lack of adequate 
human data is a major limitation. To overcome this difficulty, an alternative type of evaluation 
of the risk of adverse effects due to exposure to immunotoxic chemicals may be used; the so 
called parallellogram approach (Blaauboer et al., 1990; IPCS, 1996; Van Loveren et al., 1997; 
Figure 2). It is possible to compare the results of in vitro and in vivo animal studies using the 
same or similar endpoints of immunotoxicity, as it is possible to compare the results of in vitro 
studies in animals and in man. Based on the combined comparison of these results of species 
comparison, an improved extrapolation from animals to the human situation is now achievable. 
This approach may hold promise for the risk evaluation of chemicals that exert skin sensitizing 
properties (Van Loveren et al., 1998).  
 
Figure 2  
The parallellogram approach for immunotoxicity risk assessment. 
 
 
CHEMICALS STUDIED IN THIS THESIS 
 
Skin contact with small molecules (haptens) tends to induce cellular mediated contact 
sensitization. Contact sensitized individuals are at risk of developing the disease CHS if re-
exposed to the specific chemical. This disease is not inborn but is always a consequence of 
earlier cutaneous contact, and the prevalence at any given time varies between 2-4%. It is 
considered to be life-long, but might become weaker when exposure is avoided. Exposure can 
take place in the work environment as well as at home or in leisure time and there is a 
considerable overlap. CHS on the hands is the most frequent example. In a survey of 564 cases 
of permanent disability caused by skin diseases, 222 of the 564 were caused by CHS on the 
hands (Menné and Bauchman, 1979). Besides the hands, CHS  can also be seen in the face and 
ears (caused by cosmetics and medicaments), feet (after direct contact with the offending 
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material, most frequently chromate-tanned leather, rubber and glues; Podmore, 1995), and rest 
of the body as a consequense of textile dyes and formaldehyde-releasing textile resins (Fowler 
et al., 1992). Common high-risk occupations for CHS, common allergens associated with 
CHS, and the chemicals studied in this thesis, are shown in table 2, 3, and 4, respectively. 
 
Table 2  
Common high-risk occupations for CHS (Fregert, 1975). 
Adhesives/plastic workers Horticulturists 
Agriculturalists Leather tanners 
Cement casters Painters 
Construction workers Pharmaceutical/chemical workers 
Glass workers Rubber workers 
Graphic workers Textile workers 
Hairdressers Tilers 
Health care workers Wood workers 
 
Table 3 
Common allergens associated with CHS.  
poison ivy, poison oak, poison sumac 
other plants  
nickel or other metals  
antibiotics, especially those applied to the surface of the skin (topical antibiotics)  
rubber and latex  
cosmetics  
topical anesthetics or other medications that are applied to the surface of the skin 
detergents 
solvents 
adhesives  
fragrance, perfumes 
other chemicals and substances 
 
Table 4 
Compounds used in this thesis.  
Allergens (alphabetical order) Sources of exposure 
Benzocaine  Topical medicament 
Dibenzothiazyldisulfide (MBTS) Production of natural rubber latex 
Diethylamine (DEA) Production of natural rubber latex 
Dipentamethylenethiuramdisulfide (PTD) Production of natural rubber latex 
Dipentamethylenethiuramtetrasulfide (PTT) Production of natural rubber latex 
Dinitrochlorobenzene (DNCB) Production of azo dyes, fungicides, rubber chemicals, 
and explosives 
Hexylcinnamic aldehyde (HCA) Aroma chemical 
Mercaptobenzothiazole (MBT) Production of natural rubber latex 
Oxazolone  Color former 
Phtalic anhydride (PA) Production of alkyd resins and epoxy resins 
Tetrabutylthiuramdisulfide (TBTD) Production of natural rubber latex 
Tetraethylthiuramdisulfide (TETD) Production of natural rubber latex 
Tetramethylthiuramdisulfide (TMTD) Production of natural rubber latex 
Tetramethylthiurammonosulfide (TMTM) Production of natural rubber latex 
Toluene diisocyanate (TDI) Production of paints and polyurethane foams 
Trimellitic anhydride (TMA) Production of polyester 
Zinc dibutyldithiocarbamate (ZDBC) Production of natural rubber latex 
Zinc diethyldithiocarbamate (ZDEC) Production of natural rubber latex 
Zinc dimethyldithiocarbamate (ZDMC) Production of natural rubber latex 
Zinc mercaptobenzothiazole (ZMBT) Production of natural rubber latex 
Zinc pentamethylenedithiocarbamate (ZPC) Production of natural rubber latex 
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AIM AND DESIGN OF THIS THESIS 
 
The scope of this thesis is to evaluate the process of risk assessment for sensitizing potency of 
low molecular weight chemicals, pertaining to both in vivo and in vitro approaches. The 
identification of sensitizing activity of chemicals is carried out on a large scale, and is 
performed using animal models. In general, these tests are aimed at identifying allergens. Risk 
assessment requires, however, besides hazard identification, also the assessment of the 
sensitizing potency of allergens. A major limitation to immunotoxicity risk assessment is the 
current lack of adequate human data. 
In chapter 2, we used an approach based on dose-response relationships to quantify 
the sensitizing capacity of ten known allergens. This approach comprises non-linear regression 
analysis of data from a modified LLNA. Chemicals that elicit a stimulation index (SI) of 3 or 
more in the LLNA are considered as being sensitizers. At an SI=3, the corresponding 
concentrations (EC3) were calculated and used for classification of the sensitizers based on the 
sensitizing potency. In addition, confidence intervals were determined to take account of the 
quality of the particular data set.  
The standard GPMT gives a qualitative assessment rather than a quantitative evaluation 
as does the LLNA. To make a proper comparison between these two tests, we investigated the 
possibility for potency evaluation in the GPMT (chapter 3). With the employment of a 
multiple dose-response design, we evaluated the allergenic potency of three sensitizers and 
compared the ranking with the order of sensitizing potency seen in the LLNA. Chapter 4 
describes the method we used in chapter 2 in order to assess the allergenic potency of 
chemicals used in the production of latex medical gloves.  
Besides hazard identification and relative potency evaluation, knowledge of the 
influence of exposure duration is necessary for an effective assessment of risk. We investigated 
if prolonged (2 months) exposure to low concentrations of allergens that do not induce an SI ≥ 
3 in the LLNA, were able to surpass this threshold in order to investigate the influence of 
repeated antigen exposure (chapter 5).  
The LLNA can also be used to discriminate skin sensitizers from respiratory sensitizers. 
Contact sensitizers have been shown to selectively induce Th1 responses (IFNγ) production, 
whereas Th2 responses (IL-4, IL10), were seen after exposure to respiratory allergens. In 
general, these comparisons are based on single concentrations. Chapter 6 describes an 
approach that directly links the cytokine production to the proliferation of the same cells, to 
discriminate between respiratory and contact allergens independently of the choice of the 
concentrations used.  
There is, as yet, no accepted in vitro method for the identification of skin sensitizing 
chemicals. In the following chapters we tried to develop approaches, without the use of 
laboratory animals, to evaluate the sensitizing capacity of an allergen. In the study described in 
chapter 7, we sought to estimate the sensitizing potency of allergens solely based on their 
physico-chemical properties. The hypothesis that the irritant capacity of allergens presents an 
additional risk factor, suggests that evaluating irritant potency of allergenic chemicals may be 
helpful to establish their allergenic potency. Epidermal keratinocytes are known to produce and 
excrete a wide range of cytokines. The anatomical location of keratinocytes and their 
significant role in the development of CHS justifies the use of keratinocyte-derived cytokine 
production as read-out to evaluate sensitizing potency. In chapter 8 we determined the 
sensitizing potency of chemicals as a function of keratinocyte cytokine expression. Cytokine 
dose-response data were evaluated in a murine keratinocyte cell line by non-linear regression 
analysis and at a stimulatory index (SI) of three the corresponding estimated concentration was 
calculated (EC3). We used these EC3 values to rank these chemicals and to compare the 
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outcome of the present study with those obtained from the local lymph node assay (LLNA). 
Chapter 9 extends the latter study by evaluating cytokine dose-response data in a human 
keratinocyte cell line. These data may tell us whether the ranking based on the cytokine 
responses in the human keratinocyte cell line is in accordance with the ranking derived in the 
mouse (both in vitro as in vivo). In addition, it provides information about the differences in 
sensitivity between the different species (man vs mouse). Based on the combined comparison 
of these results, an improved extrapolation from animals to humans may be achieved. Finally, 
conclusions of the findings in the preceding chapters are summerized and discussed in chapter 
10. 
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CHAPTER 2 
 
 
A QUANTITATIVE METHOD FOR ASSESSING THE SENSITIZING 
POTENCY OF LOW MOLECULAR WEIGHT CHEMICALS USING A 
LOCAL LYMPH NODE ASSAY: EMPLOYMENT OF A REGRESSION 
METHOD THAT INCLUDES DETERMINATION OF  
THE UNCERTAINTY MARGINS 
 
François M.M. van Och, Wout Slob, Wim H. de Jong,  
Rob J. Vandebriel, Henk van Loveren 
 
 
 
Risk assessment of sensitizing chemicals requires besides hazard identification, the 
assessment of potency. To examine the sensitizing capacity of low molecular weight 
chemicals, a murine local lymph node assay (LLNA) was used. The sensitizing capacity of 
known allergens was quantified by dose-response modeling. At a stimulatory index (SI) of 
three, the corresponding estimated concentration was calculated (EC3), together with a 
confidence interval to take account the quality of the particular data set. We tested ten 
allergens (ethyl-p-aminobenzoate (benzocaine), diethylamine (DEA), 2,4- 
dinitrochlorobenzene (DNCB), 2- mercaptobenzothiazole (MBT), 4-ethoxymethylene 2- 
phenyloxazol-5-one (oxazolone), phthalic anhydride (PA), toluene diisocyanate (TDI), 
trimellitic anhydride (TMA), tetramethyl thiuram disulfide (TMTD) and zinc dimethyl 
dithiocarbamate (ZDMC)). Oxazolone showed the strongest sensitizing potency followed in 
this order by DNCB, TDI, TMA, PA, TMTD, ZDMC, MBT, benzocaine and DEA. The 
approach performed in this study is a way to accurately assess the potency of sensitizing 
chemicals and thus a possibility for classification. 
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INTRODUCTION 
 
Methods for the identification of sensitization hazards have been available for many years. The 
tests most commonly used to identify skin sensitizing capacity are the guinea pig maximization 
test (GPMT) using adjuvant  (Magnusson and Kligman, 1969) and the occluded patch test of 
Buehler without adjuvant (Buehler, 1965) in the guinea pig. More recently, the murine local 
lymph node assay (LLNA) (Kimber et. al., 1986; Kimber and Weisenberger, 1989; Kimber and 
Basketter, 1992) was introduced and validated for various chemicals. The results obtained in 
these tests give the possibility for labeling and classification of sensitizing chemicals. 
 The GPMT has been used as the preferred method for predicting skin sensitization for 
over 25 years since it was first described. Although the GPMT is able not only to detect 
chemicals with moderate and strong sensitizing potential but also chemicals with relatively 
weak sensitizing potential (Robinson, 1990), it has its drawbacks compared to the LLNA. In 
contrast to the GPMT the LLNA is able to detect allergic potency based on a quantitative 
endpoint instead of visual (semi-quantitative) assessment of challenge induced erythema. 
Moreover, the GPMT has disadvantages including the use of an adjuvant and the length and 
complexity of the test. 
 The LLNA is a method for the predictive identification of chemicals that have the 
potential to cause sensitization. In the LLNA assessment of immune reactivity of an immune 
(allergy) response is determined in the induction phase. The uptake of [3H]TdR by the local 
lymph node cells, as a response to the application of the test chemical to the mouse ear, is a 
measure for the immune response and thus can be used  as a measure of sensitization. 
 Lymph node proliferative responses of treated animals are compared to those of non-
treated or vehicle-treated animals. Chemicals that elicit a stimulation index (SI) of 3 or more in 
the LLNA are considered as being sensitizers. Currently, these EC3 (estimated concentration in 
% required for SI=3) values are used for the comparison of sensitizing potential derived from 
local lymph node responses (Kimber et al., 1995; Kimber and Basketter, 1997; Loveless et al., 
1996). In the GPMT the potency is based on the percentage of positive animals using a single 
dose. However, for determination of the potency based on lowest effective dose levels, dose-
response studies are required. In the GPMT both for the induction and challenge phase dose-
response studies would be needed. As the LLNA gives a more quantitative result, we feel that 
the LLNA is more suited for estimation of lowest effective doses in a dose-response study. To 
increase the sensitivity of the LLNA for weak allergens all animals were pretreated with 
sodium dodecyl sulphate (SDS).  
 In this study the known sensitizers ethyl-p-aminobenzoate (benzocaine), diethylamine 
(DEA), 2,4- dinitrochlorobenzene (DNCB), 2- mercaptobenzothiazole (MBT), 4-
ethoxymethylene 2- phenyloxazol-5-one (oxazolone), phthalic anhydride (PA), toluene 
diisocyanate (TDI), trimellitic anhydride (TMA), tetramethyl thiuram disulfide (TMTD) and 
zinc dimethyl dithiocarbamate (ZDMC) were evaluated.  
 
METHODS 
 
Animals 
Young adult (6-8 weeks old) male/female BALB/c strain mice were used for the experiments. 
They were obtained from our own breeding colony. The animals were bred specific pathogen 
free and kept under conventional conditions. The mice were fed Hope Farms chow pellets 
(Woerden, NL) and water ad libitum. 
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Chemicals 
Benzocaine (ethyl-p-aminobenzoate; 99% purity; Sigma-Aldrich Chemie B.V., Zwijndrecht 
NL), DEA (diethylamine; 99.5%; free base solution; Sigma-Aldrich), DNCB (2,4-
dinitrochlorobenzene; 98%; Sigma-Aldrich), MBT (2-mercaptobenzothiazole; 98%; Sigma-
Aldrich), oxazolone (4-ethoxymethylene 2- phenyloxazol-5-one; 90%; Sigma-Aldrich), PA 
(phthalic anhydride; 99%; Sigma-Aldrich), TDI (toluene 2,4-diisocyanate; 99.8%; Sigma-
Aldrich), TMA (trimellitic anhydride; 1, 2, 4- benzenetricarboxylic anhydride; 97%; Sigma-
Aldrich), TMTD (tetramethylthiuramdisulfide; 98%; Sigma-Aldrich) and ZDMC 
(zincdimethyldithiocarbamate; 90%; Fluka, Zwijndrecht NL) were tested in 4:1 acetone/olive 
oil (AOO). SDS (sodium dodecyl sulphate; >99%; Merck B.V., Amsterdam, NL) was 
dissolved in 4:1 acetone/olive oil (AOO). 
 
 
Table 1 
Concentrations used in the local lymph node assay (LLNA)  
Chemical % Concentration n 
Benzocaine 7.5, 15, 22.5, 30 6 
DEA 2.5, 5, 10, 20, 40 3 
DNCB 0.05, 0.1, 0.25, 0.5, 1 3 
MBT 0.1, 1, 5, 10, 17.5 4 
Oxazolone 0.0004, 0.0012, 0.0037, 0.011, 0.033, 0.1 3 
PA 0.25, 1, 2.5, 10, 25 3 
TDI 0.25, 0.5, 1, 2.5, 5 3 
TMA 2.5, 5, 10, 25, 50 3 
TMTD 0.0312, 0.0625, 0.125, 0.25, 0.5, 1 3 
ZDMC 0.375, 0.75, 1.5, 3, 6 3 
n= number of animals (per concentration) 
 
 
Local lymph node assay (LLNA) 
Groups of mice (n= 3,4, or 6) were pretreated with 1% SDS (w/v) one hour before exposing 
the animals to 25 µl of test solution in vehicle or vehicle alone on both ears daily for three 
consecutive days. A positive response is not seen at the SDS concentration that we used (1%). 
However, application of 1% SDS and the test chemical generally resulted in an increased 
response compared to the test chemical alone (data not shown).  
The concentrations of the test chemicals used are presented in Table 1. Three days 
following the last topical application, the auricular lymph nodes were excised. The lymph 
nodes were weighed and pooled for each animal and suspended in 5 ml RPMI- 1640 (Gibco, 
Breda, NL) supplemented with 5% heat inactivated Fetal Calf Serum (PAA, Linz, Austria), 
100 U/ml penicillin and 100 µg/ml streptomycin (standard medium). Single cell suspensions 
were prepared under aseptic conditions by pressing the lymph node through a sterile 70 µm 
nylon cell strainer (Falcon, Franklin Lakes, USA). The cells were washed twice in standard 
medium (10 minutes, 311g, 4°C) and resuspended in 1 ml standard medium with 10% FCS. 
The cells were counted using a Coulter Counter (Coulter Electronics, Mijdrecht, NL) and 
cultured at a concentration of 1.107 cells/ml. When necessary, cell suspensions of several 
animals were pooled to obtain the concentration required. The cell suspensions (200 µl) were 
seeded in triplicate into round-bottomed 96-well microtitre plates (Greiner, Alphen a/d Rijn, 
NL). The cells were cultured with 10 µl of [3H]TdR (Amersham, Buckinghamshire, UK; 37 
kBq/ml) for 24 hr at 37°C in a humidified atmosphere of 5% CO2 in air. The [
3H]TdR 
incorporation was determined by liquid scintillation counting in a β plate counter (1205 
BetaplateTM Wallac, Turku, Finland). The [3H]TdR incorporation is expressed per animal, i.e. 
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the [3H]TdR incorporation is multiplied by the cell number of the two lymph nodes and 
devided by the cell number in culture. 
 To study the potency of sensitizers, we have used a range of test concentrations to 
determine dose-response relationships on which the quantitative estimation of the allergic 
potency was based. The estimated concentration in % required for SI=3 (EC3) was determined 
as the estimated dose inducing a stimulation index of three between treated versus control. 
 
Statistical analysis  
The dose-response data were analysed by nonlinear regression analysis, using the following 
family of models: 
model 1:  y  =   a 
model 2: y  =   a exp( b x ) 
model 3: y  =   a exp( b xd) ) 
model 4: y  =   a (c - (c - 1) exp( b x) 
model 5: y  =   a (c - (c - 1) exp( b xd)). 
where y represents the response ([3H]TdR incorporation) and x the applied concentration. 
In these models the parameter a represents the background [3H]TdR incorporation of 
the particular assay. The parameter b reflects the ‘slope’ or the ‘strength’ of the response with 
increasing dose. The selection of the model to be used for a particular data set follows from a 
procedure of successively fitting the above models, and applying likelihood ratio tests to 
establish if an increase in the number of parameters leads to a significantly better fit to the data. 
A model with more parameters is considered better only if this leads to a significantly better fit 
(Slob, 1999). Then the selected model is used to derive the concentration (EC3) associated 
with a stimulation index of 3. The uncertainty in the estimate of the EC3 is assessed by a 
bootstrap method (Slob and Pieters, 1998), resulting in an uncertainty distribution from which 
any desired confidence interval can be derived. In this paper the 5% and 95% confidence limits 
are reported (i.e. 90%-confidence intervals).  
 
RESULTS 
 
The results obtained with the various chemicals are shown in Figure 1. The left panels show 
the [3H]TdR incorporation as a function of the concentration with the fitted regression 
function, and the estimated concentration at a stimulation index of three (EC3) in the [
3H]TdR 
incorporation per animal. The uncertainty distributions for the EC3 values are shown in the 
right panels. The dose-response data were analysed by nonlinear regression analysis. Based on 
the criteria, namely a threefold increase over vehicle control, every compound tested proved to 
be positive and can therefore be regarded as a sensitizer. Differences in potency were observed 
between different chemicals. An exponentially shaped curve was seen for six of the chemicals, 
three of the chemicals showed a sigmoïdally shaped curve and one curve showed a logarithmic 
dose-response profile. These differences in the shapes of the dose-response curves result from 
the selection of the model to be used for the particular data set, as discussed in Section 2.4. 
Lymph node weights and cell counts are presented in Table 2. Based on these data 
DNCB, oxazolone, PA, TDI and TMA are considered as being sensitizers according to the 
criteria for a positive response. ZDMC is regarded as a sensitizer based on the cell counts 
alone. In general, the data in Table 2 shows a ranking quite similar to the data shown in Figure 
1 and presented in Table 3. However, lymph node proliferation instead of lymph node weights 
and cell counts seems to be a better indicator of the sensitizing potential of a chemical, as was 
first suggested by Kimber and Dearman (1991).   
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Table 2 
Lymph node weights and cell counts after epicutaneous treatment of BALB/c mice. 
Chemical % Concentration  
 
Lymph node weight/animal 
(mean ± SD, in mg) 
Cell counts/animal 
 (mean ± SD x 106) 
Benzocaine 0 
7.5 
15 
22.5 
30 
5.20 ± 1.31 
9.22 ± 1.75 
6.87 ± 1.24 
8.67 ± 0.60 
8.69 ± 0.92 
4.91 ± 1.12 
6.83 ± 2.50 
11.04 ± 2.71 
9.77 ± 2.00 
11.07 ± 1.59 
DEA 0 
2.5 
5 
10 
20 
40 
2.42 ± 0.49 
2.63 ± 0.20 
2.65 ± 0.23 
2.82 ± 0.19 
2.87 ± 0.30 
4.20 ± 0.57 
3.09 ± 0.26 
3.20 ± 0.56 
3.18 ± 0.05 
3.87 ± 0.91 
4.12 ± 0.48 
7.54 ± 1.64 
DNCB 0 
0.05 
0.1 
0.25 
0.5 
1 
2.23 ± 0.54 
3.21 ± 0.50 
4.95 ± 0.63 
9.87 ± 1.39 
10.15 ± 0.88 
13.93 ± 1.31 
4.40 ± 1.11 
7.52 ± 1.54 
11.69 ± 0.34 
23.00 ± 3.22 
21.20 ± 5.10 
29.60 ± 5.54 
MBT 0 
0.1 
1 
5 
10 
17.5 
2.91 ± 0.41 
2.93 ± 0.20 
2.95 ± 0.49 
3.70 ± 0.44 
4.00 ± 0.42 
4.24 ± 0.91 
4.22 ± 1.10 
4.62 ± 1.13 
5.07 ± 1.17 
4.78 ± 1.00 
5.61 ± 0.83 
4.80 ± 0.71 
Oxazolone 0 
0.0004 
0.0012 
0.0037 
0.011 
0.033 
0.1 
2.42 ± 0.49 
2.52 ± 0.56 
2.80 ± 0.21 
3.68 ± 0.79 
4.60 ± 0.32 
6.08 ± 0.83 
11.40 ± 1.22 
3.09 ± 0.26 
3.28 ± 0.91 
3.69 ± 0.43 
5.33 ± 0.15 
6.35 ± 1.51 
10.30 ± 2.52 
21.40 ± 2.51 
PA 0 
0.25 
1 
2.5 
10 
25 
2.53 ± 0.46 
4.10 ± 0.58 
5.83 ± 0.90 
6.12 ± 1.55 
10.77 ± 1.43 
11.10 ± 2.56 
5.42 ± 0.91 
9.53 ± 2.00 
13.19 ± 3.61 
16.28 ± 4.12 
25.01 ± 8.36 
29.44 ± 2.10 
TDI 0 
0.25 
0.5 
1 
2.5 
5 
2.75 ± 0.58 
5.17 ± 1.31 
9.78 ± 1.79 
13.57 ± 2.36 
13.13 ± 2.52 
14.30 ± 3.06 
4.60 ± 0.50 
12.78 ± 4.30 
21.72 ± 6.79 
33.20 ± 7.24 
26.71 ± 6.58 
25.57 ± 9.22 
TMA 0 
2.5 
5 
10 
25 
50 
2.23 ± 0.54 
7.78 ± 1.16 
9.68 ± 1.14 
12.37 ± 1.07 
11.20 ± 1.11 
10.73 ± 1.16 
4.40 ± 1.11 
15.29 ± 1.60 
22.00 ± 0.54 
31.04 ± 5.22 
23.70 ± 6.64 
27.91 ± 2.57  
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Chemical % Concentration  
 
Lymph node weight/animal 
(mean ± SD, in mg) 
Cell counts/animal 
 (mean ± SD x 106) 
TMTD 0 
0.0312 
0.0625 
0.125 
0.25 
0.5 
1 
2.87 ± 0.20 
3.38 ± 0.31 
2.70 ± 0.49 
3.15 ± 0.42 
3.27 ± 0.26 
3.95 ± 0.58 
4.75 ± 0.81 
3.43 ± 0.25 
4.43 ± 1.61 
3.38 ± 0.74 
4.25 ± 0.45 
4.36 ± 1.41 
6.23 ± 1.08 
7.06 ± 2.30 
ZDMC 0 
0.375 
0.75 
1.5 
3 
6 
2.87 ± 0.20 
3.28 ± 0.35 
3.47 ± 0.51 
4.78 ± 0.76 
5.35 ± 1.45 
8.02 ± 2.23 
3.43 ± 0.25 
4.94 ± 1.76 
5.00 ± 2.03 
7.61 ± 1.32 
10.50 ± 3.48 
16.00 ± 5.20 
 
 
The EC3 values of [
3H]TdR incorporation per animal and the associated confidence 
intervals derived from the experiments are summarized in Table 3. The chemicals are ranked 
according to their EC3 values. The classification formerly obtained with the GPMT, and the 
LLNA as performed by other groups, and information on whether the test compounds are 
known sensitizers in humans are also presented in Table 3. The ranking according to the 
estimated EC3 values presented in Table 3 is quite similar to the classification derived from 
data formerly obtained in the GPMT and the LLNA. 
  
DISCUSSION 
 
The LLNA is used as a test for predicting sensitization in humans. A chemical that induces an 
SI of three or more is regarded as a sensitizer. Recently, it has been suggested that simple 
linear interpolation between the observed responses on either side of the threefold stimulation 
index provides a robust assessment of the EC3, without the need for recourse to more 
sophisticated statistical techniques (Basketter et. al., 1999). Rather than using the SI of three 
as a cut-off point or limit, our method evaluates all data points (animals) contributing to the 
dose-response curve to determine the EC3. In addition, information on the reliability of the 
data is obtained using the bootstrap approach, providing confidence limits. This renders the 
potency assessment more reliable. Also for very weak sensitizers inducing responses below an 
SI of three, the concentration producing an SI of three can be estimated based on the curve 
fitting method, together with its confidence limits. In such a case very high, and possibly 
unrealistic, sensitizing concentrations may be obtained. 
 It has been reported that the LLNA can detect contact allergens defined as moderate, 
strong or extreme, but not those defined as mild or weak (Basketter and Scholes, 1992). In the 
present study all chemicals reached an SI of three within the observed dose ranges and were 
thus identified as sensitizers. This may be due to the fact that in order to increase the sensitivity 
for weak allergens the animals were pretreated with SDS. This chemical is an example of an 
irritant that can give a positive response in the LLNA (Gerberick et al., 1992; Montelius et al., 
1994). The pretreatment with SDS was done to increase the sensitivity of the LLNA, aiming at 
obtaining positive results for weak allergens. Pretreatment with SDS combined with 
application of the chemical showed an increased reponse compared to treatment with the 
chemical alone. In addition, the application of 1% SDS only gave no stimulation in the LLNA 
(data not shown). 
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Figure 1  
Local lymph node dose response curves. Left panels: [3H]TdR incorporation (cpm per animal) of the local 
lymph node cells as a function of concentration (dots refer to individual animals; lines refer to averages per 
concentration), with fitted regression function at a stimulation index of three and the estimated EC3 values (in 
%). The models used for fitting were model 2 for benzocaine (A), DEA (B), MBT (D), TMTD (I) and ZDMC 
(J); model 3 for oxazolone (E); model 4 for DNCB (C), TDI (G) and TMA (H); model 5 for PA (F). Right 
panels: the associated uncertainty distribution (obtained with 500 bootstrap runs from the fitted regression 
function) for the EC3 values, shown on a linear scale (upper graph) and a log-scale (lower graph). 
 
 
Oxazolone was the most potent sensitizer in this study with an estimated EC3 of 
0.013% and an uncertainty range of 0.004-0.025%. This is approximately one order of 
magnitude higher than previous findings in the LLNA with predicted values ranging from 
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0.0007 to 0.0026% (Loveless et al., 1996). DNCB, known to cause allergic contact dermatitis 
in man (Kligman and Epstein, 1959), showed an estimated EC3 of 0.044%, consistent with 
earlier findings obtained in several laboratories (Kimber et al., 1995; Loveless et al., 1996). 
Also TDI, TMA, PA and TMTD showed an estimated EC3 below 1%. PA and TMA can 
penetrate the skin of humans and thus have the potential to elicit an allergic reaction of the skin 
(Bernstein et al., 1982). The contact sensitivity of TDI has also been demonstrated by some 
epidemiological investigations and animal experiments (Malten, 1979; Tominaga et al., 1985). 
TMTD is regarded as a moderate sensitizer based on the results obtained in the GPMT 
(Magnusson and Kligman, 1969; 1970). This was also found for ZDMC (Matsushita et al., 
1977; 1978). Besides, it has been reported that ZDMC as well as DEA, MBT and TMTD are 
able to cause allergic contact dermatitis by rubber gloves in humans (Kaniwa et al., 1993). In 
summary, all the chemicals tested in this paper have proven their sensitizing potency based on 
experimental and/or clinical data. 
 
 
Table 3 
The EC3 values and uncertainty distribution of the chemicals tested, classification of chemicals in the local 
lymph node assay (LLNA) and the guinea  pig maximization test (GPMT), and information on sensitizing 
capacity in humans. 
   Classification of sensitizing potential1  
Chemical EC3 (%) L05-L95* GPMT LLNA Human 
Oxazolone 0.013 0.004-0.025 Extreme2 +3   NA 
DNCB 0.044 0.025-0.078 Extreme +   Yes10 
TDI 0.109 0.048-0.263 NA +8   Yes11 
TMA 0.218 0.128-0.405 Moderate +   Yes12 
PA 0.357 0.226-0.560 Extreme +   Yes12 
TMTD 0.659 0.554-0.815 Moderate4 ±6   Yes13 
ZDMC 2.670 1.631-8.326 Moderate5 NA   Yes13 
MBT 9.669 8.020-12.189 Moderate4 ±6   Yes13 
Benzocaine 22.026 16.576-33.953 Mild4/ Moderate −1/±9   Yes14 
DEA 39.784 34.078-47.703 NA NA   Yes13 
*; 5th and 95th percentile 
1; Basketter and Scholes (1992), except where indicated 
2; Gad et al. (1986) 
3; Loveless et al. (1996) 
4; Magnusson and Kligman (1969, 1970) 
5; Matsushita et al. (1977, 1978) 
6; Ikarashi  et al. (1993) 
8; Dearman et al. (1996), (SI=12 for TDI 0.75%) 
9; Basketter et al. (1995) 
10; Kligman and Epstein (1959) 
11; Malten (1979), Tominaga et al. (1985)   
12; Bernstein et al. (1982) 
13; Kaniwa et al. (1993) 
14; Cronin (1980) 
NA; data not available 
+; strong, ±; moderate, −; weak 
EC3; estimated concentration in % required for SI=3 
 
 
The magnitude of the effect in the animal is estimated from the dose-response data obtained 
from the LLNA. The endpoint of the LLNA is proliferation per animal measured by [3H]TdR 
incorporation and the criteria for a positive response is a threefold increase in proliferation 
over vehicle control. The precision of the estimated EC3 is mainly governed by the total 
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number of animals in the study. In most cases, three animals per group and five concentrations 
were used. Testing more concentrations benefits the benchmark approach (Slob and Pieters, 
1997), making the results more reliable. More reliable results can be obtained by increasing the 
number of concentrations investigated and, compared to conventional toxicology, reducing the 
number of animals per group. However, a minimum of 3 animals per group seems warranted in 
order to exclude individual extreme (outlier) responses.  
 The chemicals tested can now be ranked based on the results presented in this paper. 
The ranking of the chemicals shown in Table 3 is quite similar to the ranking according to their 
sensitizing potential in the GPMT, and LLNA established by other groups. An exception is the 
relative potency of TMA and PA; the former is classified as more potent according to our 
approach, whereas the GPMT identifies PA as the more potent sensitizer (Basketter and 
Scholes, 1992). Benzocaine and TMTD are both known as moderate sensitizers in the 
classification of sensitizing potential performed in the GPMT and the LLNA (Table 3). 
However, according to the data presented in this paper EC3 values showed a considerable (30-
fold) difference between these two sensitizers. So, a more accurate distinction can be made 
between benzocaine and TMTD in terms of classification as sensitizers. In addition, the 
observed differences in EC3 values also have an impact when doing risk assessment for these 
compounds. The quality of the data is translated to uncertainty margins which benefits the 
comparison between the sensitizers. For reasons of safety it would be better to make use of the 
calculated 5% confidence limit instead of the point estimate of the EC3. The lower 5% 
confidence limit, predicts that below that particular dose there still is a 5% chance for a 
positive response in the test with an SI of three. It should be kept in mind that even when 
sensitizers are classified as strong inducers of allergy, the actual risk for developing allergy is 
also determined by exposure. 
 In conclusion, the sensitizing potential of ten chemicals was evaluated using a dose-
response analysis for LLNA data. The sensitization ability was expressed as the concentration 
able to elicit a stimulation index of three compared to the vehicle control. The sensitizing 
potential of oxazolone was strongest, followed by DNCB, TDI, TMA, PA, TMTD, ZDMC, 
MBT, benzocaine and DEA. The approach performed in this study is a way to accurately 
assess the potency of sensitizing chemicals. This enables the estimation of the lowest 
concentration needed for sensitization, and to use these data for risk evaluation. 
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CHAPTER 3 
 
 
COMPARISON OF DOSE-RESPONSES OF CONTACT ALLERGENS 
USING THE GUINEA PIG MAXIMIZATION TEST AND  
THE LOCAL LYMPH NODE ASSAY 
 
François M. M. van Och, Rob J. Vandebriel, Menk K. Prinsen,  
Wim H. de Jong, Wout Slob, Henk van Loveren 
 
 
 
The guinea pig maximization test (GPMT) has been used as a method for the prediction of 
skin sensitizing potential for over 30 years. Besides hazard identification, risk assessment of 
sensitizing chemicals requires the assessment of potency. For the determination of potency 
based on lowest effective dose levels, dose-response studies are required. In the standard 
GPMT a single concentration is used for intracutaneous and topical induction and the assay 
provides a qualitative assessment of allergenicity. This paper presents data derived from 
quantitative evaluation of the sensitizing potency of chemicals in the GPMT, based on 
multiple concentrations. We performed the GPMT in accordance with the original procedure 
of Magnusson and Kligman; and included in this procedure a range of intradermal and 
topical concentrations for induction. Three allergens with different sensitizing potencies, 
diethylamine (DEA), tetramethyl thiuram disulfide (TMTD) and zinc dimethyl 
dithiocarbamate (ZDMC) were tested. The data obtained with this test procedure were 
compared to data we previously obtained using the local lymph node assay (LLNA). Both the 
GPMT and the LLNA showed dose response relationships for the three chemicals tested. For 
the chemicals tested, both tests differed in the relative potencies based on benchmark 
concentrations. While both tests ranked DEA as the least potent allergen, the GPMT ranked 
ZDMC more potent than TMTD, the reverse being found in the LLNA. The nature of the data 
provided in the LLNA makes it likely that benchmarks as defined with this test are more 
reliable than that defined in the GPMT. However, further validation with human data is 
necessary. 
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INTRODUCTION 
 
The guinea pig maximization test (GPMT), that includes Freund's Complete Adjuvant 
(Magnusson and Kligman, 1969), and the occluded patch test of Buehler, that does not use 
adjuvant (Buehler, 1965), are the tests most commonly used to identify skin sensitizing 
capacity. The results obtained in these tests give the possibility for labeling sensitizing 
chemicals. However, risk assessment of sensitizing chemicals requires besides hazard 
identification, the assessment of potency. For the determination of potency based on lowest 
effective dose levels, dose-response studies are required. In the standard GPMT and Buehler 
test a single concentration is used for intracutaneous and/or topical induction and thus gives a 
qualitative assessment rather than a quantitative evaluation of allergenicity.  
An alternative test for assessing skin sensitization potential is the local lymph node 
assay (LLNA) (Kimber et. al., 1986; Kimber and Weisenberger, 1989; Kimber and Basketter, 
1992). The LLNA is a method in which the measurement takes place in the induction phase of 
contact hypersensitivity, rather than the elicitation phase. Besides the advantage of improved 
animal welfare (exclusion of adjuvant, topical application instead of intradermal injection of the 
compound, shorter protocol) the LLNA is, compared to the GPMT, also able to detect 
allergenic potency based on a quantitative endpoint instead of visual (semi-quantitative) 
assessment of challenge induced erythema. The LLNA identifies sensitizing chemicals, and has 
been subject to a validation study (ICVAMM, US Interagency Coordinating Committee on the 
Validation of Alternative Methods, NIH 1999), and on the basis of the outcome will be used as 
a stand-alone test. A next step, besides the identification, is to establish the sensitizing potency 
of allergens. Relative potency determination with the LLNA has been descibed in previous 
papers (Basketter et al., 2000; Van Och et al., 2000).  
In the standard GPMT, a single concentration is used for intracutaneous and/or topical 
induction and thus gives a qualitative assessment rather than a quantitative evaluation of 
allergenicity. To establish the possibility for potency evaluation with the GPMT, we chose to 
make a comparison between the LLNA and the GPMT in this respect. We therefore performed 
dose response studies in both the LLNA and the GPMT. In this paper, we were especially 
focused on the assessment of potency of the different chemicals rather than the identification of 
sensitizers in general.  
In the present study we use a multiple dose-response design for the GPMT, to evaluate 
the allergenic potency derived in the elicitation phase of contact hypersensitivity. The 
sensitizers diethylamine (DEA), tetramethyl thiuram disulfide (TMTD) and zinc dimethyl 
dithiocarbamate (ZDMC) were evaluated in this study. They are used as accelerators in the 
manufacturing of natural rubber latex products such as medical gloves. All three chemicals are 
able to induce allergic contact dermatitis in humans by use of rubber gloves (Kaniwa et al., 
1993). TMTD has been classified as a moderate sensitizer based on the results obtained in the 
GPMT (Magnusson and Kligman, 1969; 1970) and the LLNA (Ikarashi et al., 1993). ZDMC 
has been evaluated using the GPMT only and was also identified as a moderate allergen 
(Matsushita et al., 1977; 1978). Using the LLNA, we recently identified TMTD as the 
strongest sensitizer followed in this order by ZDMC and DEA (Van Och et al., 2000). Based 
on these latter results, TMTD and ZDMC were classified as moderate sensitizers, whereas 
DEA was identified as a weak allergen.  
These three compounds were studied in the GPMT. In the present study both the 
intradermal and the topical induction were applied in an increasing concentration. This 
multiple-dose-response induction protocol provides dose-response relationships that are 
essential for risk assessment of contact allergens. Dose response studies using the GPMT have 
been described by others (Nakamura et al., 1994; Andersen et al., 1995). As read-out of the 
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test, we took into account not only the percentage of reacting animals (as is usually done), but 
also the severity of the responses of the skin, measured at 24 or 48 hours. The maximal skin 
scores for each animal were summed per dose group, resulting in a total skin score. The 
potency of the sensitizing capacity, based on the effective concentrations (i.e. those causing 
minimal detectable skin reactions in the adapted GPMT), were compared to the potency as 
derived in the modified LLNA, performed in a previous study (Van Och et al., 2000).  
 
METHODS 
  
Chemicals 
DEA (diethylamine; 99.5%; free base solution; Sigma-Aldrich Chemie B.V., Zwijndrecht NL), 
TMTD (tetramethyl thiuram disulfide; 98%; Sigma-Aldrich) and ZDMC (zinc dimethyl 
dithiocarbamate; 90%; Fluka, Zwijndrecht NL) were tested in 4:1 acetone/olive oil (AOO). For 
both intradermal injection and topical treatment during the induction phase and for topical 
challenge in the guinea pig maximization test, the chemicals were dissolved in maize oil. 
Freund’s complete adjuvant (FCA) was purchased from Sigma-Aldrich. 
 
 
Table 1 
Selection of the concentrations used in the main test, based on the results of the preliminary test  
Induction* Compound 
Intradermal                     Topical 
Challenge* 
Topical 
DEA 0.3% - 0.01% 10% - 0.3% 30%, 10%, 3% and vehicle 
TMTD 0.3% - 0.01% 30% - 1% 30%, 10%, 3% and vehicle  
ZDMC 0.3% - 0.01% 30% - 1% 30%, 10%, 3% and vehicle  
* Dilution in maize oil 
 
 
The Guinea Pig Maximization Test (GPMT) 
Preliminary Test 
The irritation response to intradermal injection of various concentrations of the test substance 
(3, 1, 0.3 and 0.1%) was examined in three guinea pigs. A sufficiently large area of the flanks 
was clipped free from hair with electric clippers. Amounts of 0.1 ml of the selected 
concentrations were applied by intradermal injection. Approximately 24 hours after injection, 
the animals were examined for signs of irritation. The concentration causing slight to moderate 
irritation but otherwise well tolerated by the animals, is taken for intradermal injection of the 
test substance in the intradermal induction phase of the main study (see Table 1). 
The irritation response to topical treatment of various concentrations of the test 
substance (30, 10, 3 and 1%) was examined in three other guinea pigs. The flanks of each of 
the animals were clipped free from hair with electric clippers. Patches (Silverpatch, ½x½ cm, 
van der Bend B.V., Brielle, the Netherlands) were loaded with the test material and placed on 
the clipped skin of each animal, and covered with a piece of hypoallergenic paper bandage 
(Leukopor) that was secured by elastic adhesive tape (Tensoplast, T.J. Smith and Nephew 
Ltd., Hull, UK). The dressing was left in place for approximately 24 hours. Approximately 24 
and 48 hours after removal of the dressing, the animals were examined for signs of skin 
irritation. The concentration causing slight to moderate skin irritation is chosen for topical 
induction and a non-irritant concentration for topical challenge (see Table 1). 
 
Main Test 
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The experiments were conducted according to the maximization test method as described by 
Magnusson and Kligman (1969, and 1970), and according to OECD guideline no. 406 (1992) 
and EC guideline B.6 (1992). Approximately 3-wk-old, male SPF-outbred albino guinea pigs 
(Crl:(HA)BR) with a body weight range of 175-300 g, were purchased from Charles River 
(Wiga, Sulzfeld, Germany). They were housed in groups of no more than 10 in a mobile 
battery (IFFA CREDO, Someren, The Netherlands), containing four cages with internal 
dimensions of 967 x 512 x 250 mm in a temperature- and humidity-controlled animal room 
with a 12-hr light/dark cycle. Water and food (SDS Special Diets Services, Witham, UK) were 
provided ad libitum. The animals were kept in quarantaine for at least 1 week before the start 
of the study. During this period the health status was checked by clinical observation and 
serological examinations.  
Briefly, the maximization test consists of two induction treatments, namely 
intradermally and topically, followed by a resting period of 14 days, which precedes the 
challenge treatments. Between induction treatments, a 7-day interval was employed. For the 
induction phase, dose response studies were performed with a fixed ratio (100 for TMTD and 
ZDMC and 33 for DEA) of concentrations between the intradermal and topical administration 
(Table 1).  
 
Induction 
Induction was performed in two different ways, firstly by intradermal injection and secondly, 
one week later, by topical application over the injection sites. 
 
a. Intradermal injections 
For this purpose an area of about 24 cm2 of dorsal skin in the scapular region was clipped free 
from hair with electric clippers. Pairs of intradermal injections (0.1 ml each) were made 
simultaneously in the clipped area. The following preparations were injected: 
     
test animals 
- two injections with Freund's Complete Adjuvant (FCA) and saline (1:1), 
- two injections with the selected test concentration, 
- two injections with the selected test concentration and FCA/saline (1:1)  
  
   control animals 
- two injections with FCA/saline (1:1), 
- two injections with the vehicle,  
- two injections with the vehicle and FCA/saline (1:1) 
 
b. Topical application 
Six days after the intradermal injections, the dorsal skin in the scapular region of all test and 
control animals was closely clipped again. On the following day, the induction by topical 
application was performed. The test animals were treated as follows: an approximate 2 x 4 cm 
patch of Whatman No. 3 MM filter paper was loaded with a fixed amount of the selected 
concentration of the test substance. The loaded patch was placed over the sites of the 
intradermal injections. The patch was covered hypoallergenic paper bandage (Leukopor) which 
was then secured by elastic adhesive bandage (Tensoplast), 7.5 cm in width, wound around the 
torso of the animal. The dressing was left in place for approximately 48 hours. The control 
animals were similarly treated with vehicle alone. Skin readings were made directly after 
removal of the patches. 
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 We consider the intradermal and topical phase as the integral induction, and wanted to 
study dose response relations of induction and resulting effect. Hence, we kept the ratio of 
intradermal and topical induction constant for each compound. 
 
Challenge 
The topical challenge with the test substance was carried out 14 days after the start of topical 
induction as follows: an area of 5 x 5 cm on both flanks of each test and control animal was 
clipped free from hair. Patches (Silverpatch, ½x½ cm) were loaded with a fixed amount of the 
test concentration(s) selected and with the vehicle. Subsequently, the loaded patches were 
placed on the clipped area of the flanks of each test and control animal. The patches were 
covered with Leukopor bandage, and held in place by Tensoplast for approximately 24 hours. 
Every animal received all three challenge concentrations as well as vehicle alone (Table 1).  
 
Evaluation 
Skin reactions after challenge were evaluated at 24 and 48 hours after removal of the patches 
containing the test materials. The following ordinal grading scale was used: 0=no visible 
change, 1=discrete or patchy (slight) erythema, 2=moderate and confluent erythema, 3=intense 
(severe) erythema and swelling (Magnusson and Kligman, 1970). The positive results were 
evaluated according to the EC-standards (1993), which states that a substance is considered a 
sensitizer if 30% or more of the test animals show a positive reaction.  
To study the potency of sensitizers in the GPMT, we determined dose-response 
relationships. The scores per animal ranged from 0 to 3. We used 5 animals per group; hence 
the scores per group could range from 0-15. We used a total score of 5 (TS5), i.e. an average 
score of 1, the minimal receivable positive response for each animal, as a cut off value to 
establish the benchmark concentration. The highest score per animal read after either 24 or 48 
hours was used in the statistical analysis. One animal in the lowest dose group of ZDMC died 
intercurrently during the experiment. In that particular dose group a total score of 4, instead of 
5, was used as a cut off value to establish the benchmark concentration.  
 
Local lymph node assay (LLNA) 
The modified LLNA as previously conducted (van Och et. al., 2000) is described here. Groups 
of mice (n=3) were pretreated with 1% SDS (w/v) one hour before exposing the animals to 25 
µl of test solution in vehicle or vehicle alone on both ears daily for three consecutive days. A 
positive response is not seen at the SDS concentration that we used (1%). However, 
application of 1% SDS and the test chemical generally resulted in an increased response 
compared to the test chemical alone (data not shown). Three days following the last topical 
application, the auricular lymph nodes were excised. The lymph nodes were weighed and 
pooled for each animal and suspended in 5 ml RPMI- 1640 (Gibco, Breda, NL) supplemented 
with 5% heat inactivated Fetal Calf Serum (PAA, Linz, Austria), 100 U/ml penicillin and 100 
µg/ml streptomycin (standard medium). Single cell suspensions were prepared under aseptic 
conditions by pressing the lymph node through a sterile 70-µm nylon cell strainer (Falcon, 
Franklin Lakes, USA). The cells were washed twice in standard medium (10 minutes, 311g, 
4°C) and resuspended in 1 ml standard medium with 10% FCS. The cells were counted using a 
Coulter Counter (Coulter Electronics, Mijdrecht, NL) and cultured at a concentration of 1.107 
cells/ml. When necessary, cell suspensions of several animals were pooled to obtain the 
concentration required. The cell suspensions (200 µl) were seeded in triplicate into round-
bottomed 96-well microtitre plates (Greiner, Alphen a/d Rijn, NL). The cells were cultured 
with 10 µl of [3H]TdR (Amersham, Buckinghamshire, UK; 37 kBq/ml) for 24 hr at 37°C in a 
humidified atmosphere of 5% CO2 in air. The [
3H]TdR incorporation was determined by liquid 
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scintillation counting in a β plate counter (1205 BetaplateTM Wallac, Turku, Finland). The 
[3H]TdR incorporation is expressed per animal; i.e. the [3H]TdR incorporation is multiplied by 
the cell number of the two lymph nodes and devided by the cell number in culture. 
 To study the potency of sensitizers, we have used a range of test concentrations to 
determine dose-response relationships on which the quantitative estimation of the allergic 
potency was based. The estimated concentration in % required for SI=3 (EC3) was determined 
as the estimated dose inducing a stimulation index of three between treated versus control. 
 
RESULTS 
 
The mean scores for erythema and oedema as well as the summation over all animals of the 
highest score per animal, are shown for DEA, TMTD and ZDMC in tables 2-4, respectively. 
Because topical application of 30% DEA showed irritation in one of the test animals in the 
preliminary test (data not shown), a 10%-0.3% range was used in the induction phase for this 
compound, whereas a 30%-1% range was used for TMTD and ZDMC. The concentrations 
used during the intradermal phase was 100-fold higher for TMTD and ZDMC and 33-fold 
higher for DEA compared to the topical induction. As the intradermal induction phase is the 
dominant determinant of sensitization and topically sensitization only minimally contributes to 
the sensitization rate (Andersen et al., 1984; Rohold et al., 1991), we have plotted the 
intradermal induction concentration on the horizontal axis (Figure 1).  
 
 
Table 2 
Results of the GPMT with DEA (n=5). The positive number of animals and total skin response are shown. The 
highest score read after 24 or 48 hours was taken. The total score (TS) is the summation of each score for all 
animals. Every animal received all three challenge concentrations as well as vehicle alone. 
Challenge concentrations 
30% 10% 3% vehicle 
 
Induction 
Concentrations (%)a 24h 48h TS 24h 48h TS 24h 48h TS 24h 48h TS 
0.3 + 10  2  3  5 1  1  2 0 1  1 0 0 0 
0.1 + 3  3  3  4 1  1  3 0 1  1 0 0 0 
0.03 + 1  2  0 3 1  0 1 1  0 1 0 0 0 
0.01 + 0.3  4  1  4 0 0 0 1  0 1 0 0 0 
0 + 0  0 0 0 0 0 0 0 0 0 0 0 0 
a intracutaneous and topical, respectively, see Table 1 
 
 
No skin reactions were seen in the control group after administration of 30% DEA in 
the challenge. Both TMTD and ZDMC showed positive responses in the control groups after a 
challenge application of 30%. Therefore, we used data derived after challenge administration 
of 10% for both chemicals where none of the control animals showed positive skin reactions. 
In addition, no skin responses were seen after application of vehicle alone in the challenge 
phase, in any of the animals tested (Table 2-4).  
The maximal skin scores for each animal were summed per dose group, resulting in a 
total skin score. All three chemicals showed a decline of the number of positive animals after 
decreasing the challenge concentration as well as less severe responses per animal resulting in a 
decrease in the total skin score. The potency of the sensitizing capacity, based on the effective 
concentrations (i.e. those causing minimal detectable skin reactions in the GPMT), were 
compared to the potency as derived in a modified LLNA, performed in a previous study (Van 
Och et al., 2000). These estimated concentrations after intrapolation at a total skin score of 5 
(TS5) are summarized in Table 5. The chemicals are ranked according to their TS5 values.  
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Table 3 
Results of the GPMT with TMTD (n=5). The positive number of animals and total skin response are shown. 
The highest score read after 24 or 48 hours was taken. The total score (TS) is the summation of each score for 
all animals. Every animal received all three challenge concentrations as well as vehicle alone. 
Challenge concentrations 
30% 10% 3% vehicle 
 
Induction 
Concentrations (%)a 24h 48h TS 24h 48h TS 24h 48h TS 24h 48h TS 
0.3 + 30  5  5  12 4  5 7 3 2 4 0 0 0 
0.1 + 10  5 5  11 4  4 8 4 3 6 0 0 0 
0.03 + 3  5  4  8 3  1 4 1 0 1 0 0 0 
0.01 + 1  2  2  2 1 0 1 0 1 1 0 0 0 
0 + 0  4  2  4 0 0 0 0 0 0 0 0 0 
a intracutaneous and topical, respectively, see Table 1 
 
 
The data formerly obtained with the LLNA, being the EC3 values of [
3H]TdR 
incorporation per animal (van Och et. al., 2000), are also shown in Table 5. The lowest TS5 
value derived from analysis of the GPMT dose response data was seen for ZDMC (0.01%), 
followed in this order by TMTD (0.05%) and DEA (0.30%). The ranking according to the 
estimated TS5 values is somewhat different compared to the classification formerly obtained 
with the LLNA. The allergen DEA showed to be the least potent sensitizer in both tests. The 
allergen ZDMC showed a stronger response than TMTD in the GPMT performed here, but the 
sensitizing potential of ZDMC in the LLNA was weaker compared to the sensitizing response 
of TMTD.    
 
 
Table 4 
Results of the GPMT with ZDMC (n=5). The positive number of animals and total skin response are shown. 
The highest score read after 24 or 48 hours was taken. The total score (TS) is the summation of each score for 
all animals. Every animal received all three challenge concentrations as well as vehicle alone. 
Challenge concentrations 
30% 10% 3% vehicle 
 
Induction 
Concentrations (%)a 24h 48h TS 24h 48h TS 24h 48h TS 24h 48h TS 
0.3 + 30  4  5  11 4 5  9 2  2  4 0 0 0 
0.1 + 10  5  3 9 4 0 7 0 0 0 0 0 0 
0.03 + 3  5  4  9 4 4  6 1  1  2 0 0 0 
0.01 + 1b  3 3  6 2 1  4 1  1  2 0 0 0 
0 + 0  4 3  6 0 0 0 0 0 0 0 0 0 
a intracutaneous and topical, respectively, see Table 1 
b n=4, one animal died 
 
 
DISCUSSION 
  
In the GPMT, ZDMC showed the strongest sensitizing potency followed by TMTD and DEA. 
The LLNA showed that the sensitizing potential of TMTD was strongest, followed by ZDMC 
and DEA (van Och et. al., 2000). Hence, the ranking of the chemicals in the LLNA is not the 
same as the ranking according to their sensitizing potency in the GPMT as shown in Table 5. 
Both GPMT and LLNA are used for risk assessment of sensitizing chemicals, but the 
question which of the tests is more relevant for the assessment of risk in man, remains to be 
established. The fact that ZDMC is a more potent sensitizer compared to DEA in man was 
confirmed in a recent article by Knudsen et. al. (2000). In the latter paper, the distribution of 
positive patch test reactions to rubber accelerators was evaluated in 25 patients. For ZDMC, 8  
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out of 25 patients showed a positive patch test reaction while 1 out of 25 patients showed a 
positive patch test reaction for DEA. This finding is in accordance with our findings both in the 
GPMT and the LLNA. 
In our view, including a dose-response analysis in the GPMT provides us a more 
accurate assessment of the potency of sensitizing chemicals. It enables a better estimation of 
the lowest concentration needed for sensitization. More reliable results may be obtained by 
increasing the number of concentrations investigated, by simultaneously reducing the number 
of animals per group. This allows testing of a wider range of doses and will give a better 
characterization of the shape of the dose response curve. Of course, it should be kept in mind 
that the actual risk for humans to develop allergy depends on many factors. Besides the 
concentration, the frequency and duration of exposure and the condition of the human skin are 
important factors.   
A drawback of the GPMT, compared to the LLNA, is that skin scores are provided on 
an ordinal scale. Although dose-response modelling of ordinal data is by itself possible, the 
results of such an analysis are less easily interpreted. Further, ordinal data contain less 
information than quantitative (continuous) measures, such as the observed [3H]TdR 
incorporation in the LLNA test. Indeed, dose-response modelling of the ordinal data from the 
GPMT was not as successful as the dose-response modelling of the LLNA results, and we 
decided to apply the simple method of plotting the sum of the scores against the induction 
dose. Clearly, this rough method results in an estimate of a benchmark dose that is less precise 
than that resulting from the analysis of the LLNA results. For that reason it may be 
hypothesized that the ranking of sensitizing chemicals is more reliable when based on a LLNA.  
As cut off point we arbitrarily chose 5, which signifies the sum per group of the 
average minimal positive skin score of the animals. A skin score of 1 is the minimal positive 
score in the GPMT.  It should be mentioned that the TS5 concentrations derived in the GPMT 
are much lower compared to the EC3 values in the LLNA. This may imply that the GPMT is 
more sensitive than the LLNA due to the disparities in procedure; i.e. different species, use of 
adjuvant, both intradermal and topical application of the chemical in the GPMT versus topical 
application in the LLNA and use of different vehicles. This latter issue may be especially 
important for detection of weak sensitizers.  
All three chemicals showed a decline in the number of positive animals as well as 
decreased severity after decreasing the challenge concentration, resulting in a decreased total 
skin score. Obviously, the choice of the challenge concentration is crucial for the outcome of 
the test. Both TMTD and ZDMC, showed negative skin responses after topical application of 
30% in the preliminary test. However, in the main test, topical application of this concentration 
showed positive animals, i.e. both chemicals scored four out of five read after 24 hours. These 
disparities are most likely due to interexperimental variation. Using a range of challenge 
concentrations allowed us to use the maximal non-irritant challenge concentration to evaluate 
these results. 
 
 
Figure 1 
Dose response curves for DEA (a), TMTD (b) and ZDMC (c) using the GPMT with a multiple dose design. 
The dose response curves are based on maximal skin responses taken after 24 or 48 hours per animal. A 
challenge concentration of 10% was taken for ZDMC and TMTD, while a challenge concentration of 30% was 
taken for DEA. A total score of 5 (TS5), i.e. an average score of 1 for each animal was used, as a cut off value to 
establish the benchmark concentration. 
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Table 5 
The guinea pig maximization test (GPMT) derived concentrations (TS5) versus the local lymph node assay 
(LLNA) derived EC3.         
GPMT LLNA# Chemical 
TS5 (%)  EC3 (%) 
ZDMC  0.01  2.670 
TMTD 0.05  0.659 
DEA 0.30  39.784 
# Van Och et al. (2000) 
EC3: estimated concentration in % required for SI=3. 
TS5: estimated (intradermal) concentration in % required for a total skin score of 5. 
 
 
In conclusion, the sensitizing potential of DEA, TMTD and ZDMC was evaluated 
using a dose-response analysis for the GPMT with a multiple-dose-design and was compared 
to the outcome of the LLNA test for the same chemicals. The GPMT and LLNA differed in 
the benchmark concentrations for the chemicals tested. While both tests ranked DEA as the 
least potent allergen, the GPMT ranked ZDMC more potent than TMTD, the reverse being 
found in the LLNA. The LLNA gives a more quantitative result on which regression analysis 
can be performed. Yet, the GPMT appears to reveal sensitization at lower concentrations, and 
may therefore be more sensitive. Further validation with human data is therefore necessary.  
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CHAPTER 4 
 
 
RANKING OF ALLERGENIC POTENCY OF LATEX CHEMICALS  
IN A MODIFIED LOCAL LYMPH NODE ASSAY 
 
Wim H. de Jong, François M.M. van Och, Constance F. Den Hartog Jager, 
Sander W. Spiekstra, Rob J. Vandebriel, Henk van Loveren 
 
 
 
A modified local lymph node assay (LLNA) with ex vivo tritium thymidine (
3
H-TdR) labelling 
of the proliferating lymph node cells was used for determination of the allergenic potency of 
chemicals used in the production of rubber for latex medical gloves. Fifteen chemicals, known 
to induce contact hypersensitivity reactions in man, including various thiuram, carbamate, 
and benzothiazole compounds and one amine were tested. The EC3 (effective concentration 
inducing a threefold increase in proliferation of lymph node cells (stimulation index, SI=3)) 
was calculated with non-linear regression analysis, including a bootstrap method for 
determination of the 5%-95% confidence interval of the EC3 value. This procedure identified 
14 out of the 15 chemicals tested as sensitiser, while for one chemical, ZDBC, no EC3 could 
be calculated due to low responses and a lack of a dose response relationship in the data 
obtained. The ranking order of the chemicals with increasing EC3 values (and thus decreasing 
allergenic potency) was found to be: ZDEC, TMTD, TETD, ZPC, ZDMC, MBTS, PTD, 
TMTM, MBT, MBI, PTT, ZMBT, TBTD, DEA, and ZDBC. Our results indicate that the 
chemicals of choice for use in the production of natural rubber latex products would be for 
the thiuram compounds TBTD, for the carbamates ZDBC and for the benzothiazoles ZMBT. 
However, one has to be aware that besides potency also the total amount of residual chemical 
present in the final product is important for allergy induction.  
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INTRODUCTION 
 
The use of natural rubber latex products poses risks for the development of allergy. Latex 
products can induce both immediate type (IgE mediated type I) hypersensitivity due to the 
latex proteins and/or cellular mediated delayed type (type IV) hypersensitivity due to the 
chemicals present as residues. Chemicals are added to rubber to improve it, to prolong its life 
and to give it special properties. Some of the chemicals are added directly at harvesting of the 
latex sap as preservatives, others are added as vulcanizers, accelerators, retarders, and/or 
antioxidants (Cronin, 1980). The added chemicals have been well documented as contact 
sensitisers in experimental studies in animals and humans, as well as in clinical studies (Cronin, 
1980; Duarte et al., 1998; Estlander et al., 1986; Kaniwa et al., 1994a; Kligmann, 1966; 
Magnussen and Kligmann, 1969; Maurer et al., 1979; Taylor, 1995; Wrangsjö and Meding, 
1994). Rubber polymer itself is not allergenic (Cronin, 1980). In most cases sensitisation by 
rubber chemicals is related to the use of natural rubber latex gloves (Conde-Salazar et al., 
1993) but sensitisation from rubber shoes also has been reported (Kaniwa et al., 1994b). 
Causality has been demonstrated by identifying the particular chemical in the rubber material, 
and the presence of a positive patch test in humans to the rubber material concomitantly with a 
positive patch test to the pure chemical (Fregert et al., 1969; Rycroft et al., 1992).  
Few studies have dealt with quantitative determinations of rubber chemicals in rubber 
products (Emmet et al., 1994; Hansson et al., 1997; Kaniwa et al., 1994a; Knudsen et al., 
1993). An extraction procedure and quantitative analysis for the most common rubber 
chemicals in rubber gloves has been described recently (Knudsen et al., 2000a). There was no 
clear correlation between chemical content in latex gloves and positive patch test reactivity in 
patients (Knudsen et al., 2000b). However, a tendency was seen for gloves with a low 
combined amount of chemicals in the extracts to give few positive reactions in the patients 
while gloves with a high amount of chemicals gave many positive reactions (Knudsen et al., 
2000b). In addition, cross reactivity can occur between various chemicals i.e. between thiurams 
and carbamates (Knudsen et al., 2000b; Knudsen and Menné, 1996), and mixtures of chemicals 
can be present in the gloves. 
The chemicals most often reported as contact sensitisers belong to the thiuram,  
carbamate,  and mercaptobenzothiazole groups, but also guanidines and several antioxidants 
have occasionally been reported as sensitisers (Estlander et al., 1994). The risk for sensitisation 
and the resulting contact hypersensitivity reactions can theoretically be eliminated by a 
reduction of exposure and/or a complete substitution of sensitisers with non-sensitisers (Cardin 
et al., 1986; Rycroft et al., 1992). This is, however, not compatible with the use of natural 
rubber products. The use of new technologies such as irradiation instead of the traditional 
vulcanisation process may, however, decrease the demand for accelerators (Wan Manshol, 
1998). Also the use of products manufactured from alternative materials will reduce induction 
of allergy to rubber chemicals. However, this does not completely prevent sensitisation by 
rubber chemicals as the same accelerators and antioxidants may be used as in latex production. 
Substitution of strong allergens with weaker allergens also is a possibility. Comparison and 
rating of sensitisers has been performed using experimental models in guinea pigs (Andersen et 
al., 1995; Wang and Suskind, 1988) and mice (Basketter et al., 1999a; Ikarashi et al., 1994; 
Van Och et al., 2000). However, experiments systematically investigating a wide range of 
chemicals used in natural rubber latex products have not been reported.  
The local lymph node assay (LLNA) is now commonly used for the identification of the 
sensitising activity of chemicals and the assay has been validated to the guinea pig 
maximization test (Basketter and Scholes, 1992; Basketter et al., 1993; Kimber et al., 1995). 
Test chemicals are applied to the dorsum of the ear and lymphocyte activation is determined by 
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measuring cell proliferation in the draining auricular lymph nodes, which can be done either by 
in vivo or ex vivo tritium-thymidine labeling of the cells (Kimber and Weisenberger 1989, 
Kimber et al. 1995, Van Och et al. 2000). Analysis of 134 chemicals tested in the local lymph 
node assay (LLNA), guinea pig maximisation test (GPMT) and/or with clear clinical evidence 
for human skin sensitisation potential, revealed that an EC3 (effective concentration causing a 
stimulation index of 3 compared to vehicle control) in the LLNA is an acceptable threshold 
value for hazard identification (Basketter et al., 1999a). In the local lymph node assay 
quantitative data are obtained on the induction phase of the immune response. So, based on the 
EC3 value of sensitising chemicals an accurate assessment of sensitising potency is possible 
(Basketter et al., 1999a; Van Och et al., 2000). 
 In the LLNA responses of chemicals can be compared and a ranking order of weak, 
moderate or strong sensitisers can be established (Basketter et al., 1999a; Basketter et al., 
1999b; Van Och et al., 2000). This offers the opportunity to use the LLNA in selecting 
chemicals with low or minimal allergenic potency. In this study a modified LLNA (sodium 
dodecyl sulfate pretreatment and ex vivo cell labeling) was used for determination of the 
sensitising potential of 15 chemicals used during natural rubber latex production, and known to 
induce contact hypersensitivity reactions in man.  
 
MATERIALS AND METHODS 
 
Animals 
Young adult (6-8 weeks of age) female BALB/c mice were obtained from the Central Animal 
Laboratory of the Institute. BALB/c mice show similar responses in the LLNA compared to 
CBA/Ca mice (Woolhiser et al, 2000). The animals were bred specified pathogen free. During 
the experiments the animals were housed barrier-maintained under conventional conditions in 
light-, humidity-, and temperature controlled rooms. All animals were housed in macrolon 
cages. The mice were fed chow pellets (Hope Farms, Woerden, The Netherlands) and water ad 
libitum. 
All other husbandry conditions were maintained according to all applicable provisions 
of the following national laws: Experiments on Animals Decree, and Experiments on Animals 
Act. 
 
Chemicals 
The chemicals investigated (Table 1) belong to different groups of compounds used during 
latex rubber glove production such as thiurams, carbamates, benzothiazoles and amines. 
TMTD, TETD, ZDEC, MBT, MBI, MBTS, and DEA were obtained from Sigma-Aldrich 
Chemie BV, Zwijndrecht, The Netherlands. ZDMC was obtained from Fluka, Zwijndrecht, 
The Netherlands. TMTM was obtained from Acros Organics, Geel, Belgium. TBTD, PTD, 
ZDBC, and ZPC, Robinson Brothers Limited, West Bromwich, UK, and PTT, ICN 
pharmaceuticals, Costa Mesa, CA, USA, and ZMBT, Semperit, Vienna, Austria, were kindly 
provided by Dr. C. Hametmer, Östereichisches Institut für biomedizinische Werkstofftechnik, 
Vienna, Austria.  
All chemicals were dissolved in 4:1 aceton/olive oil (AOO), and dose response studies were 
performed with the LLNA, as previously reported (Van Och et al., 2000).  
 
Experimental design 
The sensitising potency of the chemicals was investigated in a modified local lymph node assay 
using ex vivo labeling of the proliferating lymph node cells (Kimber and Weisberger 1989, 
Vandebriel et al., 2000; Van Och et al.. 2000). One hour before the chemicals were applied 25
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Table 1 
Chemicals investigated for their sensitising potency in a modified local lymph node assay (LLNA). 
Chemical Abbreviation Purity Formula 
 
Thiurams 
  Tetramethylthiurammonosulfide  TMTM  practical grade C6H12N2S3 
  Tetramethylthiuramdisulfide TMTD   ± 98%  C6H12N2S4 
  Tetraethylthiuramdisulfide TETD ± 98%   C10H20N2S4 
  Tetrabutylthiuramdisulfide TBTD technical grade  C18H36N2S4 
  Dipentamethylenethiuramdisulfide PTD technical grade  C12H20N2S3 
  Dipentamethylenethiuramtetrasulfide PTT technical grade C12H20N2S6 
Carbamates 
  Zinc dimethyldithiocarbamate ZDMC ± 90% purity  C6H12N2S4Zn 
  Zinc diethyldithiocarbamate ZDEC technical grade  C10H20N2S4Zn 
  Zinc dibutyldithiocarbamate ZDBC technical grade C18H36N2S4Zn 
  Zinc pentamethylenedithiocarbamate ZPC technical grade  C12H20N2S4Zn 
Benzothiazoles 
  2-Mercaptobenzothiazole MBT  ± 98%   C7H5NS2 
  Zinc mercaptobenzothiazole ZMBT technical grade  C14H8N2S4Zn 
  2,2-Dibenzothiazyldisulfide MBTS 99%   C14H8N2S4 
  Mercaptobenzimidazole MBI 98%   C7H6N2S 
Amines 
 Diethylamine DEA free base solution C4H11N 
 
 
µl of 1% sodium dodecyl sulfate (SDS, Merck BV, Amsterdam, The Netherlands) was applied 
epicutaneously to the dorsum of both ears to enhance responses to weak sensitisers (De Jong 
et al. manuscript in preparation). Additionally 25 µl of test solution or vehicle control was 
applied to the dorsum of both ears (50 µl per animal) of female BALB/c mice daily for three 
consecutive days (days 0, 1, and 2). At day 5 following start of treatment animals were 
sacrificed and draining (auricular) lymph nodes (LN) were excised. Isolated left and right LN’s 
from each mouse were weighed, and single cell suspensions prepared using a cell strainer 
(Falcon, Franklin Lakes, NJ, USA). Cells were washed twice and suspended in RPMI 1640 
(Gibco, Grand Island, NY, USA) culture medium supplemented with 10% heat inactivated 
Foetal Calf Serum (PAA, Linz, Austria), 100 IU/ml penicillin, and 100 µg/ml streptomycin, 
refferred to as supplemented medium. Cells were counted in a Coulter Counter (Coulter 
Electronics, Mijdrecht, the Netherlands) and adjusted to a concentration of 1x107 cells/ml. 
When necessary cell suspensions of several animals were pooled in order to obtain cell 
concentrations of 1x107 cells/ml, notably so for vehicle AOO treated controls.  
 
Lymphocyte stimulation test 
LN cell suspensions, 2 x 106 cells in 200 µl, were cultured in RPMI 1640 supplemented 
medium in triplicate in round-bottomed 96-wells microtitre plates (Greiner, Alphen aan de 
Rijn, The Netherlands). An aliquot of 10 µl of 3H-methylthymidine, 37 kBq/well, (3H-TdR, 
Amersham International, Buckinghamshire, UK; 3.7 MBq/ml, 100 µCi/ml), specific activity 
185 GBq/mmol (5 Ci/mmol in 217.8 µg/ml cold thymidine in PBS) was added to the wells of 
the cell culture directly after initiation of culture. Cultures were maintained for 24 hours at 37 
oC in a humidified atmosphere of 5% CO2 in air. The cellular DNA was harvested on glass fiber 
filters using an automatic cell harvester (Harvester 96® Tomtec, Orange, CT, USA), 
scintillation liquid was added and incorporation of 3H-TdR into the DNA was measured by 
liquid scintillation in a β plate counter (1205 BetaplateTM Wallac, Turku, Finland). Proliferation 
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per animal was determined by calculating the 3H-TdR incorporation for the total cell number 
harvested (left and right lymph nodes combined). 
 
Statistical analysis  
The EC3 (effective concentration inducing a threefold increase in 
3H-thymidine incorporation in 
the harvested lymph node cells of treated animals compared to vehicle treated animals) was 
estimated by the benchmark approach, by fitting a nonlinear regression model to the data of all 
individual animals. The choice of the model for deriving the EC3 follows from a procedure of 
applying likelihood ratio tests on the members of the following nested family of models: 
 model 1: y = a 
 model 2: y = a exp(bx) 
 model 3: y = a exp(bxd ) 
 model 4: y = a(c-(c - 1)exp(bx))  
 model 5: y = a(c - (c - 1)exp(bxd)), 
where y is the response, and x denotes the applied concentration. The parameter a represents 
the level of the response at concentration zero, and b can be considered as the parameter 
reflecting the efficacy of the chemical. At high doses models 4 and 5 level off to the value ac, 
so the parameter c can be interpreted as the maximum relative change, compared to the 
background. Models 3 and 5 have the flexibility to mimic threshold-like responses. All these 
models are nested to each other, except models 3 and 4, which both have three parameters. 
Therefore, these two models cannot be (formally) compared to each other by a likelihood ratio 
test.  
For each data set (compound) one of these models was selected by choosing a more 
complicated model when the increase in number of parameters resulted in a significantly better 
fit to the dose-response data by choosing a more complicated model when the increase in 
number of parameters resulted in a significantly better fit to the dose-response data. The 
selected model was used to estimate the EC3 (point estimate). Additionally, an estimate of the 
uncertainty (90%-confidence interval) associated with the estimated EC3 was determined using 
a (parametric) bootstrap method (Slob and Pieters, 1998), as follows. Once a model is selected 
for describing the dose-response data, this fitted model is used as a basis for generating 200 
artificial data sets (according to the experimental design) by Monte Carlo sampling. For each 
generated data set the EC3 is re-estimated. Taking all these EC3s together results in a 
distribution representing the uncertainty associated with the EC3 estimate. The 5th and 95th 
percentiles of this empirical distribution were determined, serving as a 90%-confidence interval 
for the EC3. Full statistical details are given in Slob (2001). Other applications can be found in 
Slob 1999, Piersma et al. 2000, Van Och et al., 2000, and Woutersen et al. 2001.  
 
RESULTS 
 
Dose response evaluations of two compounds are presented in Table 2. ZDEC induced a 
strong response for all parameters determined, while ZMBT induced a weak response. For 
ZDEC the lymph node weight, number of cells isolated per animal, and the 3H-thymidine 
incorporation per cell culture (2x106 cells) and per animal (left and right lymph node 
combined) increased with higher dosages. For ZMBT only moderate changes were observed. 
Especially for the lower dosages of chemicals and the AOO control, lymph node cell 
populations had to be pooled in order to obtain a sufficient number of cells for the in vitro 3H-
thymidine labelling.  
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Figure 1  
Observations (cpm) as a function of  concentration for ZDEC (A) and ZMBT (B) together with fitted regression 
function.  
3H-TdR 
per animal 
(cpm) 
3H-TdR 
per animal 
(cpm) 
Dose (%) 
A. ZDEC 
Dose (%) 
B. ZMBT 
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Figure 2  
A. Distribution of EC3 value of ZDEC (n=200). B. Distribution of EC3 value of ZMBT (n=200). 
Number of 
bootstraps 
Number of 
bootstraps 
A. ZDEC 
B. ZMBT 
Log EC3 per bootstrap 
EC3 per bootstrap 
Log EC3 per bootstrap 
 EC3 per bootstrap 
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Table 2 
Dose response studies with the strong sensitiser ZDEC and the weak sensitiser ZMBT. 
Chemical LN   LN Cell  Proliferation  LN Proliferation 
Concentra- Weight (mg)  Number  cpm/2*10e6  cpm/animal 
tion (%)     x10e6  LN cells 
 
ZDEC 
0  3.1 ± 0.2 (12)a  5.4 ± 0.4 (6) 353 ± 68 (2)  960 ± 115 (6) 
0.0625  2.7 ± 0.3 (6)  4.4 ± 1.0 711 (1)   1,565 ± 339 
0.25  3.4 ± 0.4 (6)  6.6 ± 1.1 819 ± 344 (2)  2,936 ± 771 
1  3.5 ± 0.3 (6)  8.9 ± 1.0 1,328 ± 194   5,976 ± 1163 
4  5.7 ± 0.4 (6)  13.2 ± 2.2 1,923 ± 477  13,312 ± 4294 
16  7.2 ± 0.8 (6)  16.3 ± 1.5 2,921 ± 376  24,197 ± 4834 
 
ZMBT 
0  3.2 ± 0.2 (12)  3.6 ± 0.2 (6) 638 ± 3 (2)  1,144 ± 74 (6) 
1.25  3.0 ± 0.2 (6)  3.8 ± 0.6 655 (1)   1,244 ± 180  
2.5  3.8 ± 0.2 (6)  4.1 ± 0.9 799 (1)   1,638 ± 346  
5.0  3.9 ± 0.2 (6)  3.8 ± 0.3 1073 (1)   2,056 ± 176  
10.0  3.8 ± 0.2 (6)  3.7 ± 0.2 846 (1)   1,580 ± 99  
20.0  4.4 ± 0.2 (6)  5.3 ± 1.0 1010 (1)   2,659 ± 529  
a Arithmetic means and standard errors of the mean (SEM), (n) n=3 unless stated otherwise. 
 
 
All individual animal data (expressed as proliferation per animal) were used to estimate the best 
fitting non linear regression model as determined with the maximum likelihood. For ZDEC and 
ZMBT the best fitting curve is presented in Figures 1A and 1B, respectively. The EC3 
concentration (concentration of the chemical inducing a SI=3) was estimated using a 
benchmark approach (see M&M), by fitting a dose-response model to the observed 3H-
thymidine incorporation as a function of the concentration of the chemical (Figure 1A and B). 
The EC3 value for ZDEC (EC3= 0.4%) is shown in Figure 1A, while for ZMBT the EC3 value 
(EC3= 30.3%) was calculated by extrapolation of the experimental results shown in Figure 1B. 
The EC3 value is an estimated value from a best fitting curve. To account for the noise 
in the data, a parametric bootstrap method was used for further evaluation of the EC3 value. 
The results of 200 bootstrap runs indicating possible EC3 values based on the experimental 
data obtained for ZDEC and ZMBT, are presented in Figures 2A and 2B. For ZDEC the EC3 
value ranges from 0.1% to 0.8%, while for ZMBT the EC3 values ranges from 20% to 50%. 
With the 200 parametric bootstrap runs the 5% and 95% confidence limits of the EC3 can be 
estimated. Table 3 shows the calculated EC3 values and their 90% confidence intervals for 15 
chemicals evaluated in the modified LLNA. For 14 out of the 15 chemicals tested an EC3 was 
determined, identifying these chemicals as sensitisers. For ZDBC  the curve fitting and 
bootstrap method did not result in an EC3 value due to low responses and the lack of a dose 
response relationship of the data obtained in the LLNA. Based on the EC3 values the chemicals 
are ranked from high to low reactivity in the LLNA (Table 3).  
 
DISCUSSION 
 
We tested 15 different chemicals used in latex medical glove production. The chemicals were 
chosen because of their known sensitising capacity as they were found to induce contact 
hypersensitivity (DTH) reactions in humans (Knudsen et al., 2000b). Fourteen of the 15 
chemicals were positively identified, while the assay failed to detect ZDBC, a carbamate 
compound, as sensitiser. Using the LLNA we quantified the sensitising potency and found.  
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Table 3  
Ranking of chemicals used for latex production.  
Chemical EC3a       L05 - -L95b       Ranking       
           LLNA          
 
ZDEC 0.4 0.2 - 0.6  1  
TMTD 0.7 0.6 - 0.8  2 
TETD 1.4 0.9 - 1.9   3 
ZPC 1.8 0.7 - 6.0  4  
ZDMC 2.7 1.6 - 8.3  5  
MBTS 2.9 1.4 - 6.7  6 
PTD 5.2 2.8 - 10.7  7  
TMTM 5.4 1.9 - 11.5  8 
MBT 9.9 8.0 - 12.2  9  
MBI 14.7 11.8 - 19.8  10  
PTT 20.5 11.6 - 66.0  11  
ZMBT 30.3 22.2 - 49.0  12  
TBTD 34.8 15.6 - 114  13  
DEA 39.8 34.1 - 47.7  14  
ZDBC NRc   15  
a Effective concentration inducing a stimulation index of 3 in LLNA 
b Estimated 90%-confidence interval based on 200 bootstrap runs (see M&M)  
c NR = EC3 not reached according to fitted model. 
 
 
ZDEC the strongest and DEA the weakest sensitiser. The associated 90% confidence interval 
gives an indication of the reliability of the estimated EC3 concentration. Use of the EC3 values 
makes it possible to rank various chemicals used within a single production process, with 
regard to their sensitising potency (Basketter et al., 1999a; Van Och et al., 2000). This offers 
the possibility for manufacturers to choose chemicals with low sensitising properties. In the 
production process of natural rubber latex several different types of chemicals are used each 
with their own function in the production process (Cronin, 1980). Our results may provide 
information to make a choice between these chemicals. Especially chemicals failing to induce a 
SI=3 or needing rather high concentrations to induce a stimulation index of 3 seem warranted 
for use in latex production facilities. Our results indicate that in particular the chemicals of 
choice are for the thiuram compounds TBTD, for the carbamates ZDBC, and for the 
benzothiazoles ZMBT. Besides sensitising activity also the total amount present and the bio-
availability determines the sensitising potency of a medical glove manufactured from natural 
rubber latex. The total amount of chemicals in glove extracts varies but is in the same order of 
magnitude (approximately 2-15 µmol/g glove), although tenfold differences between different 
manufacturers may occur (Knudsen et al., 2000a).  
There was no group of chemicals as a whole showing for all compounds either a low or 
high allergenicity as indicated by the EC3 value. Our results suggest that for the thiuram 
compounds an increase in EC3 value, and thus a decrease in sensitising potency, occurs with an 
increase in the lenght of the side chains. For TMTD (methyl side chains) the EC3 was 0.7%, for 
TETD (ethyl side chains) the EC3 was 1.4%, and for TBTD (butyl side chains) the EC3 was 
34.8%.  For the corrsponding carbamates a similarity could be observed for ZDBC (butyl side 
chains) being non sensitising (EC3 value could not be determined). In contrast ZDMC (methyl 
side chains, EC3= 2.7%) was less potent than ZDEC (ethyl side chains, EC3= 0.4%). The 
benzothiazoles showed EC3 values from low (MBTS EC3= 2.9%) to high (ZMBT EC3= 
30.3%). For TMTD, ZDMC, MBT and DEA a decreasing order in sensitising potential has 
already been reported (Van Och et al., 2000). Ikarashi et al., (1993) reported a decreasing 
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order in sensitising activity for IPPD (N-isopropyl-N’-phenyl-p-phenylenediamine), TMTD, 
MBT and ZDEC. In contrast to their results we found ZDEC to be more potent than MBT. 
Furtheremore, for none of the doses investigated a SI=3 was reached for TMTD and ZDEC by 
Ikarashi et al., (1993). The comparison of sensitising potency was based on the highest 
proliferation index obtained. In our view this is less accurate than comparison on the basis of 
the EC3 value. Also the difference in vehicle used for ZDEC may have contributed to the low 
reactivity in the study of Ikarashi et al., (1993). We used acetone olive oil, which is commonly 
used in the LLNA, whereas Ikarashi et al., (1993) used chloroform. Although for strong 
sensitisers the influence of the vehicle is probably limited, it is known that the vehicle has an 
effect on the performance of the LLNA (Edwards et al., 1994; Montelius et al., 1996; 
Warbrick et al., 1999).  
Besides the qualification of a compound as sensitiser the use of non-linear regression 
analysis for calculation of the EC3 offers the advantage of a quantitative estimation of the 
confidence limits of the estimated EC3. Non linear regression analysis as applied in this study, 
uses all available individual data, and not just the mean of the treated animals. Thus, a 90%-
confidence interval could be calculated. For the stronger sensitisers in general the 90%- 
percentile confidence interval is smaller than for the weak sensitisers (also on the log-scale, i.e. 
in a relative sense). The 5th percentile level may be interesting from the point of risk 
management, as this percentile indicates that below this level there is only a 5% probability that 
positive reactions do occur. So, the 5th percentaile of the EC3 is very similar to the BMDL 
(lower confidence limit of the benchmark dose) and may be used as the lowest acceptable dose 
(or concentration for exposure) for risk management purposes. Comparing our results with 
clinical data (Knudsen et al., 2000b), for the weakest identified chemicals a low frequency of 
positive reactions was found while for the strongest identified chemicals a high frequency of 
positive reactions was observed.    
In conclusion, a ranking is presented for rubber chemicals known to induce contact  
hypersensitivity reactions in man. When using these chemicals for the production of natural 
rubber latex products, the preference would be to use chemicals with absent or low sensitising 
activity. Our results indicate that the chemicals of choice are for the thiuram compounds 
TBTD, for the carbamates ZDBC and for the benzothiazoles ZMBT. 
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CHAPTER 5 
 
 
EFFECT OF EXPOSURE DURATION ON IDENTIFICATION OF 
ALLERGENS IN A MODIFIED LOCAL LYMPH NODE ASSAY 
 
François M. M. van Och, Rob J. Vandebriel, Wim H. de Jong, 
Henk van Loveren 
 
 
 
The local lymph node assay (LLNA) is an assay in mice to identify potential allergens. 
Compounds that do not induce a stimulation index (SI) ≥ 3 are not considered sensitizers. Of 
the chemicals that do, the SI of 3 is used as a benchmark, and indicates the sensitizing 
potency of a chemical. Compared to the exposure duration of the LLNA (3 days), real life 
exposure often lasts for months or years. We therefore investigated whether prolonged 
exposure to sensitizers at concentrations that do not induce an SI ≥ 3 in the LLNA, were able 
to surpass this threshold. Mice were treated for 2 months at 7-day intervals with a range of 
concentrations of the known allergens ethyl-p-aminobenzoate (benzocaine, BENZ), 2,4- 
dinitrochlorobenzene (DNCB), and tetramethyl thiuram disulfide (TMTD). Both proliferative 
activity and cytokine production were established at day 60. Neither BENZ nor TMTD showed 
a significant increase in the proliferation rate compared to vehicle controls. Only DNCB at 
concentrations originally above the EC3 a significant increase in proliferation was seen after 
prolonged exposure. No significant effect on IFN-γ and IL-4 production was observed for all 
three compounds compared. These findings indicate that for classification of sensitizers the 
shorter exposure period in the LLNA is sufficient, and longer periods of exposure have no 
bearing on this classification.  
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INTRODUCTION 
 
Recently, the murine local lymph node assay (LLNA, Kimber et al., 1986; Kimber and 
Weisenberger, 1989) was submitted to the Interagency Coordinating Committee on the 
Validation of Alternative Methods (ICCVAM) for consideration as a stand-alone test method 
alternative to accepted guinea pig test methods. It was concluded that the LLNA is an 
acceptable alternative to methods such as the guinea pig maximization test to assess whether a 
chemical has the potential to induce allergic contact dermatitis (ACD) in humans. The criterion 
for a positive LLNA response, and for classification of a chemical as a contact sensitizer, is a 
threefold or greater increase in lymph node (LN) cell proliferative activity compared to vehicle 
treated controls. The selection of a stimulation index (SI) of 3 for the definition of skin 
sensitization potential in the LLNA was empirical, being based on experience and experimental 
observations in humans (Basketter et al., 1999a).  
Besides the identification, the relative potency of a potential contact allergen is of 
importance. Dose-response relationships in cellular proliferation results in a calculated EC3 
value (concentration inducing SI = 3) for the various chemicals (Basketter et al., 1999b). We 
have previously determined the relative potency in a quantitative manner using a modified 
LLNA (Van Och et al., 2000; De Jong et al., 2002a). For an SI = 3, we calculated the 
corresponding estimated concentration (EC3) using non-linear regression analysis, resulting in 
ranking of the various chemicals tested. These dose-response data also show that for each 
chemical a concentration exists which does not induce a significant response. Besides 
experimental evidence in the LLNA, also studies in humans suggest the presence of thresholds 
for the induction of skin sensitization (Steltenkamp et al., 1980; Danneman et al., 1983; Ford 
et al., 1988).  
Depending on the situation, humans are exposed to allergens almost every day. In most 
cases it concerns very low exposure levels at which people will not develop a specific allergic 
response. Occasionally, someone will become allergic. Previous studies have indicated that the 
frequency of antigen exposure is an additional risk factor in determining the outcome of the 
immune response (Mueller et al., 1989; Kitagaki et al., 1995). An important question that 
arises is at which time point this change will occur and what determines a change from non-
reaction to reaction. For instance, humans are continuously exposed to nickel originating from 
a variety of sources. Skin contact with nickel-containing or nickel-plated tools and other items 
adds to an occupational nickel hazard and leads eventually to contact dermatitis or nickel 
allergy (Grandjean, 1984). The potential threshold for inducing nickel sensitivity in humans 
was investigated by Allenby and Basketter (1993; 1994). Individuals were exposed by arm 
immersion twice daily for 23 days to a surfactant solution; 60% of the people tested showed 
positive reactions to 10 ppm aqueous nickel sulfate, 50% to 5 ppm, 15% to 1 ppm, and 10% to 
0.5 ppm. In contrast, a relatively high single exposure to 100 ppm showed a reaction in none of 
the 51 individuals tested (Menneé and Calvin, 1993). So, the actual risk for humans to develop 
allergy depends not only on concentration, but also on frequency of exposure. Other factors 
are the condition of the human skin, the anatomical site of exposure, and genetic background. 
The cytokines induced in the LLNA can be used to discriminate contact allergens from 
respiratory sensitizers (Dearman et al., 1994; Vandebriel et al., 2000). Both studies showed that 
compounds inducing contact hypersensitivity (CHS) produce relatively high levels of IFN-γ and low 
levels of IL-4. So, in addition to the proliferative responses we also investigated the influence of 
prolonged exposure on cytokine production. Animals were treated for 2 months at 7-day 
intervals with the chemicals ethyl-p-aminobenzoate (benzocaine, BENZ), 2,4- 
dinitrochlorobenzene (DNCB), and tetramethyl thiuram disulfide (TMTD). These compounds 
have been well documented as contact sensitizers in experimental studies in animals, as well as 
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in clinical observations (Kligman and Epstein, 1959; Magnusson and Kligman, 1969; Cronin, 
1980; Basketter and Scholes, 1992; Kaniwa et al., 1993). The concentrations used were 
chosen below and above their respective EC3 values that were formerly obtained with a 
modified LLNA (Van Och et al., 2000). Both proliferative activity and cytokine production 
were established on day 60.  
 
METHODS  
 
Animals 
Young adult (6-8 weeks old) male or female BALB/c strain mice were used for the 
experiments. They were obtained from our own breeding colony. The animals were bred 
specific pathogen free and kept under conventional conditions. The mice were fed Hope Farms 
chow pellets (Woerden, NL) and water ad libitum. The breeding colony of the animals was pre-
screened/monitored for endogenous pathogenic viruses and bacteria and was found negative.  
 The experimental setup of the studies was examined and agreed upon by the Ethical 
Committee on Experimental Animals. 
 
Chemicals 
Benzocaine (BENZ, ethyl-p-aminobenzoate; 99% purity; Sigma-Aldrich Chemie B.V., 
Zwijndrecht, NL), DNCB (2,4-dinitrochlorobenzene; 98%; Sigma-Aldrich), and TMTD 
(tetramethylthiuramdisulfide; 98%; Sigma-Aldrich) were dissolved in 4:1 acetone/olive oil 
(AOO). SDS (sodium dodecyl sulphate; >99%; Merck B.V., Amsterdam, NL) was dissolved in 
4:1 acetone/olive oil (AOO).  
 The concentrations for the different chemicals were chosen below and above the EC3 as 
previously determined in a modified LLNA (Van Och et al., 2000, see Table 1A). 
 
 
Table 1A 
Experimental design for determination of effect of prolonged exposure with low concentrations on local lymph 
node activation. Table A shows the different concentrations used in a modified LLNA and the prolonged 
exposure study, the study design is shown in Table B 
% concentration (w/v) Chemical EC3 (%) in LLNA
a 
LLNA (short-term)a             Long-term exposure 
BENZ 22.0 7.5, 15, 22.5, 30 7.5, 15, 22.5, 30 
 
DNCB 0.044 0.1, 0.25, 0.5, 1 0.01, 0.025, 0.05, 0.1 
 
TMTD 0.66 0.0312, 0.0625, 0.125, 
0.25, 0.5, 1 
0.0312, 0.0625, 0.125, 
0.25 
a EC3; estimated concentration in % required inducing an SI=3 as previously determined in a modified LLNA 
(Van Och et al., 2000) 
 
 
Sensitization and elicitation procedure 
Groups of mice (n=5 for the chemicals, and n=10 for the AOO vehicle control group) were 
exposed to 25 µl of test solution in vehicle or vehicle alone on the dorsum of both ears (50 
µl/animal) daily for three consecutive days (day 0, 1, and 2), and subsequently weekly on day 
7, 14, 21, 28, 35, 42, 49, and 56. On day 0, 1, and 2 the animals were pretreated with 1% SDS 
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(w/v) on the dorsum of both ears one hour before exposing the animals on both ears. SDS 
treatment was performed to compare the present data with previous observations (Van Och et 
al., 2000; De Jong et al., 2002b). An overview of the study design is shown in Table 1B. 
 
 
Table 1B 
Day 1% SDS  
pretreatment 
Allergen painting Excision LN 
0, 1, 2 + + - 
7, 14, 21, 28, 35, 42, 49, 56 - + - 
60 - - + 
 
 
Cell proliferation  
Four days following the last topical application (day 60), the auricular lymph nodes (LN) were 
excised. The LN were weighed and pooled for each animal and suspended in 5 ml RPMI-1640 
(Gibco, Life Technologies, Breda, NL) supplemented with 5% heat inactivated Fetal Calf 
Serum (PAA, Linz, Austria), 100 U/ml penicillin and 100 µg/ml streptomycin (standard 
medium). Single cell suspensions were prepared under aseptic conditions by pressing the LN 
through a sterile 70 µm nylon cell strainer (Falcon, Franklin Lakes, NJ, USA). The cells were 
washed twice in standard medium (10 minutes, 311g, 4°C) and resuspended in 1 ml standard 
medium with 10% FCS. The cells were counted using a Coulter Counter (Z2, Coulter 
Electronics, Mijdrecht, NL) and cultured at a concentration of 1.107 cells/ml. When necessary, 
cell suspensions of several animals were pooled to obtain the concentration required. The cell 
suspensions (200 µl) were seeded in triplicate into round-bottomed 96-well microtitre plates 
(Greiner, Alphen a/d Rijn, NL). The cells were cultured with 10 µl of [3H]TdR (Amersham 
International, Buckinghamshire, UK; 3.7 MBq/ml) for 24 hr at 37°C in a humidified 
atmosphere of 5% CO2 in air. The [
3H]TdR incorporation was determined by liquid 
scintillation counting in a β plate counter (1205 BetaplateTM Wallac, Turku, Finland). The 
[3H]TdR incorporation is expressed per animal, i.e. the [3H]TdR incorporation is multiplied by 
the cell number of the two LN and devided by the cell number in culture. 
 
Cytokine production 
 LN cell suspensions were made as described above. The suspensions were cultured at 106 cells per 
ml culture medium with Con A (5 µg/ml) and 5 x 10-5M 2-mercaptoethanol for 24 hr. Con A 
stimulation proved necessary for the detection of IFN-γ and IL-4 (Vandebriel et al., 2000). After 
culture, aliquots of supernatants were frozen on dry ice and stored at -80 °C until use. IFN-γ and 
IL-4 concentrations were determined by ELISA. Briefly, 96-well plates (Nunc-Immuno Plate, 
Roskilde, Denmark) were coated with 1 µg/ml anti-mouse IFN-γ (R4-6A2, rat IgG1; Pharmingen, 
San Diego, CA, USA) in coating buffer (0.04 M carbonate buffer, pH 9.6). After overnight 
incubation at 4°C the plates were incubated in blocking buffer (1% bovine serum albumin (BSA; 
Sigma, Axel, NL) plus 0.05% Tween-20 (Merck, Amsterdam, NL), in PBS) for 2 hrs at 37°C and 
washed (0.05% Tween-20). Recombinant mouse IFN-γ (Biosource, Camarillo, CA, USA) was 
used as a standard. Standard as well as serial dilutions of culture supernatants were added to the 
plate. Plates were incubated at 37°C for 2 hrs and washed. Biotinylated anti-mouse IFN-γ (0.5 
µg/ml; XMG1.2, rat IgG1; Pharmingen) was added and incubated for 1 hr at room temperature 
(RT). The plates were washed, and poly horseradish peroxidase labeled streptavidin (10,000-fold 
dilution, Strepta-E+, Central Laboratory of the Blood Transfusion Service, Amsterdam, NL) was 
added and incubated for 1 hr at RT. Plates were washed again and TMB solution (0.1 mg/ml TMB 
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(Sigma) plus 0.006% H2O2, in 0.1 M NaAc, pH 5.5) was added. The plates were read at 450 nm, 
using an automated reader (Titertek Multiskan, Flow Laboratories, Lugano, Switzerland). For IL-4, 
a similar protocol was used, with 0.5 µg/ml anti-mouse IL-4 (11B11, rat IgG1; Pharmingen) for 
coating, recombinant mouse IL-4 (Pharmingen) as a standard, and 0.5 µg/ml biotinylated anti-
mouse IL-4 (BVD6-24G2, rat IgG1; Pharmingen) for detection. Antibodies, standards, samples, and 
streptavidin were diluted in 0.5% BSA plus 0.05% Tween-20, in PBS (Van Halteren et al., 1997).  
 Data are expressed as mean (ng) ± SEM. Similar to cell proliferation, results are expressed 
per two LN (per animal), i.e. the response (ng/ml) is multiplied by the local LN cell number, and 
divided by the cell culture concentration (106/ml). 
 
Statistical analysis 
 Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by 
the two-tailed Student’s t test using the ANOVA calculated pooled standard deviation. 
Significance levels were (*) p < 0.05, (**) p < 0.01, and (***) p < 0.001 for proliferation data 
and cytokine production.  
For DNCB, the proliferation data were analyzed using non-linear regression, as was 
previously described (Van Och et al., 2000; De Jong et al., 2002a). 
 
 
Table 2 
IFN-γ and IL-4 production after long-term exposure to DNCB. BALB/c mice were pretreated with 1% SDS by 
topical application on both ears and one hour later treated by topical application on both ears with various 
concentrations DNCB for three consecutive days (day 0, 1, and 2) and then the chemicals were repeatedly 
applied to the originally sensitized ears from day 7 to day 56 at 7-day intervals. Four days following the final 
topical application (day 60), the auricular LN were excised. LN cell suspensions were made, and IFN-γ and IL-4  
concentrations were determined by ELISA. Results are expressed per two LN (per animal). Results are calculated by 
multiplying the cytokine concentration by the LN cell number, and are expressed as amount of cytokine (pg) ± 
SEM (n=5)  
 IFN-γ IL-4 IFN-γ/IL-4 
AOO N.D. 18 ± 5  - 
0.01% N.D. 21 ± 4 - 
0.025% 85 ± 31 25 ± 3 3.4 
0.05% 6779 ± 5525 791 ± 476 8.6 
0.075% 9760 ± 7968 578 ± 588 16.8 
N.D., not detected 
 
 
RESULTS 
 
LN cell proliferation 
Figure 1 shows the dose-response relationships of the LN cell proliferation for the different 
chemicals after prolonged exposure. The concentrations used were chosen below and/or above 
their respective EC3 values that were formerly obtained with a modified LLNA (Table 1). 
Proliferation was measured 4 days following the last application (at day 60) of BENZ, DNCB, 
and TMTD. For TMTD all concentrations used were < EC3 and showed no differences in 
proliferation compared to AOO vehicle treated animals. Also no induction of the proliferative 
activity of the LN cells was found for BENZ, even for 22.5% and 30% BENZ, being 
concentrations > EC3. DNCB induced significantly higher proliferative responses relative to 
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vehicle treatment for the two highest concentrations used (p < 0.01 for 0.05%, and p < 0.05 for 
0.075%), both concentrations being > EC3. DNCB concentrations < EC3 did not induce 
proliferation. The concentration inducing an SI = 3 over vehicle control was calulated by non-
linear regression analysis together with the corresponding 90%-confidence interval. The EC3 
value in the present study (0.092%) was two-fold higher than the concentration obtained in a 
modified LLNA (0.044%). No overlap between the corresponding 90%-confidence intervals 
(0.079%-0.122% and 0.025%-0.078%, respectively) was observed.  
 
 
Table 3 
IFN-γ and IL-4 production for DNCB obtained with a modified LLNA. BALB/c mice were pretreated with 1% 
SDS by topical application on both ears and one hour later treated by topical application on both ears with 
various concentrations DNCB for three consecutive days. Five days following the first topical application, the 
auricular LN were excised. LN cell suspensions were made, and IFN-γ and IL-4 concentrations were determined 
by ELISA. Results are expressed per two LN (per animal). Results are calculated by multiplying the cytokine 
concentration by the LN cell number, and are expressed as amount of cytokine (pg) ± SEM (n=4). (*), (**), and 
(***), significantly different from AOO (P < 0.05, P < 0.01, and P < 0.001, respectively) 
 IFN-γ IL-4  IFN-γ/IL-4 
AOO 157 ± 50 N.D. - 
0.1% 359 ± 321 22 ± 30 16.3 
0.25% 27940 ± 11443** 916 ± 281 30.5 
0.5% 76791 ± 8743*** 2394 ± 207*** 32.1 
1% 163893 ± 20829*** 2950 ± 660*** 55.6 
N.D., not detected 
 
 
Cytokine production 
The production of IFN-γ and IL-4 was measured after prolonged exposure (2 months) to 
BENZ, DNCB, and TMTD. After prolonged exposure, only DNCB induced detectable 
amounts of IFN-γ and IL-4 (Table 2). However, the cytokine production was reduced 
compared to (short-term) 3-day exposure. These findings were compared to cytokine 
production derived from a modified LLNA after (short-term) 3-day exposure (Table 3). 
Remarkably, the IFN-γ/IL-4 ratio increased with increasing dose.   
 
DISCUSSION  
 
In the present study, we investigated if prolonged (2 months) exposure to low concentrations 
of allergens that do not induce an SI ≥ 3 in the LLNA, were able to surpass this threshold. To 
this end, the concentrations used were chosen around their respective EC3 values that were 
formerly obtained with a modified LLNA (Van Och et al., 2000). The EC3 values derived for  
 
 
Figure 1  
LN cell proliferation after long-term exposure. BALB/c mice were treated by topical application on both ears 
with various concentrations BENZ, DNCB, and TMTD for three consecutive days and then the chemicals were 
repeatedly applied to the originally sensitized ears from day 7 to day 56 at 7-day intervals. Four days after the 
last application, the local LN were excised, pooled (per animal for allergen treatment and per 2 animals for 
vehicle treatment), and cell suspensions were prepared. Cells were cultured for 24 hrs in the presence of 3H-
thymidine, and 3H-incorporation was measured. Results are calculated by multiplying the 3H-incorporation by the 
LN cell number, and expressed as cpm ± SEM (n=5, except AOO control group n=10). (*), (**), significantly 
different from AOO (P < 0.05, P < 0.01, respectively). 
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BENZ, DNCB, and TMTD in a modified LLNA were 22.03%, 0.044%, and 0.66%, 
respectively. The data shown in the present paper are the results of three independent 
experiments. 
First, TMTD, with all concentrations chosen below the EC3 value (see Table 1A), was 
examined. Prolonged exposure did not result in induction of proliferation with an SI > 3. For 
the second compound studied, BENZ, we chose two concentrations above the EC3 value and 
the other concentrations below this value. Again, none of the concentrations tested showed a 
proliferation rate with an SI > 3. Even 22.5 % and 30% BENZ, concentrations above the EC3 
value formerly obtained with a modified LLNA, showed no induction of proliferation. Because 
BENZ showed variable results in the past in both the GPMT and the LLNA (Basketter et al., 
1995), we performed a third experiment, using the more potent allergen DNCB. After 
prolonged exposure, DNCB showed significantly higher proliferative responses relative to 
vehicle treatment for the highest two concentrations used, both concentrations being above the EC3 
value for DNCB. Moreover, the EC3 value obtained in the present study (0.092%), was higher than 
the concentration found in a modified LLNA (0.044%; Van Och et al., 2000). No overlap was 
found between the corresponding confidence intervals of the EC3 values, since the 90%-
confidence interval as obtained in a modified LLNA for EC3= 0.044% was [0.025%, 0.078%], 
and the 90%-confidence interval found in the present study for EC3= 0.092% was [0.079%, 
0.122%]. So, none of the concentrations used that are known to induce LN cell proliferation 
below an SI = 3, induced a significant increase in LN cell proliferation after prolonged 
exposure. 
 Besides proliferation, IFN-γ and IL-4 production were determined. Again, no 
significant induction of cytokine production for the different chemicals was seen after 
prolonged exposure to concentrations of allergens that did not induce an SI ≥ 3 in a modified 
LLNA. Even concentrations that did surpass this threshold, such as 0.05% DNCB and 0.075% 
DNCB, showed no significant increase in cytokine production compared to vehicle treated 
control animals. However, although not significantly increased for these two highest 
concentrations, cytokine production was clearly induced (Table 2). 
Regarding the qualitative effect on the response (T-helper 1/T-helper 2 ratio, measured 
as IFN-γ/IL-4 ratio), the highest DNCB concentration in the long-term exposure study 
(0.075%, Table 2) showed an equivalent ratio compared to the lowest DNCB concentration in 
a modified LLNA (0.1%, Table 3). So, no evidence was found for a shift in the T-helper 1/T-
helper 2 ratio depending on exposure time. However, longer exposure time did show a 
quantitative effect. Both 0.05% DNCB and 0.075% DNCB induced considerable amounts of 
IFN-γ and IL-4 compared to the production seen in the draining LN cells after exposure to 
0.1% DNCB in a modified LLNA. This was not caused by the increase in LN cell number in 
time, because the same effect was found for cytokine production on a per cell basis (data not 
shown).  
Remarkably, the ratio between IFN-γ and IL-4 showed a clear dose-dependency for 
DNCB, i.e. in favour of T-helper 1 at higher concentrations of DNCB. This confirms the 
proposal that it is neccessary to study a range of concentrations instead of only a single 
concentration, for an allergen to be identified as a contact sensitizer or as a respiratory 
allergen (Van Och et al., submitted). 
In conclusion, for risk evaluation it is neccessary to estimate the lowest concentration 
needed for sensitization. We investigated the influence of exposure duration on the EC3 value, 
since this parameter is the criterion for classification of a chemical as a contact sensitizer in the 
LLNA. For the three chemicals tested, none of the concentrations used that are known to 
induce LN cell proliferation below an SI = 3, induced a significant increase in LN cell 
proliferation after prolonged exposure. So, prolonged exposure to concentrations of allergens 
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below an SI of three in the LLNA, did not result in a response in the draining LN and thus 
were not able to surpass this threshold.  
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CHAPTER 6 
  
 
CYTOKINE PRODUCTION INDUCED BY LOW MOLECULAR 
WEIGHT CHEMICALS AS A FUNCTION OF THE STIMULATION 
INDEX IN A MODIFIED LOCAL LYMPH NODE ASSAY: AN 
APPROACH TO DISCRIMINATE CONTACT SENSITIZERS  
FROM RESPIRATORY SENSITIZERS 
 
François M. M. van Och, Henk van Loveren, Wim H. de Jong,  
 Rob J. Vandebriel 
 
 
 
In general, contact sensitizers have been shown to selectively induce Th1 immune responses, 
such as IFN-γ production, whereas Th2 responses, such as IL-4 production, were seen after 
exposure to respiratory allergens. However, these features may be dependent on the dose of 
the particular allergen. Therefore, the aim of the present study was to investigate the 
distinction between contact sensitizers and respiratory allergens, by establishing dose-
dependent cytokine profiles. The contact allergens 2,4- dinitrochlorobenzene (DNCB), hexyl 
cinnamic aldehyde (HCA) and oxazolone (OXA, 4-ethoxymethylene 2- phenyloxazol-5-one), 
as well as the respiratory allergens fluorescein 5-isothiocyanate (FITC), phthalic anhydride 
(PA), toluene diisocyanate (TDI), and trimellitic anhydride (TMA) were tested. For a range of 
concentrations, both proliferative responses and cytokine production were established. 
Estimated concentrations were derived at several stimulation indices (SI’s). From the 
estimated concentrations, IFN-γ, IL-4, and IL-10 production as a function of stimulation 
indices were plotted. All four respiratory allergens showed significantly higher IL-4 and IL-
10 production patterns compared to the contact allergens. Positive identification of DNCB, 
HCA, and OXA as contact allergens on the basis of IFN-γ production, was observed only at 
very high stimulation indices (SI≥35) for DNCB and OXA and already at low SI’s (SI≤7) for 
HCA. We propose that by direct linkage of proliferation and cytokine production in a dose-
response manner, distinguishing contact allergens from respiratory allergens may be 
improved compared to present approaches. 
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INTRODUCTION 
 
The murine local lymph node assay (LLNA) is a method for the predictive identification of 
chemicals that have the potential to cause sensitization (Kimber et al., 1995; Loveless et al., 
1996). In this test, the lymph node (LN) proliferative responses of treated animals are 
compared to those of vehicle-treated animals. Chemicals that elicit a stimulation index (SI) of 3 
or more in the LLNA are considered as being sensitizers. In addition, these EC3 (estimated 
concentration in % required for SI=3) values can be used for the comparison of sensitizing 
potential derived from local LN responses (Kimber et al., 1995; Kimber and Basketter, 1997; 
Loveless et al., 1996). Besides linear evaluation the dose response can be evaluated by 
nonlinear regression analysis. This latter approach was previously taken by us using a modified 
LLNA (Van Och et al., 2000), where the concentration inducing an SI of three is estimated 
based on a curve fitting method. In addition, confidence limits provide information on the 
reliability of the data.  
However, the LLNA as such does not discriminate between contact and respiratory 
allergens. Another, experimentally used test in mice is also based on dermal exposure, but in 
contrast to the LLNA comprises both a sensitizing and effector phase (Dearman et al., 1994, 
1995, 1996ab). This test showed that contact allergens preferentially induce a T-helper 1 
(TH1) response, whereas respiratory allergens preferentially induce a T-helper 2 (TH2) 
response. These responses can be discriminated on the basis of cytokine production, such as 
IFN-γ, that is produced by TH1 cells, and IL-4 and IL-10, that are produced by TH2 cells.  
In a previous study, using a modified LLNA (Vandebriel et al., 2000), we tried to 
establish whether the LLNA proved sufficient not only to identify allergens, but also to mark 
them as either a contact or a respiratory allergen. To compare the different chemicals, 
concentrations were chosen that induced similar levels of LN cell proliferation. Our findings 
showed that respiratory allergens can be identified on the basis of IL-4 production, since 
application of the respiratory allergens phthalic anhydride (PA), toluene diisocyanate (TDI), 
and trimellitic anhydride (TMA) resulted in a 15- to 30-fold higher IL-4 production compared 
to the contact allergen 2,4- dinitrochlorobenzene (DNCB). Application of TDI, TMA, and PA 
induced similar amounts of IFN-γ compared to DNCB and thus IFN-γ seemed not suitable as a 
positive indicator for the identification of contact allergens.  
The approaches referred to above are comparisons based on single concentrations. 
However, linking cytokine production to proliferation of the same cells over the entire range of 
concentrations used may provide a more complete insight in the capacity of sensitizers to 
induce cytokines. Therefore, dose-response studies in a modified LLNA were performed for 
both proliferative responses and cytokine production after exposure to the contact allergens 
DNCB, HCA, and OXA, as well as the respiratory allergens FITC, PA, TDI, and TMA. From 
that, using non-linear regression analysis for both parameters individually, models describing 
proliferative responses vs. cytokine production were plotted. By evaluating the cytokine profile 
based on the proliferative response, it can be established whether an unknown allergen is a 
contact or respiratory allergen. In addition, since this approach directly links cytokine 
production to proliferation of the same cells, this approach is excluding the need for parallel, 
dissimilar experiments. The approach presented in this study is a way to discriminate between 
contact allergens and respiratory allergens independently from the choice of the concentrations 
used. The use of a single short assay for both proliferation (for identification of sensitizers) and 
cytokine production (for discrimination between sensitizers) is in line with one of the three R’s 
(reduction, refinement, and replacement) of animal welfare policies. 
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METHODS 
 
Chemicals  
DNCB (2,4-dinitrochlorobenzene; 98%; Sigma-Aldrich, Zwijndrecht, the Netherlands), FITC 
isomer I (Fluorescein 5-isothiocyanate; 90%; Sigma-Aldrich), oxazolone (OXA, 4-
ethoxymethylene 2- phenyloxazol-5-one; 90%; Sigma-Aldrich), PA (phthalic anhydride; 99%; 
Sigma-Aldrich), TDI (toluene 2,4-diisocyanate; 99.8%; Sigma-Aldrich),  and TMA (trimellitic 
anhydride; 1, 2, 4- benzenetricarboxylic anhydride; 97%; Sigma-Aldrich), were dissolved in 4:1 
acetone/olive oil (AOO). HCA (hexyl cinnamic aldehyde; 85%; Sigma-Aldrich) was dissolved 
in 4:3:3 dimethylacetamide/acetone/ethanol (DAE). AOO and DAE were used as vehicle 
control. 
 
Animals 
Male BALB/c mice were used at the age of 6-8 weeks. They were obtained from our own 
breeding colony. The diet consisted of ground standard laboratory chow (RMH-B, Hope Farms, 
Woerden, the Netherlands). Food and water were given ad libitum. The breeding colony of the 
animals was pre-screened/monitored for endogenous pathogenic viruses and bacteria and was found 
negative.  
 The experimental setup of the studies was examined and agreed upon by the Ethical 
Committee on Experimental Animals. 
 
Modified local lymph node assay (LLNA) 
 Groups of mice (n=4, n=8 for the AOO control group, except HCA, n=6 for test groups and 
control group) were exposed to 25 µl of test solution in vehicle or vehicle alone on both ears 
daily for three consecutive days. Five days following the first topical application, the auricular 
lymph nodes were excised. The lymph nodes (LN) were weighed and pooled for each animal 
and suspended in 5 ml RPMI- 1640 (Gibco, Breda, the Netherlands) supplemented with 5% 
heat inactivated Fetal Calf Serum (PAA, Linz, Austria), 100 U/ml penicillin and 100 µg/ml 
streptomycin (standard medium). Single cell suspensions were prepared under aseptic 
conditions by pressing the LN through a sterile 70 µm nylon cell strainer (Falcon, Franklin 
Lakes, NJ). The cells were washed twice in standard medium (10 minutes, 311g, 4°C) and 
resuspended in 1 ml standard medium with 10% FCS. The cells were counted using a Coulter 
Counter (Coulter Electronics, Mijdrecht, the Netherlands) and cultured at a concentration of 
1.107 cells/ml. LN cells from allergen treated animals were seeded for individual animals, while 
LN cells from AOO treated animals were seeded from pooled animals (2 animals). The reason 
to pool LN cells from different animals was that in case of AOO treated animals the number of 
LN cells obtained per animal was insufficient to perform the subsequent assays. The cell 
suspensions (200 µl) were seeded in triplicate into round-bottomed 96-well microtitre plates 
(Greiner, Alphen a/d Rijn, the Netherlands). The cells were cultured with 10 µl of [3H]TdR 
(Amersham, Little Chalfont, United Kingdom; 37 kBq/ml) for 24 hr at 37°C in a humidified 
atmosphere of 5% CO2 in air. The [
3H]TdR incorporation was determined by liquid 
scintillation counting in a β plate counter (1205 BetaplateTM Wallac, Turku, Finland). The 
[3H]TdR incorporation is expressed per animal, i.e. the [3H]TdR incorporation is multiplied by 
the cell number of the two lymph nodes and divided by the cell number in culture (2x106). 
 We have used a range of test concentrations to determine dose-response relationships. 
The estimated concentration in % required for a certain SI=x (ECx) was determined as the 
estimated dose inducing a stimulation index of x between treated versus control animals.  
Cytokine production as a function of the SI 
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Table 1 
Concentrations used in the modified local lymph node assay (LLNA)  
Chemical % Concentration (w/v) 
 
DNCB 0.1, 0.25, 0.5, 1 
 
FITC 0.025, 0.1, 0.25, 1 
 
HCA 3, 10, 30 
 
OXA 0.0025, 0.01, 0.025, 0.1 
 
PA 0.25, 1, 2.5, 10 
 
TDI 0.1, 0.25, 1, 2.5 
 
TMA 1, 2.5, 5, 10 
 
 
ELISA.  
LN cell suspensions were made as described above. The suspensions were cultured at 106 cells per 
ml culture medium with Con A (5 µg/ml) and 5 x 10-5M 2-mercaptoethanol for 24 hrs. After 
culture, aliquots of supernatants were frozen on dry ice and stored at -80 °C until use. IL-4, IL-10 
and IFN-γ concentrations were determined by ELISA. Briefly, 96-well plates (Nunc-Immuno Plate, 
Roskilde, Denmark) were coated with 1 µg/ml anti-mouse IFN-γ (R4-6A2, rat IgG1; Pharmingen, 
San Diego, CA) in coating buffer (0.04 M carbonate buffer, pH 9.6). After overnight incubation at 
4°C the plates were incubated in blocking buffer (1% bovine serum albumin (BSA; Sigma, Axel, the 
Netherlands) plus 0.05% Tween-20 (Merck, Amsterdam, the Netherlands), in PBS) for 2 hrs at 
37°C and washed (0.05% Tween-20). Recombinant mouse IFN-γ (Biosource, Camarillo, CA) was 
used as a standard. Standard as well as serial dilutions of culture supernatants were added to the 
plate. Plates were incubated at 37°C for 2 hrs and washed. Biotinylated anti-mouse IFN-γ (0.5 
µg/ml; XMG1.2, rat IgG1; Pharmingen) was added and incubated for 1 hr at room temperature 
(RT). The plates were washed, and poly horseradish peroxidase labeled streptavidin (10,000-fold 
dilution, Strepta-E+, Central Laboratory of the Blood transfusion service, Amsterdam, the 
Netherlands) was added and incubated for 1 hr at RT. Plates were washed again and TMB solution 
(0.1 mg/ml TMB (Sigma) plus 0.006% H2O2, in 0.1 M NaAc, pH 5.5) was added. The plates were 
read at 450 nm, using an automated reader (Titertek Multiskan, Flow Laboratories, Lugano, 
Switzerland). For IL-4, a similar protocol was used, with 0.5 µg/ml anti-mouse IL-4 (11B11, rat 
IgG1; Pharmingen) for coating, recombinant mouse IL-4 (Pharmingen) as a standard, and 0.5 µg/ml 
biotinylated anti-mouse IL-4 (BVD6-24G2, rat IgG1; Pharmingen) for detection. The IL-10 content  
 
 
Figure 1 
Effect of topical application on lymphocyte proliferation. BALB/c mice were treated by topical application on 
both ears with various concentrations DNCB, FITC, HCA, OXA, PA, TDI, and TMA for three consecutive 
days. Five days after the first application, the local LN were excised, pooled (per animal for allergen treatment 
and per 2 animals for vehicle treatment), and cell suspensions were prepared. Cells were cultured for 24 hrs in 
the presence of 3H-thymidine, and 3H-incorporation was measured. Results are calculated by multiplying the 3H-
incorporation by the LN cell number, and expressed as cpm ± SEM (n=4). (*), (**), (***), significantly different 
from AOO (P < 0.05, P < 0.01, P < 0.001, respectively). 
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of culture supernatants was measured using 4 µg/ml anti-mouse IL-10 (JES052A5, rat IgG1; R&D 
Systems, Oxon, UK) for coating and 400 ng/ml biotinylated goat-anti-mouse IL-10 (IgG; R&D 
Systems) for detection. Recombinant mouse IL-10 (R&D Systems) was used as a standard. 
Antibodies, standards, samples, and streptavidin were diluted in 0.5% BSA plus 0.05% Tween-20, 
in PBS (Van Halteren et al., 1997).  
 Data are expressed as mean (ng) ± SEM. Similar to cell proliferation, results are expressed 
per two LN (per animal), i.e. the response (ng/ml) is multiplied by the local LN cell number, and 
divided by the cell culture concentration (106/ml). 
 
Statistical analysis  
Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by 
the two-tailed Student’s t test using the ANOVA calculated pooled standard deviation. 
Significance levels were (*) p < 0.05, (**) p < 0.01, and (***) p < 0.001. 
 
The dose-response data were analyzed by nonlinear regression analysis, using the following 
family of models: 
 
model 1:  y  =   a       
model 2: y  =   a exp( b x )     
model 3: y  =   a exp( b xd)     
model 4: y  =   a (c - (c - 1) exp( b x)    
model 5: y  =   a (c - (c - 1) exp( b xd))    
model 6: y  =   d + a ( xc/(b + xc ))    
 
where y represents the response and x the applied concentration. In these models the parameter 
a represents the background of the particular assay. In all models the parameter a is 
constrained to being larger than zero, since it denotes the value of the response at dose zero. 
The parameter b reflects the ‘slope’ or the ‘strength’ of the response with increasing dose. 
Parameter c determines whether the function increases or decreases, by being larger or smaller 
than unity, respectively. To render model 3 describing a decreasing response d has to be 
changed into -d. The parameter d is constrained to values larger than (or equal to) one, to 
prevent the slope of the function at dose zero from being infinite, this being biologically unreal. 
The selection of the model to be used for a particular data set follows from a procedure of 
successively fitting the above models, and applying likelihood ratio tests to establish if an 
increase in the number of parameters leads to a significantly better fit to the data. A model with 
more parameters is considered better only if this leads to a significantly better fit (Slob, 1999). 
The selected model is used to derive the estimated concentration (EC) associated with a 
stimulation index or cytokine production. Full statistical details are given in Slob (2002). 
 
 
Figure 2  
Effect of topical application on IL-4 production. BALB/c mice were treated by topical application on both ears 
with various concentrations DNCB, FITC, HCA, OXA, PA, TDI, and TMA for three consecutive days. Five 
days following the first topical application, the local LN were excised, pooled per animal, and cell suspensions 
were prepared. Cells were cultured for 24 hrs in the presence of Con A and supernatants were analyzed for 
cytokine content using ELISA. Results are calculated by multiplying the IL-4 concentration by the LN cell number, 
and expressed as amount of IL-4 (ng) ± SEM (n=4). (**), and (***), significantly different from AOO (P < 0.01, 
and P < 0.001, respectively).  
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RESULTS 
 
Lymphocyte proliferation 
Figure 1 shows the dose-response relationships for the proliferation of LN cells for the 
different chemicals. The concentrations used in the LLNA for DNCB, FITC, OXA, PA, TDI, 
and TMA are shown in Table 1. DNCB and TDI, induced significantly higher proliferative 
responses after topical application relative to vehicle treatment for the highest three 
concentrations used (p < 0.001, except 0.25% where p < 0.01). PA induced significantly higher 
proliferative responses for the three highest concentrations used (p < 0.001, except 1% where p < 
0.05). FITC, OXA, and TMA induced significantly higher proliferative responses relative to 
vehicle treatment for the highest two concentrations used (p < 0.001, except 0.25% FITC where p 
< 0.01 and 0.025% OXA where p < 0.05). Only for the highest concentration of HCA, a 
statistically significant difference was found (p < 0.001). Application of DNCB, OXA, PA, and 
TMA resulted in similar dose-response curves for the LN cell proliferation. Application of 
TDI resulted in a higher maximal proliferative response, compared to the other compounds. 
The lowest proliferative responses were seen for FITC and HCA.  
 
Cytokine production 
We have measured cytokine dose-responses induced by the contact sensitizers DNCB, HCA, 
and OXA and the respiratory allergens FITC, PA, TDI, and TMA, at the same concentrations as 
were tested for proliferation. All chemicals showed a clear dose-response relationship for the 
three cytokines tested, IL-4, IL-10, and IFN-γ (Fig. 2, 3, and 4, respectively), except HCA that 
showed no dose-response relationship for IL-10. FITC, PA, TDI and TMA induced significantly 
higher IL-4 production after topical application relative to vehicle treatment (p < 0.001, except 
1% PA and 2.5% TMA where p < 0.01, and 0.1% FITC where p < 0.05), with the exception of 
the lowest concentration. DNCB, HCA and OXA showed significant IL-4 production only at the 
highest two concentrations (p < 0.001, except 10% HCA where p < 0.05 and 0.025% OXA 
where p < 0.01). For the different chemicals, IL-10 production was rather similar compared to IL-
4 production (Fig. 3). DNCB, PA, TDI, and TMA induced significant IL-10 production at the 
highest three concentrations (p < 0.001, except 2.5% TMA where p < 0.01, and 0.5% DNCB and 
1 % PA, where p < 0.05). For FITC and OXA, only the highest concentration induced 
significantly higher IL-10 production relative to vehicle treatment (p < 0.001). HCA showed no 
statistically significant increase of IL-10 production. The LN cells derived from vehicle (AOO)-
treated mice failed to produce detectable levels of IL-4 and IL-10. For FITC, HCA, PA, and 
TMA, IFN-γ production showed significant production only at the highest two concentrations (p 
< 0.001, except 0.25% FITC were p < 0.01, 2.5% PA and 10% HCA where p < 0.05). DNCB 
induced significantly higher IFN-γ production after topical application relative to vehicle 
treatment (0.25% where p < 0.01; and 0.5% and 1% where p < 0.001). TDI showed significant 
IFN-γ levels even at the lowest concentration (p < 0.001, except 0.1% where p < 0.05). OXA 
showed significant IFN-γ production only at the highest concentration (p < 0.001). 
 Generally, topical application of TDI resulted in the highest IL-4 production (Fig. 2). PA 
induced IL-4 similar to TMA. For PA, TDI, and TMA, topical application strongly induced IL-4 
production, even at very low concentrations. DNCB and HCA induced much lower amounts of 
IL-4 compared to the respiratory allergens. At the highest concentrations, DNCB induced 2- to 3-
fold less IL-4, while HCA induced 4- to 5-fold less IL-4 compared to the respiratory allergens. 
OXA showed similar IL-4 production compared to FITC. PA induced IL-10 similar to TMA, and 
the induction by DNCB, OXA, and FITC was about 5-fold lower than by PA and TMA (Fig. 3). 
Only TDI, showed a very high IL-10 production compared to DNCB and OXA (14-fold), FITC 
(11-fold), and PA and TMA (2- to 3-fold). The induction of IFN-γ was strongest for DNCB  
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Figure 3  
Effect of topical application on IL-10 production. Results are calculated by multiplying the IL-10 concentration by 
the LN cell number, and expressed as amount of IL-10 (ng) ± SEM (n=4). (*), (**), and (***), significantly 
different from AOO (P < 0.05, P < 0.01, and P < 0.001, respectively). 
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Figure 4 
Effect of topical application on IFN-γ production. Results are calculated by multiplying the IFN-γ concentration by 
the LN cell number, and expressed as amount of IFN-γ (ng) ± SEM (n=4). (*), (**), and (***), significantly 
different from AOO (P < 0.05, P < 0.01, and P < 0.001, respectively). 
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compared to the other six chemicals (Fig. 4). Even TDI, which showed a 2-fold higher 
proliferative response compared to the other chemicals (Fig. 1), showed lower IFN-γ  production 
compared to DNCB. Similar responses were seen for OXA and TMA, while the induction of 
IFN-γ by FITC, HCA and PA was 2- to 4- fold lower compared to the other chemicals tested.  
  
Cytokine production as a function of proliferative response 
At several stimulation indices (SI’s), the corresponding effective concentrations (EC) were 
calculated. For these EC-values, the corresponding IL-4, IL-10, and IFN-γ production was 
determined for the different chemicals (Tables 2, 3, and 4, respectively). Next, the IL-4, IL-10, 
and IFN-γ production was plotted against the stimulation indices (SI’s), based on 
corresponding EC values (Fig. 5A, B, and C, respectively). HCA showed a maximal SI of 7, 
FITC of 20, PA of 30, and OXA of 50, compared to vehicle treated animals. For DNCB, TDI, 
and TMA, a maximal SI of 70 was used in the evaluation of the data. Even at low stimulation 
indices, clear differences in IL-4 and IL-10 production were seen between the contact 
sensitizers DNCB, HCA, OXA and the respiratory allergens FITC, PA, TDI, and TMA. At a 
SI=7, HCA induced lower amounts of IL-4 compared to FITC (1.6-fold), PA (3.1-fold), TDI 
(2.4-fold), and TMA (1.6-fold). Because no induction of IL-10 was found after exposure to 
HCA, EC values could not be calculated for this cytokine. OXA showed even greater 
differences in IL-4 production at a SI=7 compared to FITC (2.6-fold), PA (5.3-fold), TDI 
(4.1-fold) and TMA (2.8-fold). At a SI=10 very large differences were seen for FITC (41-
fold), PA (83-fold), TDI (58-fold), and TMA (45-fold) compared to DNCB. At a SI=20, for 
FITC a 6.7-fold increase and for PA a 14.8-fold increase in IL-4 production was seen 
compared to DNCB. TDI (6.8-fold) and TMA (3.8-fold), showed increased IL-4 production at 
the maximal SI=70 (Fig. 5A) compared to DNCB. Similar IL-10 production were seen for 
FITC (5.5 fold at a SI=20), PA (6.4-fold at a SI=30), TDI and TMA (18.7-fold and 5.1-fold at 
a SI=70, respectively) compared to DNCB (Fig. 5B). OXA showed a similar IL-10 production 
as DNCB. TDI induced higher amounts of IL-10 production compared to the other six 
allergens, including the respiratory allergens FITC, PA, and TMA. TDI showed a 3- to 4-fold 
difference from a SI=30 and higher compared to TMA. At a SI=20, FITC induced higher 
amounts of IL-10 compared to the contact allergen OXA (3.9-fold). At a SI=7, HCA induced 
considerably higher IFN-γ production compared to FITC, PA and TMA (3.2-fold, 6.4-fold and 
4.5-fold, respectively). At a SI=5 lower IFN-γ production was found for DNCB and OXA 
compared to the other allergens, whereas higher IFN-γ production was observed from a SI=35 
and higher (Fig. 5C) for both contact allergens. Again, TDI induced higher amounts of IFN-γ 
production compared to the respiratory allergens FITC, PA and TMA (2.2-fold, 2.7-fold and 
2.6-fold at SI=20, respectively). 
 
DISCUSSION 
 
The results presented in this paper, suggest that by directly linking the cytokine production to 
proliferation of the same cells, one can simultaneously identify, classify (based on lymphocyte 
proliferation), and characterize (based on cytokine production) chemicals in one single test. 
This approach is able to discriminate between respiratory and contact allergens independently 
of the choice of the concentrations used.  
For respiratory allergens production of IL-4, and to a lesser extent IL-10, were 
discriminating already at low SI levels. For DNCB and OXA, even at a SI=3 much lower IL-4 
production was seen compared to FITC, PA, TDI, and TMA. At a SI=20 a 6.7–fold lower IL-
4 induction by DNCB compared to FITC was still seen, while even higher differences were 
seen compared to PA (14.8-fold), TDI (10.8-fold), and TMA (9.1-fold). 
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Relative to DNCB, OXA showed smaller differences in IL-4 induction compared to FITC (1.7-
fold), PA (3.7-fold), TDI (2.7-fold), and TMA (2.3-fold) (see Table 2). Both contact allergens 
DNCB and OXA showed even greater differences in IL-10 production compared to the 
respiratory allergens (see Table 3). In the smaller range of proliferation for HCA, IL-4 
production suggests it being a respiratory allergen but the absence of IL-10 production and the 
high IFN-γ production suggests it to be a contact allergen. Notably, in contrast to DNCB and 
OXA, HCA showed no induction of IL-10, while at a SI=7 higher IFN-γ production was seen 
compared to PA and TMA (6.4-fold and 4.5-fold, respectively). From a SI≥20 DNCB and 
OXA showed higher IFN-γ production compared to the respiratory allergens FITC, PA, and 
TMA. TDI induced a higher IFN-γ production for 3<SI<35 compared to DNCB and OXA, 
and lower IFN-γ production from SI>35. Moreover, TDI showed a much higher IFN-γ 
production compared to the other respiratory allergens FITC, PA, and TMA (2.2-fold, 2.7-
fold, and 2.6-fold at SI=20, respectively). IL-10 production from SI≥ 30 was considerable 
higher after application of TDI compared to all other allergens. 
DNCB is a potent contact allergen known to cause allergic contact dermatitis in man 
(Kligman and Epstein, 1959), but is considered not to cause respiratory allergy (Botham et al., 
1989). HCA is a contact allergen of mild to moderate potency (Dearman et al., 1998) and one 
of the chemicals that are recommended by the Organization for Economic Cooperation and 
Development (OECD, 1992) for use as a positive control in skin sensitization testing. Previous 
findings suggest OXA to be a potent contact allergen in both the GPMT (Gad et al., 1986) and 
the LLNA (Loveless et al., 1996). FITC was previously shown to be a contact sensitizer 
(Thomas et al., 1980). Recent observations, however, identified FITC as a respiratory allergen 
based on a type 2 cytokine profile and specific IgE antibody response (Dearman and Kimber, 
2000). PA, TDI, and TMA are all recognized occupational respiratory allergens (Hagmar et 
al., 1987; Murdoch and Pepys, 1987). However, PA and TMA can also penetrate the skin of 
humans and thus have the potential to elicit an allergic reaction in the skin (Bernstein et al., 
1982). Contact sensitivity by TDI has also been demonstrated in humans (Malten, 1979) and 
animals (Tominaga et al., 1985; Scheerens et al., 1996). So, some compounds are capable in 
causing allergic reactions in either skin or respiratory tract and others in both. Our data 
indicate that the cytokine profile was clearly able to identify respiratory sensitizers, such as 
FITC, PA, and TMA and skin sensitizers, such as DNCB, HCA, and OXA. Somewhat 
different cytokine responses were seen after application of the contact allergen HCA compared 
to DNCB and OXA. HCA induced a considerably higher amount of IL-4 compared to DNCB, 
but still significant differences were seen compared to the respiratory allergens. Also higher 
amounts of IFN-γ were induced following application of HCA compared to DNCB and OXA, 
while no induction of IL-10 was observed. HCA can therefore be identified as a contact 
allergen. In addition, this result indicates that even at low levels of proliferation this distinction 
can be made. 
 
 
Figure 5 
Cytokine production as a function of the proliferative response. At certain stimulation indices (SI), the 
corresponding estimated concentrations were calculated (EC). Based on these EC-values, corresponding IL-4, 
IL-10 and IFN-γ production (A, B and C, respectively) was determined for DNCB (∆), FITC (∇), HCA (◊), 
OXA ( ), PA (+), TDI (•), and TMA (ο). The curves for the contact allergens are shown as dashed lines and 
the curves for the respiratory allergens as contineous lines.            
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TDI seems to be of a mixed nature, depending on the concentration used for 
sensitization. Remarkably, the fact that TDI besides considerable IL-4 production, also induces 
considerable amounts of IFN-γ may have been expected, because the compound has shown 
features of both contact and respiratory allergens in both humans and animals (Malten, 1979; 
Tominaga et al., 1985; Scheerens et al., 1996). In general, compounds that induce Th2 cells, 
mediate type I (immediate) hypersensitivity, and induce IgE and IgG1 production are 
respiratory sensitizers, and are associated with the production of high levels of IL-4 by the 
draining LN cells. However, skin sensitization with TDI can induce respiratory hypersensitivity 
with features of type IV hypersensitivity in mice (Scheerens et al., 1996). Also in humans, 
specific IgE is only detected in a minority of patients suffering from respiratory allergy induced 
by TDI (Karol, 1981; Karol et al., 1994). It may be postulated that TDI induces different types 
of responses, depending on the exposure concentrations. Our results are in line with recent 
observations by Manetz et al. (2001), who investigated IL-4 and IFN-γ mRNA levels of draining 
lymph node cells following dermal exposure to TDI, and found both to be increased. 
Consequently, we propose that chemicals should be evaluated at concentrations that 
induce a similar induction of proliferation. When under these conditions a chemical induces a 
similar (or higher) IL-4 and IL-10 production compared to FITC, PA, TDI, and TMA, the 
sensitizer may be designated a respiratory sensitizer. A chemical may be identified as a contact 
allergen when IFN-γ production is similar to DNCB, HCA, and OXA while IL-4 production is 
similar to HCA, or IL-4 and IL-10 production are similar to DNCB and OXA. Importantly, 
these comparisons should be made on the entire dose response curve. 
In conclusion, the aim of the present study was to develop a new approach to 
distinguish between contact and respiratory allergens, by measuring dose-dependent cytokine 
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profiles in a modified LLNA. For a range of concentrations, both proliferative responses and 
cytokine production were established. Estimated concentrations were derived at several 
stimulation indices (SI’s). From the estimated concentrations, IFN-γ, IL-4, and IL-10 
production as a function of stimulation indices were plotted. The data showed that FITC, PA, 
TDI, and TMA can be discriminated from DNCB, HCA, and OXA on the basis of both IL-4 
and IL-10 production. A positive identification of the contact allergens on the basis of IFN-γ 
production, was observed only at very high stimulation indices (SI≥35) for DNCB and OXA, 
and already at low SI’s (SI≤7) for HCA. On the basis of IL-10 and IFN-γ production, TDI 
showed different responses compared to FITC, PA, and TMA. By directly linking the cytokine 
production to proliferation of the same cells, discrimination between respiratory and contact 
allergens can be done independently of the choice of the concentrations used. 
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MODELLING PHYSICO-CHEMICAL PROPERTIES OF LOW 
MOLECULAR WEIGHT CHEMICALS FOR PREDICTION  
OF ALLERGENIC POTENCY 
 
François M. M. van Och, Josien C. van Wolfswinkel, Katsushisa Takumi,  
Cees A. van Walree, Henk van Loveren, Rob J. Vandebriel 
 
 
 
In the present study we sought to predict the allergenic potency of chemicals solely on the 
basis of their molecular features. We calculated the physico-chemical properties of ten 
allergens (ethyl-p-aminobenzoate (BENZ), diethylamine (DEA), 2,4- dinitrochlorobenzene 
(DNCB), hexyl cinnamic aldehyde (HCA), 2- mercaptobenzothiazole (MBT), 4-
ethoxymethylene 2- phenyloxazol-5-one (OXA), phthalic anhydride (PA), toluene diisocyanate 
(TDI), trimellitic anhydride (TMA), and tetramethyl thiuram disulfide (TMTD). Multiple 
regression analysis of the EC3 (estimated concentration in % required for stimulation index of 
three in LLNA) against the different molecular features resulted in different models. EC3 
values formerly obtained with a modified LLNA were used as reference. For each model the 
predicted sensitizing values (PSVs) were calculated for the different chemicals and compared 
to the LLNA data. The weak allergens BENZ and DEA showed a PSV > 19, whereas a PSV < 
5 was observed for the strong allergens DNCB, PA, TDI, TMA, and TMTD. Only the potent 
allergen OXA, together with the moderate allergens HCA and MBT, showed PSVs between 5 
and 19. Based on the outcome, a scaling of chemicals can be suggested. For instance, if the 
PSV of an allergen is < 5, it is likely to be a potent allergen, between 5 and 10 a moderate 
allergen, and if an allergen has a PSV > 10 it is most likely to be a weak allergen. Because 
only a limited number of allergens was evaluated, the approach taken in this study can only 
be seen as a first step in the development of a model. Extension to a substantially larger 
dataset is neccessary in order to obtain a more reliable model. If succesfull, this approach 
may be used as a prescreen for the allergenic potency of chemicals and such an in silico 
approach may ultimately lead to a reduction in the use of experimental animals. 
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INTRODUCTION 
 
Identification of contact allergens (skin sensitizers) is generally performed using animal models. 
The tests most commonly used are the guinea pig maximization test (GPMT) and the murine 
local lymph node assay (LLNA). The LLNA (Kimber et al., 1986; Kimber and Weisenberger, 
1989) identifies the sensitizing capacity of low molecular weight chemicals as a function of 
induced proliferative responses in lymph nodes draining the site of application. For risk analysis 
an important next step is the determination of the sensitizing potency of allergens. Besides 
others (Basketter et al., 1999), we have previously described relative potency determination 
using a modified LLNA (Van Och et al., 2000; De Jong et al., 2002). 
One approach to predict the sensitizing capacity, or even the potency, without the use 
of animals is the use of computer-based models (expert systems). These models link physico-
chemical properties of a range of compounds with human clinical data or experimental animal 
data to identify structural alerts for skin sensitization. The characteristics of a chemical are 
generally thought to be determined by its atomic composition and structure. Especially 
physico-chemical properties are thought to predict a large portion of a molecule’s behaviour. 
Several studies have been described in which the sensitizing potential of chemicals together 
with certain physical and chemical parameters of these compounds were used to build a 
mathematical model (Magee et al., 1994; Graham et al., 1996; Hostynek and Magee, 1997). 
Examples of parameters used in these models are parameters for reactivity (water solubility, 
molecular weight), and penetration (molecular refraction, log P (octanol/water partition 
coefficient)). 
Barratt et al. (1994) reported the as yet greatest success in predicting the activity of 
contact sensitizers, notably a sensitivity rate of 98%. They used a knowledge-based computer 
system called DEREK (“Deductive Estimation of Risk from Existing Knowledge”; Sanderson 
and Earnshaw, 1991). DEREK embodies both a controlling program and a chemical rulebase 
and is originally based on an Unilever database containing the results of 294 defined substances 
in the GPMT. This rulebase contains a subset of approximately 50 rules that describes chemical 
substructures known or believed to be responsible for the chemical reactivity component of 
skin sensitization. Moreover, Barratt (1996) developed a mathematical model to calculate the 
theoretical irritation potential of chemicals. In this model the predicted irritation index (PII), 
which is a measure for erythema and oedema occurring during the first 3 days of exposure to 
the chemical, was predicted using the octanol-water partition coëfficient (logP) and the 
molecular volume (MV) as markers for skin permeability, and the dipole moment (dipole) as a 
marker for chemical reactivity. 
In the present study we sought to estimate the sensitizing potency of allergens solely 
based on their physico-chemical properties. Besides the properties mentioned above we 
included five properties in our investigation, i.e. octanol-water partition coefficient (logP), 
molecular volume (MV), melting point (mpt), adsorption coefficient (AC), molecular weight 
(MW), and surface. These parameters are supposed to indicate the accessibility of the 
chemicals to the cells. Dipole moment, aqueous solubility (AS), and ionisation constant (pKa) 
are supposed to indicate the reactivity of the allergen. Because the LLNA is able to provide 
quantitative data on the sensitizing potency, much more than the GPMT, we used the data we 
previously obtained with a modified LLNA (Van Och et al., 2000) as reference. Stepwise 
regression analysis resulted in simple mathematical models described as equations. Predicted 
sensitizing values (PSVs) were calculated for the different chemicals and the potency of the 
sensitizing capacity was compared to the classification we previously found in a modified 
LLNA (Van Och et al., 2000).  
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MATERIALS AND METHODS 
 
Chemicals 
Benzocaine (BENZ, ethyl-p-aminobenzoate; 99% purity; Sigma-Aldrich Chemie B.V., 
Zwijndrecht, NL, CAS 94-09-7), DEA (diethylamine; 99.5%; free base solution; Sigma-
Aldrich, CAS 109-89-7), DNCB (2,4-dinitrochlorobenzene; 98%; Sigma-Aldrich, CAS 97-00-
7), HCA (hexyl cinnamic aldehyde; 85%; Sigma-Aldrich, CAS 101-86-0), MBT (2-
mercaptobenzothiazole; 98%; Sigma-Aldrich, CAS 149-30-4), oxazolone (OXA, 4-
ethoxymethylene 2- phenyloxazol-5-one; 90%; Sigma-Aldrich, CAS 15646-46-5), PA (phthalic 
anhydride; 99%; Sigma-Aldrich, CAS 85-44-9), TDI (toluene 2,4-diisocyanate; 99.8%; Sigma-
Aldrich, CAS 584-84-9), TMA (trimellitic anhydride; 1, 2, 4- benzenetricarboxylic anhydride; 
97%; Sigma-Aldrich, CAS 552-30-7), TMTD (tetramethylthiuramdisulfide; 98%; Sigma-
Aldrich, CAS 137-26-8) were tested.  
 
Calculation of physico-chemical properties 
For the estimation of physico-chemical properties of the different chemicals, the chemical 
structures were constructed using ChemSketch software from ACD labs (version 5.0 for 
Microsoft Windows, Advanced Chemistry Development Inc., Ontario, Canada).  Dipole 
moments were calculated using MOPAC software (version 6.0, Fujitsu Systems, Amsterdam, 
NL). Surface areas were calculated from the same structures using PCMODEL software 
(version 4.0, Serena Software, CA, USA), with the spacing increment set at 0.25 Å. For the 
calculation of structural properties, the structures were optimised according to the PM3 
method (Stewart, 1989). Molecular volume (MV) was calculated from the surface under the 
assumption that the molecule is spherically shaped. Values for octanol-water partition 
coëfficient (logP), adsorption coefficient (AC), aqueous solubility (AS), and molecular weight 
(MW) were calculated using the ACD/I-Lab Web service (Advanced Chemistry Development 
Inc., Ontario, Canada, http://www2.acdlabs.com/ilab/). Melting points (mpt) were obtained 
from catalogues of commercial suppliers. The calculated physical and chemical properties are 
shown in Table 1.  
 
Correlation/multiple regression analysis 
Correlation of the different properties with the EC3 values in the LLNA were derived with 
Mathematica version 4.0 (Wolfram Software, Oxfordshire, UK) and are summerized in a 
correlation matrix (Table 2).  
The different models were generated by stepwise regression analysis using 
Mathematica version 4.0.  
 
RESULTS 
 
Calculation of the physico-chemical properties 
In order to predict the behaviour of the chemicals used in this study, several of their physico-
chemical properties were calculated. These properties are given in table 1.  
The ionisation constant (pKa), formerly used as a measure of cytotoxicity (Barratt, 
1998), could not be calculated for DNCB, HCA, PA, and TDI because these molecules 
contained unsupported atoms according to the ACD/I-Lab software program. Therefore, the 
parameter pKa was not used in further analysis.  
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Table 1  
Physico-chemical properties of the chemicals analysed. Values are shown as indicated by the manufacturer, or 
found in chemical databases, or as calculated using chemical modelling software (see Materials and Methods 
for details). Indicated in the table are molecular weight (MW), melting point (Mpt), octanol-water partition 
coëfficient (LogP), dipole moment, surface area, molecular volume (MV), adsorption coefficient (AC), and 
aqueous solubility (AS). The different properties (Px) are numbered for use in mathematical modelling. 
 P1 P2 P3 P4 P5 P6 P7 P8 
Chemical MW 
(Dalton) 
Mpt 
(Celsius) 
LogP Dipole 
(Debyes) 
Surface MV (Å3) AC AS 
(mol/L) 
BENZ 165.19 90 1.80 2.96 170 210 2.7 4.4e-3 
DEA 73.14 -50 0.63 1.79 129 138 1.0 1.7 
DNCB 202.50 53 2.06 4.94 170 210 2.5 4.4e-4 
HCA 216.32 39 5.33 2.25 201 268 4.3 4.3e-6 
MBT 167.25 180 2.38 5.81 146 165 0.2 5.4e-2 
OXA 217.22 96 2.22 2.67 211 288 2.6 2.4e-3 
PA 148.12 133 1.12 5.67 138 152 2.0 6.8e-2 
TDI 174.16 13 2.32 1.72 67 52 2.6 0.2 
TMA 192.13 165 1.07 5.04 27 13 1.0 8.1e-3 
TMTD 240.41 155 1.31 5.90 233 334 2.3 9.2e-4 
 
 
Correlation factors 
The correlation factors between the different properties and the correlation factors of the 
different properties with the reference (EC3 value in the LLNA) were calculated, and are 
shown as a correlation matrix (Table 2). The correlation factors range from −1 (100% negative 
correlation) to 1 (100% positive correlation). A correlation factor of zero indicates no 
correlation between two variables. Molecular volume (MV) and surface show a +0.992 
correlation, with MV being calculated from the surface. Negative correlations were found for 
AC, dipole moment, LogP, MP, MV, and MW compared to the reference parameter EC3, 
whereas AS and surface show a positive correlation. Aqueous solubility (AS) shows the 
highest correlation with EC3 (+0.806), whereas the lowest correlation was found for MV (-
0.025). 
 
 
Table 2  
Correlation matrix. The correlation factors between the different properties and the correlation factors of the 
different properties with the reference (EC3 value in the LLNA) were calculated. 
 MW  Mpt  LogP Dipole  Surface MV AC AS EC3 
MW 1 0.488 0.449 0.303 0.406 0.493 0.492 -0.826 -0.748 
Mpt 0.488 1 -0.139 0.829 0.0384 0.0861 -0.330 -0.680 -0.569 
LogP 0.449 -0.139 1 -0.320 0.331 0.333 0.682 -0.379 -0.114 
Dipole  0.303 0.829 -0.320 1 0.065 0.084 -0.432 -0.450 -0.489 
Surface 0.406 0.0384 0.331 0.065 1 0.992 0.462 -0.172 0.035 
MV 0.493 0.0861 0.333 0.084 0.992 1 0.482 -0.222 -0.025 
AC 0.492 -0.330 0.682 -0.432 0.462 0.482 1 -0.351 -0.174 
AS -0.826 -0.680 -0.379 -0.450 -0.172 -0.222 -0.351 1 0.806 
EC3 -0.748 -0.569 -0.114 -0.489 0.035 -0.025 -0.174 0.806 1 
 
 
Stepwise regression analysis 
In order to estimate the contribution of each physico-chemical property to the empirical 
endpoint, stepwise regression analysis was performed.   
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The different properties as shown in Table 1 are indicated by corresponding P numbers, 
such as P1 for molecular weight, P2 for melting point, P3 for logP etc. 
 
Step 1: 
{P1, P2, P3, P4, P5, P6, P7, P8} 
 [Partial Sum of Squares {265.64, 125.25, 225.42, 50.10, 201.98, 208.24, 140.28, 133.52}] 
P4 (dipole) was removed (value 50.10). 
 
Step 2: 
{P1, P2, P3, P5, P6, P7, P8} 
[Partial Sum of Squares {284.07, 86.41, 207.34, 192.53, 200.16, 90.32, 87.03}] 
P2 (MP) was removed (value 86.41). 
 
Step 3: 
{P1, P3, P5, P6, P7, P8} 
[Partial Sum of Squares {239.44, 135.43, 121.15, 135.14, 5.15, 2.98}] 
P8 (AS) was removed (value 2.98). 
 
Step 4: 
{P1, P3, P5, P6, P7} 
[Partial Sum of Squares {1016.73, 134.99, 191.88, 227.18, 4.73}] 
P7 (AS) was removed (value 4.73). 
 
Step 5: 
{P1, P3, P5, P6} 
[Partial Sum of Squares {1017.16, 161.25, 187.40, 222.45}] 
P3 (logP) was removed (value 161.25). 
 
Step 6: 
{P1, P5, P6} 
[Partial Sum of Squares {877.24, 85.56, 114.73}] 
P5 (surface) was removed (value 85.56). 
 
Step 7: 
{P1, P6} 
[Partial Sum of Squares {1134.24, 247.92}] 
P6 (MV) was removed (value 247.92). 
 
For each step described above a corresponding model was generated to describe the predicted 
sensitizing value (PSV): 
Model 1: 
PSV1 =385.19 – 1.32MW – 0.45mpt + 9.69LogP + 4.30Dipole – 3.79Surface + 
2.66MV – 18.90AC – 84.61AS  
n = 10; r2 = 0.96 
Model 2: 
PSV2 =252.70 – 0.88MW – 0.22mpt + 6.36LogP – 2.32Surface + 1.65MV – 
11.86AC– 46.99AS  
n = 10; r2 = 0.93 
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Model 3:  
PSV3 = 110.29 – 0.50MW + 4.70LogP – 1.03Surface + 0.74MV – 0.99AC – 2.96AS 
n = 10; r2 = 0.88 
Model 4:  
PSV4 = 98.36 – 0.45MW + 4.51LogP – 0.92Surface + 0.66MV – 0.94AC 
n = 10; r2 = 0.87 
Model 5:  
PSV5 = 97.32 – 0.45MW + 4.02LogP – 0.90Surface + 0.65MV 
n = 10; r2 = 0.87 
Model 6:  
 PSV6 = 77.38 – 0.36MW – 0.55P5 + 0.43MV 
n = 10; r2 = 0.78 
Model 7:  
PSV7 = 46.92 – 0.27MW + 0.059MV 
n = 10; r2 = 0.72 
 
The inclusion of more variables resulted in a refinement of the model (i.e. a further 
increase in r2). Only the removal of the adsorption coefficiënt (AC) in the equation (from 
model 4 to model 5) did not result in an decrease of r2. The PSVs for each chemical were 
calculated in the different models and are summerized in Table 3. The allergens BENZ, DEA, 
HCA, and MBT showed high similarity with the EC3 values formerly obtained in model 4–7. 
These differences in potency were similar to the LLNA data. BENZ, DEA, and HCA showed a 
PSV > 10. A PSV < 5 was observed for the allergens DNCB, PA, TDI, TMA, and TMTD, 
whereas a PSV between 5 and 10 was observed for OXA and MBT.  
 
DISCUSSION  
 
In the present study we sought to determine the allergenic potency of chemicals solely on the 
basis of their physico-chemical properties. Using multiple regression analysis, various models, 
being linear equations with different number of parameters, were generated and predicted 
sensitising values (PSVs) were calculated for the different chemicals and compared to LLNA 
data formerly obtained by us (Van Och et al., 2000). Based on the quantitative data (Table 3) 
and the classification (Table 4), model 2 was chosen for further evaluation. Since the dipole 
moment is not included in model 2, it is of little value to the specific model. This model was 
used to calculate the predicted sensitizing value (PSV). The weak allergens BENZ and DEA 
(EC3 > 20% in the LLNA), showed PSVs > 19 in model 1 and 2. HCA and MBT, known as 
mild to moderate allergens (5 < EC3 < 18 in the LLNA), showed PSVs between 9 and 15. The 
more potent allergens DNCB, PA, TDI, TMA, and TMTD (EC3 < 1% in the LLNA), showed 
PSVs below 5. Only OXA, the most potent allergen in the LLNA, showed a higher PSV 
compared to the other strong allergens. Based on these findings, a scaling of chemicals can be 
suggested. For instance, if the PSV of an allergen is < 5, it is likely to be a potent allergen, 
between 5 and 10 a moderate allergen, and if an allergen has a PSV > 10 it is most likely to be 
a weak allergen.  
The different chemicals can now be ranked based on the derived PSVs presented in this 
paper. The predicted classification proved to be promising. It showed similar ranking for the 
allergens BENZ, DEA, HCA, and MBT compared to the classification found in the LLNA. 
These allergens showed no overlap of the 90%-confidence intervals in the LLNA. The more 
potent allergens showed variable responses. The most plausible explanation for this 
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discrepancy is that these allergens show an EC3 level in the same range. DNCB, OXA, PA, 
TDI, TMA, and TMTD showed EC3 values between 0.044% and 0.66% with overlapping 
90%-confidence intervals in the LLNA (Table 3).  
 
 
Table 3 
Predicted sensitizing values (PSVs) of the allergens in different models and the EC3 values formerly obtained in 
a modified local lymph node assay (LLNA), together with their corresponding 90%-confidence intervals. 
Chemical Model 7 Model 6 Model 5 Model 4 Model 3 Model 2 Model 1 LLNAa 
EC3 (%)
b L05-L95 c  
BENZ 14.76 14.78 13.81 11.89 13.87 19.02 20.29 22.026 16.58-33.95 
DEA 35.35 39.49 40.6 39.81 39.98 40.14 40.56 39.784 34.08-47.70 
DNCB 4.63 1.28 -2.04 -3.62 -3.45 -1.63 2.92 0.044 0.025-0.078 
HCA 4.41 4.31 14.85 13.11 14.37 12.82 13.24 17.689 15.08-20.85 
MBT 11.56 7.91 7.59 8.34 9.34 9.89 13.11 9.669 8.02-12.19 
OXA 5.32 7.05 5.89 4.23 5.32 9.27 5.77 0.013 0.004-0.025 
PA 15.92 13.56 9.82 8.29 9.56 4.05 8.14 0.357 0.23-0.56 
TDI 3.01 0.25 1.85 0.76 0.50 1.60 -2.13 0.109 0.048-0.26 
TMA -4.15 -1.00 -0.63 -0.41 0.12 0.81 2.82 0.218 0.13-0.41 
TMTD 1.83 6.45 1.99 0.19 1.34 -1.01 -1.40 0.659 0.55-0.82 
a Van Och et al., 2000 
b estimated concentration in % required for SI=3 
c 5th and 95th percentile 
 
 
The scope of the investigation as presented in the present paper, was not the 
identification of allergens but to assess the potency of known allergens, by analyzing the 
molecular features of a chemical in order to predict its sensitizing potency.  
For a low molecular weight chemical to act as skin sensitizer it is critical to penetrate the outer 
lipophilic layer of the skin (the stratum corneum) into the viable epidermis where it binds 
covalently to skin proteins thus forming an immunogenic complex (Landsteiner and Jacobs, 
1936). The percutaneous adsorption of a chemical is a vital characteristic in the risk assessment 
process for chemicals that come into contact with the skin and is therefore a popular subject of 
research (Flynn, 1990; Potts and Guy, 1992; Barratt, 1994; 2000). Previously, Barratt (2000) 
showed regression analysis with the inclusion of the variables logP, molecular volume, and 
melting point. The melting point of a chemical, together with its lipophilicity, modeled by logP, 
has been shown to be an important determinant of its aqueous solubility (Suzuki, 1991). As a 
refinement of that approach we added molecular weight and adsorption coefficient as 
determinants important for accessibility to cells. Dipole moment, aqueous solubility, and pKa 
were chosen as indicators of the reactivity of a chemical. Dipole moment has previously been 
used succesfully, as a reactivity parameter in a QSAR study of the eye irritation potential 
(Barratt, 1995). 
The chemicals presented in this paper, are all recognized allergens. In animal studies as 
well as from clinical data these chemicals have shown their ability to induce allergenic reactions 
in the skin. In a previous study, we quantified the sensitizing capacity of the chemicals used in 
the present study by dose-response modeling. At a stimulatory index of three, which is 
generally recognized as a threshold of sensitizing potency (Basketter et al., 1999), the 
corresponding estimated concentration was calculated (EC3). Here, the order of the chemicals 
with increasing EC3 values (and thus decreasing allergenic potency) was found to be: OXA < 
DNCB < TDI < TMA < PA < TMTD < MBT < HCA < BENZ < DEA (Van Och et al., 2000; 
Table 3). 
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Table 4 
Ranking of the allergens in different models (decreasing potency from top to bottom), and classification of the 
allergens in a modified local lymph node assay (LLNA). The number of parameters are shown between 
parentheses. 
Model 7 (2) Model 6 (3) Model 5 (4) Model 4 (5) Model 3 (6) Model 2 (7) Model 1 (8) LLNAa 
TMA TMA DNCB DNCB DNCB DNCB TDI OXA 
TMTD TDI TMA TMA TMA TMTD TMTD DNCB 
TDI DNCB TDI TMTD TDI TMA TMA TDI 
HCA HCA TMTD TDI TMTD TDI DNCB TMA 
DNCB TMTD OXA OXA OXA PA OXA PA 
OXA OXA MBT PA MBT OXA PA TMTD 
MBT MBT PA MBT PA MBT MBT MBT 
BENZ PA BENZ BENZ BENZ HCA HCA HCA 
PA BENZ HCA HCA HCA BENZ BENZ BENZ 
DEA DEA DEA DEA DEA DEA DEA DEA 
a Van Och et al. (2000) 
 
 
The allergen ZDMC was not taken in the present study. According to the ACD/I-Lab 
software program, certain properties such as logP, AC, and AS, could not be calculated for a 
multicomponent structure (data not shown).  
In conclusion, allergens (here low molecular weight chemicals) need certain 
characteristics that convey them with the potential to induce allergic sensitization. In the 
present study, we sought to develop a model with the incorporation of a variety of molecular 
features, being determinants important for permeability through the skin and reactivity in the 
skin. Multiple regression analysis of the EC3 with the different properties resulted in different 
equations from which the PSV could be calculated. Potency evaluation resulted in a 
classification of the different chemicals, where the weak allergens could be distinguished from 
the strong allergens. Such an in silico approach may ultimately lead to a reduction in the use of 
experimental animals. Nevertheless, further validation with additional sensitizers, irritants and 
negative compounds is neccessary. 
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CHAPTER 8 
 
 
ASSESSMENT OF POTENCY OF ALLERGENIC ACTIVITY OF LOW 
MOLECULAR WEIGHT COMPOUNDS BASED ON IL-1α AND IL-18 
PRODUCTION BY A MURINE KERATINOCYTE CELL LINE 
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Anja J. C. Machielsen, Rob J. Vandebriel 
 
 
 
Screening for allergenic potency of low molecular weight compounds is generally performed 
using animal models. The tests most commonly used are the guinea pig maximization test and 
the murine local lymph node assay (LLNA). Over the last decade considerable progress has 
been made in unraveling the mechanisms of skin sensitization, including effects on the 
production of cytokines by the different cell types of the skin. This knowledge provides us with 
the opportunity to develop in vitro tests as an alternative to in vivo sensitization testing. In the 
present study we used a test system comprised of the murine epidermal keratinocyte cell line 
HEL30. We exposed this cell line to the allergen ethyl-p-aminobenzoate (benzocaine), 
diethylamine (DEA), 2,4- dinitrochlorobenzene (DNCB), and phthalic anhydride (PA). IL-1α 
and IL-18 dose-response data were evaluated by non-linear regression analysis, and at a 
certain ratio of cytokine production of treatment versus control, the corresponding allergen 
concentration was calculated. For both cytokines DNCB showed the strongest potency 
followed in this order by PA, benzocaine, and DEA. This classification was similar to our 
previous findings obtained in the LLNA. The approach taken in this study may be used as a 
screening method for the allergenic potency of chemicals, especially since the ranking of 
chemicals on the basis of allergenicity also proves to be possible in vitro.  
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INTRODUCTION 
 
Predictive tests to identify sensitizing properties of chemicals are carried out on a large scale. 
The tests most commonly used are the guinea pig maximization test (Magnusson and Kligman, 
1969) and the occluded patch test of Buehler (Buehler, 1965) in the guinea pig. More recently, 
alternative test methods have been described in the mouse, including the local lymph node 
assay (LLNA, Kimber et al, 1986; Kimber and Weisenberger, 1989) and the mouse ear 
swelling test (Gad et al, 1986). However, there is as yet, no accepted method for the 
identification in vitro of skin sensitizing chemicals. 
Besides the identification of sensitizers, an important next step, is to establish the 
sensitizing potency of allergens. We have previously described relative potency determination 
with the LLNA (Van Och et al, 2000), where dose responses were evaluated by nonlinear 
regression analysis. Concentrations inducing a certain stimulation index (SI) were estimated 
based on a curve fitting method. Chemicals that elicit a SI of 3 (treated animals over vehicle 
control) or more in the LLNA are considered as being sensitizers. The concentrations inducing 
a SI=3 (EC3) were used for the comparison of sensitizing potential.  
In the present study we investigated the relative potency of known allergens in vitro based on 
cytokine dose-response relationships using the murine keratinocyte cell line HEL30. The 
anatomical location of keratinocytes and their significant role in the development of allergic 
contact dermatitis justifies the use of keratinocyte-derived cytokine production as read-out to 
evaluate sensitizing potency. Keratinocytes not only represent the first target for irritants 
(DeLeo et al, 1987) but may also act as a signal transducer, converting non-specific exogenous 
stimuli into the production of cytokines and chemotactic factors, and expression of adhesion 
molecules (Barker et al, 1991). In principle, a test system comprised of keratinocytes alone 
may not be useful in establishing allergenic potency as these cells lack antigen presenting 
capacity. In the epidermis this function is exerted by Langerhans cells (LC). Nevertheless, it 
has been hypothesized that the irritant capacity of allergens presents an additional risk factor 
(Cumberbatch et al, 1993; Grabbe et al, 1996) so that irritant allergens may be stronger 
allergens than non-irritant ones. This suggests that evaluating irritant potency of allergenic 
chemicals may be helpful to establish their allergenic potency. For this reason, it can be 
suggested that the potency of chemicals to induce cutaneous sensitization can be assessed as a 
function of keratinocyte cytokine expression, mediators produced by these cells, and adhesion 
molecule expression. In vitro responses of keratinocytes to sensitizing agents may therefore 
yield information that may be helpful in classification of the sensitizing potency of such 
chemicals. 
All four chemicals tested in this paper have proven their sensitizing potency based on 
clinical data. 2,4- dinitrochlorobenzene (DNCB) is a potent contact allergen known to cause 
allergic contact dermatitis in man (Kligman and Epstein, 1959). Also ethyl-p-aminobenzoate 
(benzocaine; Cronin, 1980), diethylamine (DEA; Kaniwa et al, 1993) and phthalic anhydride 
(PA; Bernstein et al, 1982) have the potential to elicit an allergic reaction in human skin. 
Besides a skin allergen, PA is also known as an occupational respiratory allergen (Hagmar et 
al, 1987).  
Epidermal keratinocytes are known to produce and excrete a wide range of cytokines (Haas et 
al, 1992). Cells were exposed to benzocaine, DEA, DNCB and PA, known allergens with 
different sensitizing potency (Van Och et al, 2000). The cytokine dose-response data were 
evaluated by non-linear regression analysis and at a stimulatory index (SI) of three the 
corresponding estimated concentration was calculated (EC3). We used these EC3 values to 
rank these chemicals and to compare the outcome of the present study with those obtained 
from the local lymph node assay (LLNA).  
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METHODS 
 
Chemicals 
Benzocaine (ethyl-p-aminobenzoate; 99% purity; Sigma-Aldrich Chemie B.V., Zwijndrecht 
NL), DEA (diethylamine; 99.5%; free base solution; Sigma-Aldrich), DNCB (2,4-
dinitrochlorobenzene; 98%; Sigma-Aldrich), PA (phthalic anhydride; 99%; Sigma-Aldrich) 
were used. In the LLNA these chemicals were tested in 4:1 acetone/olive oil (AOO). For the in 
vitro analysis the chemicals were dissolved in ethanol. The final ethanol concentration was 1%.  
 
Cell culture and treatment 
The C3H mouse-derived keratinocyte cell line HEL30 (Fusenig et al, 1983, 1985) was kindly 
provided by Prof. N. Fusenig (German Cancer Institute, Heidelberg, Germany). HEL30 cells 
were cultured in Dulbecco`s modified Eagle`s medium (Gibco, Life Technologies, Breda, the 
Netherlands) supplemented with 10% fetal calf serum (PAA, Linz, Austria),  penicillin-
streptomycin (100 U/ml-0.1 mg/ml), and L-glutamine (2 mM). Cells were cultured at 37°C in a 
humidified atmosphere with 5% CO2 in air. The medium was changed twice a week and 
cultures were split by treating the cells with 0.25% trypsin (in PBS) for 5 min at 37°C before 
reaching confluency. 
Cells were seeded in 12-well plates (Costar, Cambridge, MA) at a density of 
1.5x105/ml. After 24 hr the cells were washed once with phosphate buffered saline (PBS) and 
exposed to several concentrations of various sensitizers in culture medium per well. After 24 hr 
of incubation, supernatants were obtained and used for the determination of extracellular 
cytokine levels. The cells were then washed once with PBS and lysed with 0.5 ml 0.5% Triton 
X-100 (Merck, Amsterdam, NL) for 1 hr at 37°C. The cell lysate was used for determination 
of intracellular cytokine levels. In parallel cultures the cells were counted using a Coulter 
Counter (Z2, Coulter Electronics, Mijdrecht, NL). All tests were performed in triplicate. 
Samples were stored at -80°C until the assay was performed. 
 
RNA isolation 
Keratinocytes were harvested by trypsinization followed by centrifugation (10 minutes, 311g, 
4°C), and were counted using a Coulter Counter. RNA was isolated using the SNAP total 
RNA isolation kit (Invitrogen, San Diego, CA) according to the manufacturer’s instructions. 
All steps were performed at room temperature, except when indicated. Centrifugation steps 
were performed at 13.000 rpm. Briefly, 2 volumes (vol; 1 vol = 300 µl) of lysis buffer (5.3 M 
guanidine-HCl, 1.5% Triton-X100, 2.5 mM Tris-HCl, pH 7.5, 0.25 mM EDTA) was added to 
the KC. The KC were then homogenized using a pellet pestle, and 1 vol isopropanol was 
added. After mixing the sample was transferred to a column. The column was centrifuged for 1 
min and 1 vol wash solution (100 mM NaCl) was added. The column was centrifuged again for 
1 min and again 1 vol wash solution was added. The column was centrifuged for 2 min. After 
adding 0.225 vol water to the column and 5 min incubation, RNA was eluted by centrifugation 
for 1 min. After DNase treatment for 10 min at 37°C, 0.75 vol binding buffer (7M guanidine-
HCl, 2% Triton-X100) was added and mixed. Then 0.5 vol isopropanol was added. After 
mixing the sample was transferred to a fresh column. The column was washed as described 
above. After adding 0.07 vol water to the column and 5 min incubation, RNA was eluted by 
centrifugation for 1 min. The RNA concentration was measured spectrophotometrically at 260 
nm. RNA was subjected to electrophoresis on a 1 % agarose gel and visualized by ethidium 
bromide staining. RNA was used only when both 28 S rRNA and 18 S rRNA bands were 
intact. Samples were stored at -70 °C until use. 
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cDNA synthesis  
One µg RNA was reverse transcribed using the Reverse Transcription System (Promega, 
Leiden, the Netherlands). Briefly, 10.5 µl water containing 1 µg RNA was mixed with 0.5 µl 
oligo(dT) primer (500 µg/ml) and incubated for 10 min at 70 °C. Samples were then incubated 
at 4 °C for at least 5 min. To the mixture, 4 µl MgCl2 (25 mM), 2 µl 10*RT-buffer, 2 µl dNTP 
(10 mM each), 0.5 µl RNasin (50 U/µl) and 0.5 µl AMV-RT (30 U/µl) was added and 
incubated at 42 °C for 1 hr. The reaction was stopped by heating the samples for 5 min at 72 
°C. Samples were stored at -20 °C until use. 
 
Polymerase chain reaction 
The PCR mixture contained 5 µg/ml of 5’-primer, 5 µg/ml of 3’-primer, 1.5 mM MgCl2, 200 
µM of each of the nucleotides dATP, dCTP, dGTP and dTTP (Boehringer Mannheim, 
Almere, the Netherlands), and 2 U AmpliTaq Gold DNA polymerase (Perkin Elmer, 
Nieuwerkerk a/d IJssel, the Netherlands) in 1*PCR buffer II (Perkin Elmer). Primers were 
synthesized by Gibco, and are listed in Table 1. PCR was performed by incubation for 12 min 
at 94°C, followed by 33 and 36 cycles each of 45 sec at 94°C, 45 sec at 60°C, and 2 min at 
72°C, and a final incubation for 7 min at 72°C. PCR products were electrophorized on a 2 % 
agarose gel and visualized by ethidium bromide staining. PCR for HPRT was used as a 
control for the cDNA synthesis. Ladder is marker IX (72-1353 bp; Boehringer, Mannheim, 
Germany). 
 
 
Table 1 
PCR primers used in this study. 
Gene Sequence 5’primer Sequence 3’primer  Lengt
h (bp) 
Number 
of cyclesa 
IL-1α TTACAGTGAAAACGAAGA TGTTTGTCCACATCCTG 417 33 
IL-1β TTGACGGACCCCAAAAGATG AGAAGGTGCTCATGTCCTCA 204 33 
IL-2 GACACTTGTGCTCCTTGTCA TCAATTCTGTGGCCTGCTTG 227 n.d. 
IL-4 CCAGCTAGTTGTCATCCTGCT
CTTCTTTCTCG 
CAGTGATGTGGACTTGGACTC
ATTCATGGTGC 
384 n.d. 
IL-6 GTTCTCTGGGAAATCGTGGA TGTACTCCAGGTAGCTATGG 208 36 
IL-10 ATGCAGGACTTTAAGGGTTAC
TTG 
TAGACACCTTGGTCTTGGAGC
TTA 
254 36 
IL-12 p35 AACAGCCTCACCCTCGGC GTTGATGGTCACGACGCG 258 36 
IL-12 p40 CAGTACACCTGCCACAAAGGA GTGTGACCTTCTCTGCAGACA 277 36 
IL-18 ACAAAGAAAGCCGCCTCAAAC GTCTGGTCTGGGGTTCACTGG 294 33 
GM-CSF TCTCATCAGTTCTATGGCCC GGGAGTAGACAAGGTACAAC 212 33 
IFN-γ TTCCTGGGCATTGTGGTCT TGGATTCAGAGCTGGCCTGG 431 n.d. 
MIP-2 TGCATCTTGGTCTTGCAGCTCT
TCCTCATGGC 
TGGACCTGTGGGTTGTTGACC
TCAACCTTGGC 
365 33 
TNF-α GCCAGTGAACTGCGCTGTCAA
TGC 
GTTAGCCTTGCCTTTGTTCAGT
ATG 
211 33 
HPRT GTCAAGCAGTACAGCCCCAAA
ATGG 
TAGTGCAAATCAAAAGGGAC
GCAGC 
385 30 
n.d. not detected 
a minimal number of cycles needed for detection 
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ELISA 
For cytokine determinations, ELISA reagents from R&D Systems (Oxon, UK) were used in 
accordance to the manufacturer`s specifications. Briefly, 96-well plates (Nunc-Immuno Plate, 
Roskilde, Denmark) were coated with the capture antibody in PBS and incubated overnight at room 
temperature (RT). The plates were blocked by adding PBS containing 1% bovine serum albumin 
(BSA; Sigma, Axel, the Netherlands) plus 0.05% Tween-20 (Merck, in PBS) for 2 hr at 37°C and 
washed (0.05% Tween-20). Standard as well as serial dilutions of culture supernatants were added 
to the plate. Plates were incubated at 37°C for 2 hr and washed. Biotinylated detection antibody 
was added and incubated for 2 hr at RT. The plates were washed, and poly horseradish peroxidase 
labeled streptavidin (10,000-fold dilution, Strepta-E+, Central Laboratory of the Blood transfusion 
service, Amsterdam, the Netherlands) was added and incubated for 20 min at room temperature. 
Plates were washed again and TMB solution (0.1 mg/ml TMB (Sigma) plus 0.006% H2O2, in 0.1 M 
NaAc, pH 5.5) was added. The plates were read at 450 nm, using an automated reader (Titertek 
Multiskan, Flow Laboratories, Lugano, Switzerland). Antibodies, standards, samples, and 
streptavidin were diluted in 0.5% BSA plus 0.05% Tween-20, in PBS (Van Halteren et al, 1997).  
 
Lactate dehydrogenase (LDH) 
Extracellular LDH was measured after 24 hr of incubation with the test agents by measuring 
the enzymatic activity in the media using a commercial detection kit (Merck). Background 
values were subtracted from the obtained LDH concentrations. Results are presented as 
percentage of the total LDH content. Total LDH content was determined by incubating 
HEL30 cells for 2 hr with 1% Triton X-100 (Corsini et al, 1994). All tests were performed in 
duplicate. Only non-toxic concentrations were chosen based on the outcome of the LDH 
cytotoxicity test and are shown in Table 2. 
 
 
Table 2 
Concentrations used in the in vitro analysis.  
Chemical Concentration (µM) 
 
Benzocaine 
 
 
1400, 140, 14, 1.4 
DEA 
 
1400, 140, 14, 1.4 
DNCB 7, 1.4, 0.14, 0.014 
PA 1400, 140, 14, 1.4 
 
 
Local lymph node assay (LLNA) 
Groups of mice (n=3, 4, or 6) were pretreated with 1% SDS (w/v) one hour before exposing 
the animals to 25 µl of test solution in vehicle or vehicle alone on both ears daily for three 
consecutive days. Three days following the last topical application, the auricular lymph nodes 
(LN) were excised. The lymph nodes were weighed and pooled for each animal and suspended 
in 5 ml RPMI-1640 (Gibco) supplemented with 5% heat inactivated Fetal Calf Serum (PAA), 
100 U/ml penicillin and 100 µg/ml streptomycin (standard medium). Single cell suspensions 
were prepared under aseptic conditions by pressing the LN through a sterile 70 µm nylon cell 
strainer (Falcon, Franklin Lakes, USA). The cells were washed twice in standard medium (10 
minutes, 311g, 4°C) and resuspended in 1 ml standard medium with 10% FCS. The cells were 
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counted using a Coulter Counter and cultured at a concentration of 1.107 cells/ml. When 
necessary, cell suspensions of several animals were pooled to obtain the concentration 
required. The cell suspensions (200 µl) were seeded in triplicate into round-bottomed 96-well 
microtitre plates (Greiner, Alphen a/d Rijn, the Netherlands). The cells were cultured with 10 
µl of [3H]TdR (Amersham, Buckinghamshire, UK; 37 kBq/ml) for 24 hr at 37°C in a 
humidified atmosphere of 5% CO2 in air. The [
3H]TdR incorporation was determined by liquid 
scintillation counting in a β plate counter (1205 BetaplateTM Wallac, Turku, Finland). The 
[3H]TdR incorporation is expressed per animal, i.e. the [3H]TdR incorporation is multiplied by 
the cell number of the two lymph nodes and devided by the cell number in culture. 
 
Statistical analysis  
The dose-response data were analyzed by nonlinear regression analysis, using the following 
family of models: 
model 1:  y  =   a 
model 2: y  =   a exp( b x ) 
model 3: y  =   a exp( b xd) ) 
model 4: y  =   a (c - (c - 1) exp( b x) 
model 5: y  =   a (c - (c - 1) exp( b xd)). 
 
where y represents the response and x the applied concentration. In these models the parameter 
a represents the background of the particular assay. The parameter b reflects the ‘slope’ or the 
‘strength’ of the response with increasing dose. The selection of the model to be used for a 
particular data set follows from a procedure of successively fitting the above models, and 
applying likelihood ratio tests to establish if an increase in the number of parameters leads to a 
significantly better fit to the data. A model with more parameters is considered better only if 
this leads to a significantly better fit (Slob, 1999). The estimated concentration in % required 
for SI=3 (EC3) was determined as the estimated dose inducing a stimulation index of three 
between treated versus control. We have used a range of test concentrations to determine 
dose-response relationships on which the quantitative estimation of the allergenic potency was 
based.  
The uncertainty in the estimate of the EC3 can be assessed by a bootstrap method (Slob 
and Pieters, 1998), resulting in an uncertainty distribution from which any desired confidence 
interval can be derived. In this paper the 5% and 95% confidense limits are reported (i.e. 90%-
confidence intervals). 
 
RESULTS 
 
Cytokine mRNA expression and production in HEL30 cells 
Cytokine mRNA expression was investigated using RT-PCR. IL-1α, IL-1β, IL-6, IL-
10, IL-12 p35, IL-12 p40, IL-18, GM-CSF, MIP-2, and TNF-α mRNA expression was found 
in the HEL30 cell line (Figure 1). No IFN-γ, IL-2, and IL-4 mRNA expression was found (data 
not shown). Hypoxanthine phosphoribosyl transferase (HPRT) was used as a housekeeping 
control for the cDNA synthesis. Cytokines that were expressed by this cell line were analyzed 
on the protein level by ELISA. IL-6, IL-12 p35, and IL-12 p40 production was inconsistent, 
while IL-10 production was completely lacking (data not shown). A summary of cytokine 
mRNA expression and production is shown in Table 3. 
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Figure 1  
RT-PCR analysis of gene expression for various cytokines by the unstimulated murine keratinocyte cell line 
HEL30. Amplification was for 36 cycles. For each cytokine, (the lanes show from left to right) molecular 
weight marker, 2 and 4 µl cDNA of sample 1, and 2 and 4 µl cDNA of sample 2 are shown. 
 
 
 
Table 3 
Cytokine mRNA expression measured by RT-PCR and protein production measured by ELISA in the HEL30 
cell line. 
 mRNA protein 
IL-1α yes yes 
IL-1β yes yes 
IL-2 no n.d. 
IL-4 no n.d. 
IL-6 yes ? 
IL-10 yes ? 
IL-12 p35 yes ? 
IL-12 p40 yes ? 
IL-18 yes yes 
GM-CSF yes yes 
IFN-γ no n.d. 
MIP-2 yes yes 
TNF-α yes yes 
n.d. not done 
? inconsistent results 
 
IL-1α                IL-1β                   IL-6                     MIP-2                      TNF-α 
IL-10       IL-12 p35    IL-12 p40      IL-18                       GM-CSF 
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Figure 2 
Leakage of lactate dehydrogenase (LDH) due to exposure to different concentrations (in µM) of various 
sensitizers by the HEL30 cell line. Leakage is expressed as the percentage of total LDH in the extracellular 
medium. Total LDH content was determined resulting from a 2 hr incubation with PBS containing 1% Triton 
X-100. All experiments were performed in duplicate, with similar results. 
 
 
LDH leakage  
Preceding the in vitro exposure tests, we performed a lactate dehydrogenase (LDH) leakage 
test to investigate the cytotoxic concentrations for the various chemicals (Figure 2). A lower 
intracellular cytokine content at cytotoxic concentrations is likely to result from leakage rather 
than secretion of IL-1α or IL-18. Leakage of the enzyme LDH after 24 hr of incubation with 
the various chemicals, was investigated by measuring the extracellular concentration. Leakage 
is expressed as the percentage of total LDH and is shown in Figure 2. No significant increase 
in LDH leakage compared to the 1% ethanol control was found for Benzocaine, DEA, and PA. 
DNCB showed 100% leakage at the two highest concentrations, while 14 µM still resulted in a 
leakage of approximately 60%. Only 1.4 µM DNCB showed a similar LDH leakage compared 
to the control. The control (1% ethanol) showed no effect compared to standard medium.  
 
Cytokine dose-responses  
Cytokines produced by the keratinocyte cell line HEL30 were analyzed by ELISA. Cytokine 
dose-response studies were carried out for all cytokines, except IL-2, IL-4, and IFN-γ. Both 
intracellular and extracellular cytokine levels were determined (data not shown). Consistent 
dose-response relationships were found only for intracellular IL-1α and intracellular IL-18.  
The exposure effects of  the various allergens on the production of intracellular IL-1α 
and intracellular IL-18 production is shown (Figure 3 and 4, respectively). Cytokine 
concentrations were measured after 24 hr of incubation to Benzocaine (panel A), DEA (panel 
B), DNCB (panel C), and PA (panel D). All tests were performed in triplicate. The panels 
show the cytokine production as a function of the dose of the various allergens on a log-scale 
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with the fitted regression function. The dose-response data were analyzed by nonlinear 
regression analysis. Clear differences in the calculated EC3 values were observed between the 
different chemicals. Both IL-1α and IL-18 production showed DNCB as the allergen with the 
lowest EC3 value followed in this order by PA, benzocaine, and DEA.  
The EC3 values and the associated confidence intervals for the different cytokine 
responses are summarized in Table 4. The chemicals are ranked according to their EC3 values. 
The classification formerly obtained with the LLNA is also presented in Table 4. The ranking 
obtained using the in vitro studies presented here is similar to the classification derived from 
data formerly obtained in the LLNA.  
 
 
Figure 3 
Intracellular IL-1α content (in pg/1.106 cells) in the murine keratinocyte cell line HEL30 as a function of 
sensitizer concentration (in µM). Using non-linear regression analysis the concentration, that induced a 3-fold 
increase over control, was calculated. The intracellular IL-1α concentration was measured after 24 hr of 
incubation to Benzocaine (A), DEA (B), DNCB (C) and PA (D). The cytokine concentrations are shown on 
the vertical axis on a linear scale and the concentrations of the chemicals are shown on the horizontal axis on 
a log-scale. Number of experiments =3. 
D C 
B A 
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Figure 4 
Intracellular IL-18 content (in pg/1.106 cells) in the murine keratinocyte cell line HEL30 as a function of 
sensitizer concentration (in µM). Using non-linear regression analysis the concentration, that induced a 3-fold 
increase over control was calculated. The intracellular IL-18 concentration was measured after 24 hr of 
incubation to Benzocaine (A), DEA (B), DNCB (C) and PA (D). The cytokine concentrations are shown on 
the vertical axis on a linear scale and the concentrations of the chemicals are shown on the horizontal axis on 
a log-scale. Number of experiments =3. 
 
 
DISCUSSION 
 
In the present study, dose-response studies were performed by exposure of the keratinocyte 
cell line HEL-30 to allergens of different sensitizing potency. For both intracellular IL-1α and 
intracellular IL-18 dose-response relationships were evaluated by nonlinear regression analysis  
C D 
B A 
C D 
B A 
C D 
B A 
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Table 4 
Classification of low molecular weight chemicals based on cytokine responses in the HEL30 cell line and 
proliferative lymph node responses in the local lymph node assay (LLNA), together with the associated 
uncertainty distribution  
Chemical HEL30 
IL-1α                                              IL-18 
EC3
b(µM)       L05-L95c                   EC3 (µM)       L05-L95 
LLNA
a
 
 
EC3 (%)       L05-L95 
DNCB 2.2*10-2 2.4*10-2-3.9*10-2 3.0*10-5         NC-3.4*10-4 0.04             0.02-0.08 
PA 1.15 0.81-1.62 8.2*10-3         6.0*10-5-6.3*10-2  0.36             0.23-0.56 
Benzocaine 2.4*104 3.4*103-2.9*104 0.47               0.15-1.02 22.03           16.57-33.95 
DEA 9.9*106 6.0*105-1.5*109 638                487-927 39.78           34.08-47.70 
a Van Och et al., 2000. 
b Estimated concentration required for induction of three compared to control value. 
c 5th and 95th percentile 
NC, could not be calculated 
 
 
and EC3 values were estimated based on a curve fitting method. Subsequently, these EC3 
values were used for ranking the potency of the allergens. The ranking based on these in vitro 
results corresponds well to the ranking based on the LLNA (Van Och et al, 2000). 
A chemical that elicits a stimulation index (SI) of 3 or more in the LLNA is considered 
a sensitizer. Moreover, the concentration necessary to induce this SI can be employed for 
ranking (Basketter et al, 2000; Van Och et al, 2000). In the in vitro studies described in this 
paper, we chose a SI of three (over vehicle control) of IL-1α and IL-18 production. If a SI=2 
or SI=5 were chosen, a similar ranking was obtained. 
Epidermal keratinocytes constitutively synthesize IL-1α (Dinarello, 1984), and contain 
a large amount of preformed and biologically active IL-1α (Mizutani, 1991). Once the physical 
barrier of the upper epidermis is damaged, IL-1α is rapidly released so that this IL-1α reservoir 
represents a rapid response system for immune and inflammatory regulation in the skin, and IL-
1α acts as a first line of defence against injury (Kupper, 1988). We found a consistent dose-
response relationship for IL-1α. Previous findings using the HEL30 cell line showed that only 
contact allergens were able to increase intracellular IL-1α in a dose dependent fashion (Corsini 
et al, 1998). Besides IL-1α, we found a consistent dose-response relationship for IL-18, a 
cytokine that was originally discovered to induce IFN-γ production from Th1 and NK cells 
(Okamura et al, 1995; 1998). Recent studies revealed that IL-18 also induces the production 
of Th2 cytokines from T cells, NK cells, basophils, and mast cells (Hoshino et al, 1999; 
Yoshimoto et al, 1999; Nakanishi et al, 2001). Also IL-18 is known to be constitutively 
produced by keratinocytes (Stoll et al, 1997). IL-18 acts synergistically with IL-12 to induce a 
Th1 response through induction of IFN-γ by T-lymphocytes (Micallef et al, 1996; Robinson et 
al, 1997), and might result in induction of IL-4 and IL-13 in the skin in an IgE-independent 
manner, directly inducing allergic inflammatory responses (Nakanishi et al, 2001). Recent 
findings reveal that contact allergen-induced LC migration and dendritic cell accumulation in 
draining lymph nodes require IL-18 (Cumberbatch et al, 2001), important for the development 
of allergic responses in the skin. We found low baseline levels of intracellular IL-18, but a 
considerable increase as a result of allergen exposure. This is in accordance with previous 
findings observed in another murine keratinocyte cell line, being PAM 212, where contact 
allergens, but not irritants, induced expression and production of IL-18 (Stoll et al, 1997).  
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Both IL-1α and IL-18 seem to be good parameters for allergenic potency, as clear 
differences are seen between the various allergens (Table 4). IL-18 seems to be a more 
sensitive parameter compared to IL-1α. As 10 M of DEA was needed to obtain a SI=3 for IL-
1α production, only a fraction of that amount (0.64 mM) was needed to induce a similar 
induction of IL-18 production.  
The quality of the data can be translated to uncertainty margins which benefits the 
comparison between the sensitizers (Van Och et al, 2000). The uncertainty in the estimate of 
the EC3 was assessed by a bootstrap method (Slob and Pieters, 1998), resulting in an 
uncertainty distribution from which any desired confidence interval can be derived. This 
bootstrap method was performed for both IL-1α and IL-18 responses. No overlap of the 
confidence intervals was found for the different sensitizers, which underscores the reliability of 
the ranking. Except DNCB and PA show for IL-18 production a small overlap of the 
confidence intervals. 
Whereas murine keratinocytes do not express IL-1β (Ansel et al, 1988), we found both 
mRNA expression and production of the protein in the HEL30 cell line. Biologically inactive 
pro-IL-1β has to be cleaved into the active form by the intracellular protease IL-1β-converting 
enzyme (ICE, recently termed caspase-1). Although murine keratinocytes synthesize caspase-1 
(Ariizumi et al, 1995), it is unlikely that this is constitutively active since mature IL-1β is not 
produced. However, while also IL-18 relies on caspase-1 (Ghayur et al, 1997) for processing 
in these cells, biologically active IL-18 is found. This contradiction is difficult to explain. 
Possibly, HEL30 cells are different in that respect compared to normal murine keratinocytes.  
 A logical next step is to perform similar in vitro studies with human keratinocytes and 
compare the differences in potency with the outcome of the present study and the ranking 
formerly obtained in the LLNA. Data derived from the analysis in human cells may also 
provide us with information about differences in sensitivity between murine and human 
keratinocytes. This can be helpful in the calculation or estimation of extrapolation factors, 
which can be used to translate in vivo data (LLNA) towards an actual risk estimate in man. 
The ranking of the allergens based on the EC3 values derived from the IL-1α and IL-
18 dose-response relationships corresponded to the in vivo classification data based on the 
LLNA. These data support the hypothesis that the irritating component of an allergen decides 
to a great extent the ultimate strength of the sensitizing effect. Therefore, IL-1α and IL-18 
production by keratinocytes may be seen as a possible tool for the prediction of sensitizing 
strength of a particular chemical. Such in vitro testing may be useful for ranking chemicals for 
their sensitizing potential resulting in a reduction of animal testing. 
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CHAPTER 9 
 
 
CYTOKINE RESPONSES IN HUMAN KERATINOCYTES BY 
EXPOSURE TO LOW MOLECULAR WEIGHT CHEMICALS: 
PREDICTIVE VALUE AND A TOOL FOR EXTRAPOLATION 
 
François M. M. Van Och, Henk Van Loveren, Almar Kuipers, 
Anja J. C. Machielsen, Rob J. Vandebriel 
 
 
 
The final step of the immunotoxicity risk assessment process is risk characterization. 
Unfortunately, the current lack of adequate human data is a major limitation. To rely on 
animal data, important for risk characterization are dose-response relationships and tools for 
extrapolation from experimental animals to humans. In the present study we used a test 
system comprised of the human epidermal keratinocyte cell line HaCaT. We exposed this cell 
line to the allergens ethyl-p-aminobenzoate (benzocaine), diethylamine (DEA), 2,4- 
dinitrochlorobenzene (DNCB), and phthalic anhydride (PA). IL-1α and IL-18 dose-response 
data were evaluated by non-linear regression analysis, and at a ratio of three of cytokine 
production of treatment versus control, the corresponding allergen concentration was 
calculated. For IL-18, DNCB showed the strongest potency followed in this order by PA, 
benzocaine, and DEA. This classification was similar to our previous findings obtained in a 
modified local lymph node assay (LLNA). Dose-response analysis of IL-1α ranked 
benzocaine more potent than PA. The ranking based on the in vitro results in the human cell 
line HaCaT corresponded to a large extent to the results obtained in experimental animals 
(LLNA). In addition, cytokine responses by the human HaCaT cell line were compared to 
responses of the murine epidermal keratinocyte cell line HEL30 in order to obtain 
information on differences in sensitivity to sensitizers between humans and mice. The HaCaT 
cell line showed to be less sensitive compared to its murine counterpart. This in vitro 
approach not only provides significant knowledge on the predictive value of animal tests, it 
can also provide us with a tool for improved extrapolation from animals to the human 
situation. 
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INTRODUCTION 
 
The process of risk assessment from chemical exposures can be divided into four different 
steps: (1) hazard identification; (2) hazard characterization; (3) exposure assessment; and (4) 
risk characterization. Traditionally, in vitro studies have most frequently been applied for 
hazard identification purposes. However, over the last 20 years there has been an increased 
recognition that in vitro studies can also be of use for risk characterization (Holme and 
Dybing, 2002). Human cell and tissue models are being used increasingly for prediction of 
drug-specific organ toxicities, to predict human metabolism, and to identify potential drug-
drug interactions. Establishment of the dose-response relationships for critical effects and 
extrapolation from experimental animals to humans are two elements important in hazard 
characterization (European Commission, 2000). 
The local lymph node assay (LLNA) is now commonly used for the identification of the 
sensitising activity of chemicals and the assay has been validated to the guinea pig 
maximization test (Basketter and Scholes, 1992; Basketter et al., 1993; Kimber et al., 1995). 
Test chemicals are applied to the dorsum of the ear and lymphocyte activation is determined by 
measuring cell proliferation in the draining auricular lymph nodes, which can be done either by 
in vivo or ex vivo tritium-thymidine labeling of the cells (Kimber and Weisenberger, 1989; 
Kimber et al., 1995; Van Och et al., 2000). Analysis of 134 chemicals tested in the local lymph 
node assay (LLNA), guinea pig maximisation test (GPMT) and/or with clear clinical evidence 
for human skin sensitisation potential, revealed that an EC3 (effective concentration causing a 
stimulation index of  3 compared to vehicle control) in the LLNA is an acceptable threshold 
value for hazard identification (Basketter et al., 1999a). In the LLNA quantitative data are 
obtained on the induction phase of the immune response. So, based on the EC3 value an 
accurate assessment of sensitising potency is possible (Basketter et al., 1999b; Van Och et al., 
2000). 
Classification of the allergenic potency of a chemical in humans is problematic, since it 
depends on a number of endogenous and exogenous factors (Jerschow et al., 2001) which 
results in a current lack of adequate human data. To overcome this difficulty, an alternative 
type of evaluation of the risk of adverse effects due to exposure to (immunotoxic) chemicals 
may be used; the so-called parallellogram approach (Blaauboer et al., 1990; Van Loveren et 
al., 1997). It is possible to compare the results of in vitro and in vivo animal studies using the 
same or similar endpoints of immunotoxicity, as it is possible to compare the results of in vitro 
studies in animals and in man. Based on the combined comparison of these results, an 
improved extrapolation from animals to the human situation is thus achievable.   
In the present study, a spontaneously immortalized human keratinocyte cell line, 
HaCaT, was used as an in vitro model to predict the sensitizing potency of allergens. It has 
been hypothesized that the irritant capacity of allergens presents an additional risk factor 
(Cumberbatch et al., 1993; Grabbe et al., 1996). This suggests that evaluating irritant potency 
of allergenic chemicals may be helpful to establish their allergenic potency. Epidermal 
keratinocytes are known to produce and excrete a wide range of cytokines (Haas et al, 1992). 
Therefore, it can be suggested that the potency of chemicals to induce cutaneous sensitization 
can be assessed as a function of keratinocyte cytokine expression. The anatomical location of 
keratinocytes and their significant role in the development of allergic contact dermatitis, justify 
the use of keratinocyte-derived cytokine production as read-out to evaluate sensitizing 
potency.  
Cells were exposed to benzocaine, DEA, DNCB and PA, known allergens with 
different sensitizing potency (Van Och et al, 2000). The cytokine dose-response data were 
evaluated by non-linear regression analysis and at a stimulatory index (SI) of three the 
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corresponding estimated concentration was calculated (EC3). We used these EC3 values to 
rank these chemicals and to compare the outcome of the present study with those obtained 
from the local lymph node assay (LLNA). These data will tell us whether the ranking based on 
the cytokine responses in the human keratinocyte cell line is in accordance with the ranking 
derived in the mouse (in vivo). In addition, the EC3 values obtained in the human HaCaT cell 
line were compared to EC3 values previously obtained in the murine HEL30 cell line (Van Och 
et al., submitted). This comparison may provide information on the differences in sensitivity 
between the two species mouse and man. Based on the combined comparison of these results, 
an improved extrapolation from animals to humans may be achieved. 
 
MATERIALS AND METHODS 
 
Chemicals 
Benzocaine (ethyl-p-aminobenzoate; 99% purity; Sigma-Aldrich Chemie B.V., Zwijndrecht, 
the Netherlands), DEA (diethylamine; 99.5%; free base solution; Sigma-Aldrich), DNCB (2,4-
dinitrochlorobenzene; 98%; Sigma-Aldrich), and PA (phthalic anhydride; 99%; Sigma-Aldrich) 
were used. The chemicals were dissolved in ethanol. 
 
Materials 
The human keratinocyte cell line HaCaT and the murine keratinocyte cell line HEL30 were 
kindly provided by Prof. N. Fusenig (German Cancer Institute, Heidelberg, Germany).  
 
Cell culture and exposure 
Both HaCaT and HEL30 cells were cultured in Dulbecco`s modified Eagle`s medium (Gibco, 
Life Technologies, Breda, the Netherlands) supplemented with 10% fetal calf serum (PAA, 
Linz, Austria), penicillin-streptomycin (100 U/ml-0.1 mg/ml), and L-glutamine (2 mM). Cells 
were cultured at 37°C in a humidified atmosphere with 5% CO2 in air. The medium was 
changed twice a week and cultures were split by treating the cells with 0.25% trypsin (in PBS) 
for 5 min at 37°C before reaching confluency. 
Cells were seeded in 12-well plates (Costar, Cambridge, MA) at a density of 
1.5x105/ml. After 24 hr the cells were washed once with PBS and exposed to several 
concentrations of various sensitizers in culture medium (Table 1). These cultures contained 1% 
ethanol. After 24 hr of incubation, supernatants were obtained and used for the determination 
of extracellular cytokine levels. The cells were then washed once with PBS and lysed with 0.5 
ml 0.5% Triton X-100 (Merck, Amsterdam, the Netherlands) for 1 hr at 37°C. The cell lysate 
was used for determination of intracellular cytokine levels. In parallel cultures the cells were 
counted using a Coulter Counter (Z2, Coulter Electronics, Mijdrecht, the Netherlands). All 
tests were performed in triplicate. Samples were stored at -80°C until the assay was 
performed. 
 
 
Table 1  
Concentrations used in the in vitro analysis.  
Chemical Concentration (µM) 
Benzocaine 14000, 1400, 140, 14, 1.4 
DEA 14000, 1400, 140, 14, 1.4 
DNCB 7, 1.4, 0.14, 0.014 
PA 1400, 140, 14, 1.4 
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Cytokine ELISAs 
For cytokine determinations, ELISA reagents from R&D Systems (Oxon, UK) were used in 
accordance to the manufacturer`s specifications. Briefly, 96-well plates (Nunc-Immuno Plate, 
Roskilde, Denmark) were coated with the capture antibody in PBS and incubated overnight at room 
temperature (RT). The plates were blocked by adding PBS containing 1% bovine serum albumin 
(BSA; Sigma, Axel, the Netherlands) plus 0.05% Tween-20 (Merck, in PBS) for 2 hr at 37°C and 
washed (0.05% Tween-20). Standard as well as serial dilutions of culture supernatants were added 
to the plate. Plates were incubated at 37°C for 2 hr and washed. Biotinylated detection antibody 
was added and incubated for 2 hr at RT. The plates were washed, and poly horseradish peroxidase 
labeled streptavidin (10,000-fold dilution, Strepta-E+, Central Laboratory of the Blood transfusion 
service, Amsterdam, the Netherlands) was added and incubated for 20 min at room temperature. 
Plates were washed again and TMB solution (0.1 mg/ml TMB (Sigma) plus 0.006% H2O2, in 0.1 M 
NaAc, pH 5.5) was added. The plates were read at 450 nm, using an automated reader (Titertek 
Multiskan, Flow Laboratories, Lugano, Switzerland). Antibodies, standards, samples, and 
streptavidin were diluted in 0.5% BSA plus 0.05% Tween-20, in PBS (Van Halteren et al., 1997).   
 
Local lymph node assay (LLNA) 
Groups of mice (n=3, 4, or 6) were pretreated with 1% SDS (w/v) one hour before exposing 
the animals to 25 µl of test solution in vehicle or vehicle alone on both ears daily for three 
consecutive days. Three days following the last topical application, the auricular lymph nodes 
(LN) were excised. The LN were weighed and pooled for each animal and suspended in 5 ml 
RPMI-1640 (Gibco) supplemented with 5% heat inactivated Fetal Calf Serum (PAA), 100 
U/ml penicillin and 100 µg/ml streptomycin (standard medium). Single cell suspensions were 
prepared under aseptic conditions by pressing the LN through a sterile 70 µm nylon cell 
strainer (Falcon, Franklin Lakes, USA). The cells were washed twice in standard medium (10 
minutes, 311g, 4°C) and resuspended in 1 ml standard medium with 10% FCS. The cells were 
counted using a Coulter Counter and cultured at a concentration of 1.107 cells/ml. When 
necessary, cell suspensions of several animals were pooled to obtain the concentration 
required. The cell suspensions (200 µl) were seeded in triplicate into round-bottomed 96-well 
microtitre plates (Greiner, Alphen a/d Rijn, the Netherlands). The cells were cultured with 10 
µl of [3H]TdR (Amersham, Buckinghamshire, UK; 37 kBq/ml) for 24 hr at 37°C in a 
humidified atmosphere of 5% CO2 in air. The [
3H]TdR incorporation was determined by liquid 
scintillation counting in a β plate counter (1205 BetaplateTM Wallac, Turku, Finland). The 
[3H]TdR incorporation is expressed per animal, i.e. the [3H]TdR incorporation is multiplied by 
the cell number of the two LN and devided by the cell number in culture. 
 
Statistical analysis 
The dose-response data were analyzed by nonlinear regression analysis, using the following 
family of models: 
model 1:  y  =   a 
model 2: y  =   a exp( b x ) 
model 3: y  =   a exp( b xd) ) 
model 4: y  =   a (c - (c - 1) exp( b x) 
model 5: y  =   a (c - (c - 1) exp( b xd)). 
 
where y represents the response and x the applied concentration. In these models the parameter 
a represents the background of the particular assay. In all models the parameter a is 
constrained to being larger than zero, since it denotes the value of the response at dose zero. 
The parameter b reflects the ‘slope’ or the ‘strength’ of the response with increasing dose. 
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Parameter c determines whether the function increases or decreases, by being larger or smaller 
than unity, respectively. To render model 3 describing a decreasing response d has to be 
changed into -d. The parameter d is constrained to values larger than (or equal to) one, to 
prevent the slope of the function at dose zero from being infinite, this being biologically unreal. 
The selection of the model to be used for a particular data set follows from a procedure of 
successively fitting the above models, and applying likelihood ratio tests to establish if an 
increase in the number of parameters leads to a significantly better fit to the data. A model with 
more parameters is considered better only if this leads to a significantly better fit (Slob, 1999). 
The selected model is used to derive the estimated concentration (EC) associated with a 
stimulation index or cytokine production. Full details on these statistics are given in Slob 
(2002). 
 The uncertainty in the estimate of the EC3 can be assessed by a bootstrap method (Slob 
and Pieters, 1998), resulting in an uncertainty distribution from which any desired confidence 
interval can be derived. In this paper the 5% and 95% confidense limits are reported (i.e. 90%-
confidence intervals). 
 
RESULTS 
 
Preceding the in vitro exposure tests, for the various chemicals the cytotoxic concentrations 
were determined by measuring lactate dehydrogenase (LDH) leakage (data not shown). For 
the various chemicals, the highest non-toxic concentration was chosen as the highest 
concentration of exposure. Remarkably, the highest non-toxic concentration of DNCB was 
200- to 2,000-fold lower compared to the other chemicals tested. In preliminary studies, we 
have tested a range of cytokines in dose-response studies. (Only) intracellular IL-1α and 
intracellular IL-18 showed clear dose-response relationships (data not shown). 
 
Potency evaluation 
Dose-response studies measuring intracellular cytokines were carried out for IL-1α and IL-18 
and are shown in Figure 1 and 2, respectively. Cytokine concentrations were measured after 24 
hr of incubation to Benzocaine (panel A), DEA (panel B), DNCB (panel C), and PA (panel D). 
All tests were performed in triplicate. The panels show the cytokine production as a function of 
the dose of the various allergens on a log-scale with the fitted regression function.  
Both cytokines showed consistent dose-response relationships for DNCB and PA. The 
chemicals benzocaine and DEA showed a significant increase in cytokine production only for 
the highest concentration used (14 mM). The dose-response data were analyzed by nonlinear 
regression analysis. Differences in the calculated EC3 values were observed between the 
different chemicals. For IL-18, DNCB showed the the lowest EC3 value followed in this order 
by PA, benzocaine, and DEA. For IL-1α, the same order was seen, except for benzocaine that 
showed a lower EC3 value compared to PA.  
The EC3 values and the associated confidence intervals for the different cytokine 
responses are summarized in Table 2. The chemicals are ranked according to their EC3 values. 
The classification formerly obtained with the LLNA is also presented in Table 2. The ranking 
obtained using the in vitro studies presented here is similar to the classification derived from 
data formerly obtained in the LLNA.  
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Figure 1 
Intracellular IL-1α content (in pg/1.106 cells) in the human keratinocyte cell line HaCaT as a function of 
sensitizer concentration (in µM). Using non-linear regression analysis the concentration, that induced a 3-fold 
increase over control, was calculated. The intracellular IL-1α concentration was measured after 24 hr of 
incubation to Benzocaine (A), DEA (B), DNCB (C) and PA (D). The cytokine concentrations are shown on the 
vertical axis on a linear scale and the concentrations of the chemicals are shown on the horizontal axis on a 
log-scale. Number of experiments =3. 
 
 
Species comparison in vitro 
The EC3 values measured in the human keratinocyte HaCaT cell line after exposure to 
Benzocaine, DEA, DNCB, and PA were compared to EC3 values previously obtained in the 
murine keratinocyte HEL30 cell line. These observations are summerized for IL-1α and IL-18 
in Table 3 and 4, respectively. Based on the outcome of the LDH test, the highest non-toxic 
concentration chosen for benzocaine and DEA in the human cell line, were one order of 
magnitude higher (14 mM) compared to the highest non-toxic concentration chosen in the 
murine cell line (1.4 mM). In contrast to HEL30, HaCaT showed clear differences in the 
calculated EC3 values (without overlap of the confidence intervals) between the different 
chemicals. In the HaCaT cell line, for IL-1α, an overlap of the 90%-confidence interval was 
seen for PA and benzocaine, whereas for IL-18 an overlap was seen for benzocaine and DEA. 
In the HaCaT cell line a smaller range of the cytokine responses was found between the lowest  
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Figure 2 
Intracellular IL-18 content (in pg/1.106 cells) in the human keratinocyte cell line HaCaT as a function of 
sensitizer concentration (in µM). Using non-linear regression analysis the concentration, that induced a 3-fold 
increase over control was calculated. The intracellular IL-18 concentration was measured after 24 hr of 
incubation to Benzocaine (A), DEA (B), DNCB (C) and PA (D). The cytokine concentrations are shown on the 
vertical axis on a linear scale and the concentrations of the chemicals are shown on the horizontal axis on a 
log-scale. Number of experiments =3. 
 
 
and the highest concentration tested, and also between the strongest and the weakest allergen 
tested. 
 
DISCUSSION  
 
In the present study, we investigated if the ranking found in vitro using production of 
cytokines by human keratinocytes corresponded to the findings previously obtained in 
experimental animals (LLNA). Dose-response studies were performed by exposure of the 
human keratinocyte cell line HaCaT to allergens of different sensitizing potency. Intracellular 
IL-1α and IL-18 dose-response relationships were evaluated by nonlinear regression analysis 
and EC3 values were estimated based on a curve fitting method. Subsequently, these EC3 
values were used for ranking the potency of the allergens. Uncertainty in the estimate of the 
EC3 was assessed by a bootstrap method (Slob and Pieters, 1998), from which any desired 
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confidence interval can be derived. For both IL-1α and IL-18, DNCB showed the strongest 
potency followed in this order by PA, benzocaine, and DEA. Dose-response analysis of IL-1α 
ranked benzocaine more potent than PA. However, an overlap of the confidence intervals was 
seen between benzocaine and PA, suggesting no clear difference in potency between these 
chemicals. This may be the result of the use of two different models (Figure 1) for the analysis 
of the dose-response data of these two chemicals. So in general, these classifications were 
similar to our previous findings obtained in the LLNA (Van Och et al., 2000).  
 
 
Table 3  
Classification of low molecular weight chemicals based on IL-1α responses in the human HaCaT and the 
murine HEL30 cell line, together with the associated uncertainty distribution.  
Chemical HaCaT 
EC3
a(µM)                    L05-L95b                     
HEL30c 
EC3 (µM)                    L05-L95 
DNCB 4.8*10-2 1.6*10-2-1.3*10-1 2.2*10-2 2.4*10-2-3.9*10-2 
PA 2.0*103 1.4*103-3.3*103 1.15 0.81-1.62 
Benzocaine 1.1*103 1.0*103-1.2*103 2.4*104 3.4*103-2.9*104 
DEA 1.8*104 1.5*104-2.1*104 9.9*106 6.0*105-1.5*109 
a Estimated concentration required for induction of three compared to control value 
b 5th and 95th percentile 
c Van Och et al., submitted 
 
 
Table 4  
Classification of low molecular weight chemicals based on IL-18 responses in the human HaCaT and the 
murine HEL30 cell line, together with the associated uncertainty distribution.  
Chemical HaCaT 
EC3
a(µM)                    L05-L95b                     
HEL30c 
EC3 (µM)                     L05-L95 
DNCB 4.9*10-3  1.2*10-3-2.6*10-2 3.0*10-5    NC-3.4*10-4 
PA 2.4*103 1.0*103-7.1*103 8.2*10-3          6.0*10-5-6.3*10-2 
Benzocaine 10.6*103 10.6*103-11.1*103 0.47                0.15-1.02 
DEA 10.9*103 10.8*103-11.3*103 638    487-927 
a Estimated concentration required for induction of three compared to control value 
b 5th and 95th percentile 
c Van Och et al., submitted  
NC, could not be calculated 
 
 
Although it is helpful to have available in vitro methods to assess skin sensitization 
potential, it would be even more valuable to have available methods that can be used to 
extrapolate data from animal studies to humans (Gerberick and Robinson, 2000). Data derived 
from the analysis in human cells may provide us with information about differences in 
sensitivity between murine and human keratinocytes and may therefore be helpful in the 
calculation or estimation of extrapolation factors. For HaCaT, the highest non-toxic 
concentrations were found to be one order of magnitude higher for benzocaine and DEA, 
while for DNCB and PA similar concentrations were used for both HaCaT and HEL30 cells. In 
addition, a smaller range of cytokine responses was found in the HaCaT cell line, both between 
the lowest and the highest concentration tested and between the strongest and the weakest 
allergen tested as compared to similar responses in murine HEL30 cells. For IL-18, for each 
chemical only a fraction of the concentration is needed for a three-fold induction over vehicle 
control in the HEL30 cell line compared to the HaCaT cell line. For IL-1α, this was only seen 
for DNCB and PA. These observations indicate that the human HaCaT cell line showed less 
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sensitive responses compared to the murine HEL30 cell line. This may suggest that mice are 
more sensitive than humans. It should however be noted that the difference in overall 
sensitivity may be a function of intrinsic capacity of the cell lines, rather than indicate species 
differences. The use of primary keratinocytes may overcome this problem. 
 In conclusion, the ranking observed in the human in vitro model based on the EC3 
values derived from the IL-1α and IL-18 dose-response relationships corresponded in the 
human keratinocyte cell line HaCaT with the ranking previously obtained in the LLNA and 
with the ranking obtained from murine HEL30 cells. These data not only support the 
hypothesis that the irritant component of an allergen decides to a great extent the ultimate 
strength of the sensitizing effect, it also underscores the predictive value of the LLNA. In 
addition, the in vitro approach can also provide us with missing information on differences in 
sensitivity between murine and human keratinocytes. Our investigations showed less sensitive 
responses in the human cell line compared to the murine cell line. This may be helpful in the 
calculation or estimation of extrapolation factors, which can be used to translate in vivo data 
(LLNA) towards an actual risk estimate in man. However, tumor cell lines were used in the 
present approach, and further validation with primary keratinocytes is necessary. 
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CHAPTER 10 
 
 
SUMMARY AND GENERAL DISCUSSION 
 
 
 
The skin not only functions as a physical-mechanical barrier between an individual and his/her 
environment, it also acts as an immunologically active organ. Allergic skin diseases can be 
quite incapacitating and form a serious occupational and consumer health problem. One of the 
most important allergic diseases caused by chemicals, contact hypersensitivity (CHS) or skin 
sensitization, forms a serious problem for individuals experiencing such a reaction. The 
prevalence of CHS tends to grow proportionally to the increasing exposure to an expanding 
variety of chemicals. Predictive animal tests to identify sensitizing properties of chemicals are 
therefore carried out at a large scale. For a better risk assessment, a more quantitative 
assessment of the sensitizing potency of chemicals is needed. These two current developments 
result in an increasing number of animals used. The aim of this thesis was to evaluate the risk 
assessment process for sensitizing potency of contact allergens in a more reliable manner, and 
to investigate the possibility of developing alternative approaches to in vivo testing, which may 
ultimately lead to a refinement, reduction, or replacement of animal testing.  
The animal tests most commonly used to identify skin sensitizing capacity are the 
guinea pig maximization test (GPMT; Magnusson and Kligman, 1969, 1970) and the local 
lymph node assay (LLNA; Kimber et al., 1986; Kimber and Weisenberger, 1989). The murine 
LLNA has been recently accepted as a stand-alone test (OECD 1992; OECD 2000). It 
investigates sensitization potential by measuring cell proliferation in the lymph node (LN) 
draining the site of application, being the ear. In chapter 2 the sensitizing potential of ten 
model allergens was evaluated using a dose-response analysis on data obtained using the 
LLNA. Usually, the stimulation index (SI) of three is used as a cut-off in the LLNA, whereas 
our method evaluated all data points (animals) that contribute to the dose-response curve to 
determine the EC3 (effective concentration inducing a 3-fold increase in proliferation of lymph 
node cells). In addition, information on the reliability of the data is obtained using a bootstrap 
approach (Slob and Pieters, 1998). This provides uncertainty margins which benefit the 
comparison between the sensitizers. The approach performed in this study is a way to 
accurately (with more knowledge of confidence) assess the potency of sensitizing chemicals 
and enables the estimation of the lowest concentration needed for sensitization. The latter 
approach was employed to test 15 different chemicals used in latex medical glove production 
(chapter 4). These chemicals are known to induce contact hypersensitivity reaction in man 
(Knudsen et al., 2000). The sensitizing potency was quantified, resulting in a ranking of this 
potency. Now, based on the outcome of the study, chemicals preferable with lower sensitizing 
activity may be selected over more potent sensitizing agents for the production of natural 
rubber latex products. 
In the standard GPMT a single concentration is used for intracutaneous and topical 
induction and the assay provides a qualitative assessment of allergenicity. This experimental 
design is not well suited for the establishment of threshold values. Therefore, we performed a 
quantitative evaluation of the sensitizing potency of three model allergens of different 
senstizing potency in the GPMT, based on multiple concentrations (chapter 3). Although 
dose-response studies with the GPMT have been described by others (Nakamura et al., 1994; 
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Andersen et al., 1995), we took into account not only the percentage of reacting animals, but 
also the severity of the skin response. A major drawback of the GPMT, compared to the 
LLNA, is that skin scores are provided on an ordinal scale. Dose-response modelling of the 
ordinal data from the GPMT was not as successful as the dose-response modelling of the 
LLNA results which are continuous in nature, and we decided to apply the simple method of 
plotting the sum of the scores over all the animals in an experimental group against the 
induction dose. This resulted in a different ranking of the chemicals in the GPMT compared to 
the LLNA (chapter 2). Although dose-response modelling of ordinal data is by itself possible, 
the results of such an analysis are less easily interpreted. For that reason it may be hypothesized 
that the ranking of sensitizing chemicals is better when based on a LLNA, providing a more 
quantitative result on which regression analysis can be performed. Yet, the GPMT appears to 
reveal sensitization at lower concentrations, and may therefore be more sensitive. Besides, the 
GPMT measures responses in a challenge phase, which is a better reflection of the real 
situation when compared to the LLNA, which only measures the sensitization phase. 
 Previous studies have indicated that the frequency of antigen exposure is an additional 
risk factor in determining the outcome of the immune response (Mueller et al., 1989; Kitagaki 
et al., 1995). Compared to the exposure duration of the LLNA (3 days), real life exposure 
often lasts for months or years. Therefore, knowledge of the influence of exposure duration is 
necessary for an effective assessment of risk. We therefore investigated whether prolonged 
exposure (2 months) to sensitizers at concentrations that do not induce an SI ≥ 3 in the LLNA, 
was able to surpass this threshold (chapter 5). Prolonged exposure to concentrations of 
allergens below an SI of three in the LLNA, did not result in a response in the draining LN and 
thus were not able to surpass this threshold. This finding indicates that for classification of 
sensitizers the shorter exposure period in the LLNA is sufficient, and longer periods of 
exposure have no bearing on this classification. 
 The LLNA has been developed further to discriminate skin sensitizers from respiratory 
sensitizers (Dearman et al., 1992; 1996; Vandebriel et al., 2000). In this test, contact 
sensitizers have been suggested to selectively induce Th1 immune responses, such as IFN-γ 
production, whereas Th2 responses, such as IL-4 production, were seen after exposure to 
respiratory allergens (Dearman et al., 1995). This approach compares cytokine profiles of 
contact allergens and respiratory allergens based on single concentrations. Comparisons should 
be made based on similar SI’s. Furthermore, these features may be dependent on the dose of 
the particular allergen. Therefore, we investigated the distinction between contact sensitizers 
and respiratory allergens by establishing dose-dependent cytokine profiles (chapter 6). Our 
observations indeed showed that contact allergens preferentially induce IFN-γ production, and 
respiratory allergens preferentally induce IL-4 and IL-10. Nevertheless, our findings also 
indicated that allergens of a mixed nature exist, the nature depending on the concentration used 
for sensitization. This finding underscores the notion to study a range of concentrations instead 
of only a single concentration. The use of a single short assay for both proliferation (for 
potency evaluation of sensitizers) and cytokine production (for discrimination between contact 
and respiratory sensitizers) would therefore seem a better approach and has the added 
advantage that it is in line with animal welfare policies. 
Another approach for the identification of potential sensitizing capacity, that would not 
rely on in vivo animal (or human) testing, is directed towards the construction of alternative 
experimental models. Low molecular weight allergens need certain characteristics that convey 
them with the potential to induce allergic sensitization. Parameters that are of particular 
importance are protein reactivity (ability to conjugate with proteins) and lipophilicity 
(Basketter and Roberts, 1990). The correlation between the protein reactivity of chemicals and 
their skin-sensitizing potential has been well established (Dupuis and Benezra, 1982). We 
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sought to develop a model to incorporate a variety of molecular features, being determinants 
important for permeability through the skin and reactivity in the skin, to determine the 
allergenic potency of chemicals (chapter 7). Multiple regression analysis of the EC3 with the 
different properties resulted in different equations from which predicted sensitising values 
(PSVs) could be calculated. Potency evaluation resulted in a classification of the different 
chemicals, in which the weak allergens could be distinguished from the strong allergens.  
KC are pivotal during skin sensitization since they produce and secrete a number of 
proinflammatory cytokines, chemokines, and growth factors (Matsue et al., 1992), and there is 
evidence that they play a role in immune-mediated skin diseases (Schwarz and Luger, 1992). 
These characteristics together with their relative ease of culture, make KC an appealing target 
for predictive contact sensitization testing. We investigated the relative potency of four known 
allergens in vitro based on cytokine dose-response relationships using the murine keratinocyte 
cell line HEL30 (chapter 8) and the human keratinocyte cell line HaCaT (chapter 9). For both 
intracellular IL-1α and intracellular IL-18 dose-response relationships were evaluated by 
nonlinear regression analysis and EC3 values were estimated based on a curve fitting method. 
Subsequently, these EC3 values were used for ranking the potency of the allergens. The 
ranking based on the in vitro results in the mouse (HEL30) corresponded to the in vivo 
classification data based on the LLNA (chapter 2). Subsequently, the ranking based on the in 
vitro results in the human cell line HaCaT corresponded to a large extent to the in vitro results 
found in the murine cell line HEL30. 
The latter in silico (chapter 7) and in vitro approaches (chapters 8 and 9) described 
in the preceding alineas may be seen as possible tools for the prediction of sensitizing potency 
of a particular chemical, and may ultimately lead to a reduction in the use of experimental 
animals. Nevertheless, further validation with additional sensitizers, irritants and negative 
compounds is necessary. In general, major limitations and technical complexities of in vitro 
approaches are the lack of biotransformation in cultured cells, allergen toxicities, the possible 
non-specific immunological effects of tested chemicals, and the lack of external influences 
(such as other cell types or neuro-endocrine interactions). On the other hand, single-cell in 
vitro assays provide us with several advantages compared to in vivo assays: it saves animals, it 
is less expensive and time consuming, and a wider range of concentrations can be used.  
 With the approach described in this thesis, we are now able to assess the potency of 
sensitizing chemicals in the LLNA in a more accurate way. This results in a better estimation of 
the minimal number of test animals needed, which inevitably leads to a decrease in animal use. 
Another important issue is that this predictive method also provides us with information about 
the threshold of an allergen. The 90% confidence limits take into account the quality of the 
particular dataset where the lower 5% confidence limit predicts that below that particular dose 
there is only a 5% chance for a positive response (sensitization) and may therefore be used to 
define the threshold dose. Data on thresholds in humans cannot be derived directly from animal 
tests. Therefore, we developed an in vitro assay where cytokine responses derived from both 
murine as human keratinocytes were used as read-out for sensitizing strength. The in vitro 
approach provided us with more insight on the differences in sensitivity between the two 
species. With these findings it is now possible to interpolate LLNA dose response data towards 
an estimation of risk in man. At this point, the GPMT and the LLNA are used for the 
identification of sensitizing chemicals leading to labelling. If it is possible to determine 
thresholds in humans, for certain very weak allergens this may ultimately lead to the descision 
not to label a chemical as an allergen. The use of cytokines for the assessment of sensitizing 
potency seems promising and is one of numerous possibilities of in vitro tests for the 
assessment of sensitizing potency. Currently, the application of genomic technology to 
toxicology (toxicogenomics) is a relatively new and rapidly developing discipline holding great 
Summary and general discussion 
 124 
promise. Hazard identification and risk assessment processes will advance from such genomics 
techniques, which will definitely lead to greater understanding of action of allergens, 
development of novel biomarkers of exposure and effect, and better identification of sensitive 
subpopulations. 
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SAMENVATTING EN DISCUSSIE 
 
De huid fungeert niet alleen als een fysisch-mechanische barrière tussen het lichaam en 
zijn/haar omgeving, maar treedt ook op als een actief immunologisch orgaan. Allergische 
aandoeningen van de huid zijn vaak heel vervelend voor de persoon in kwestie en vormen een 
serieus probleem. Een van de belangrijkste en meest voorkomende huidaandoeningen 
veroorzaakt door chemische stoffen is contact overgevoeligheid (CHS), ook wel bekend als 
sensibilisering van de huid. Door een veranderende levensstijl en een toename van het aantal 
chemische stoffen waaraan men blootgesteld wordt, groeit de laatste jaren de prevalentie van 
CHS proportioneel. Daarom wordt er op grote schaal gebruik gemaakt van voorspellende 
diermodellen om stoffen die een allergische reactie in de huid kunnen veroorzaken tijdig te 
identificeren. Naast identificatie, is het voor een goede inschatting van het risico ook 
noodzakelijk om de mate van sensibiliserende potentie (kwantificering) vast te stellen. Deze 
ontwikkelingen resulteren in een toename in het gebruik van proefdieren. Een doelstelling van 
het onderzoek zoals beschreven in dit proefschrift was om het proces van risicoschatting te 
evalueren op een betrouwbare manier. Een tweede doelstelling was om de mogelijkheid te 
onderzoeken een in vitro model te ontwikkelen voor de identificatie van huidallergenen. Beide 
doelstellingen passen in het streven naar een verfijning, vermindering of vervanging van 
bestaande diermodellen (3 V’s). 
 De meest gehanteerde diermodellen voor de identificatie van huidallergenen zijn de 
“guinea pig maximization test” (GPMT) in de cavia en de “local lymph node assay” (LLNA; 
lokale lymfklier test) in de muis. De LLNA meet de proliferatie van de cellen in de lymfeklieren 
die de plaats van blootstelling (oortjes) draineren, als een maat voor de allergene potentie van 
een stof. Hoofdstuk 2 beschrijft een studie waarbij de allergene potentie van 10 bekende 
allergenen is bepaald met behulp van een dosis-respons analyse in de LLNA. Doorgaans wordt 
een stimulatie-index (SI) van 3 gehanteerd als “cut-off” in de standaard LLNA, waarbij stoffen 
die boven deze grens uitkomen als allergeen worden bestempeld. Onze methode, daarentegen, 
beschouwt alle datapunten (dieren) die bijdragen aan de dosis-respons curve om zo de EC3 
(effectieve concentratie die een 3-voudige toename van label in het DNA van de cellen 
induceert) waarde te bepalen. Daarnaast verschaft deze methode ook informatie over de 
betrouwbaarheid van de EC3 waarde door de toepassing van de zgn. “bootstrap approach”. 
Deze methodiek levert onzekerheids marges wat belangrijk is voor de onderlinge vergelijking 
van allergenen. De methodiek gehanteerd in deze studie is een meer nauwkeurige manier (met 
informatie over de betrouwbaarheid) om de allergene potentie (lees: sterkte) van 
sensibiliserende verbindingen te bepalen. Bovendien geeft het een schatting van de laagste 
concentratie nodig om een allergene respons te veroorzaken (belangrijk voor risico-evaluatie). 
De bovengenoemde methode is in een vervolgstudie toegepast voor het testen van 15 
verbindingen gebruikt in de productie van latex handschoenen (als ontharders, katalysatoren 
etc.). Na bepaling van de allergene potentie, op basis van de EC3 waarde van deze 
verbindingen, werden deze geclassificeerd van sterk naar zwak allergeen (of zelfs niet 
allergeen). Deze bevindingen staan beschreven in hoofdstuk 4. Gebaseerd op de uitkomst van 
deze studie kunnen nu de verbindingen worden geselecteerd, die minder of zelfs niet allergeen 
zijn voor de productie van natuurlijke rubber latex producten.  
 De standaard GPMT hanteert één enkele concentratie voor inductie en verschaft een 
kwalitatieve bepaling van de allergeniciteit (in tegenstelling tot een kwantitatieve bepaling in de 
LLNA). De experimentele opzet van de GPMT, waarbij de mate van roodheid op de huid van 
de cavia wordt gehanteerd als maat voor allergeniciteit, is niet geschikt voor de vaststelling van 
een ‘threshold’ (=drempelwaarde). Om een onderlinge vergelijking mogelijk te maken hebben 
we getracht de GPMT op een meer kwantitatieve manier toe te passen door gebruik te maken 
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van meerdere concentraties in de inductiefase (dosis-respons; hoofdstuk 3). Hierbij werd 
zowel het aantal positieve dieren als de mate van huidreactie gebruikt voor de evaluatie van de 
allergene potentie van 3 model-allergenen. Dit resulteerde in een verschillende ranking van de 
betreffende allergenen in de GPMT en de LLNA. Hoewel de semi-kwantitatieve interpretatie in 
de GPMT de dosis-respons modellering bemoeilijkt, lijkt deze test gevoeliger te zijn dan de 
LLNA. Bovendien meet de GPMT responsen in de challenge fase (de ‘echte’ respons), wat een 
betere reflectie geeft van de werkelijkheid  vergeleken met de LLNA welke meet in de 
sensibilisatie fase.    
 Hoe vaak iemand blootgesteld wordt (frequentie) zou mede bepalend kunnen zijn voor 
de uiteindelijke uitkomst van een immunologische respons. In de praktijk wordt men vaak 
maanden of jaren blootgesteld, terwijl de duur van blootstelling in de LLNA ‘maar’ 3 dagen is. 
Wij hebben getracht de invloed van langdurig blootstellen te onderzoeken met de LLNA. De 
dieren zijn daarbij 2 maanden blootgesteld aan concentraties lager dan de EC3, om te kijken of 
de proliferatieve responsen uiteindelijk boven een SI=3 uitkwamen (beschreven in hoofdstuk 
5). Daar dit niet het geval was kunnen we concluderen dat de kortdurende blootstelling in de 
LLNA voldoende is voor identificatie en kwantificering van allergenen. 
 De LLNA is verder ontwikkeld om huid (contact) allergenen en respiratoire allergenen 
van elkaar te onderscheiden. Hierbij wordt uitgegaan van de aanname dat contact allergenen 
een Th1 respons (zoals IFN-γ productie) en respiratoire allergenen een selectieve Th2 respons 
(zoals IL-4 productie) induceren. Deze methode vergelijkt cytokinen profielen op basis van één 
enkele concentratie, waarbij de vergelijking zou moeten berusten op basis van gelijke SI’s en 
dus afhankelijk is van de concentratie van het allergeen. Daarom hebben wij de mogelijkheid 
onderzocht om deze twee typen allergenen van elkaar te onderscheiden op basis van dosis-
afhankelijke cytokinen profielen (hoofdstuk 6). Wij vonden dat, naast de duidelijke IFN-γ 
productie door contact allergenen en IL-4/IL-10 productie door respiratoire allergenen, ook 
allergenen van een gemengde aard bestaan, waarbij het profiel afhankelijk is van de 
concentratie. Deze bevinding onderschrijft nog eens hoe belangrijk het is om bij deze type 
studies een concentratiereeks te gebruiken in plaats van één enkele concentratie. De methode, 
zoals wij deze hebben toegepast, is een enkele korte assay die zowel de proliferatie (allergene 
potentie) als de cytokine-productie (onderscheid tussen contact- en respiratoire allergenen) 
bestudeert en lijkt daarom een betere methode en is bovendien in lijn met het beleid over het 
welzijn van dieren (“animal welfare policies”). 
 Een alternatief voor in vivo testen, voor identificatie van sensibiliserende capaciteit, is 
de ontwikkeling van experimentele mathematische modellen. Allergenen hebben specifieke 
eigenschappen waardoor ze in staat zijn een allergische respons te veroorzaken. Voor laag-
moleculaire allergenen zijn belangrijke parameters o.a. reactiviteit en lipofiliciteit, waarbij 
correlatie tussen deze eigenschappen en sensibilisering van de huid reeds is aangetoond.  
Gebaseerd op deze gegevens hebben we getracht een mathematisch model te ontwikkelen, 
waarin een aantal moleculaire kenmerken belangrijk voor permeabiliteit door de huid en 
reactiviteit in de huid zijn opgenomen, om de allergene potentie van stoffen te voorspellen 
(hoofdstuk 7). Regressie-analyse van de EC3 met de verschillende parameters/eigenschappen 
heeft geresulteerd in verschillende mathematische vergelijkingen waaruit ”predicted sensitizing 
values” (PSV’s) kunnen worden berekend. Na classificatie van de verschillende allergenen 
konden de relatief zwakke allergenen van de sterkere worden onderscheiden. 
Epidermale keratinocyten (KC) produceren een verscheidenheid aan pro-inflammatoire 
cytokinen, chemokinen en groeifactoren. Er is reeds aangetoond dat zij een rol spelen in een 
aantal immunologisch gemediëerde huidziekten. Bovendien zijn ze makkelijk te kweken, wat 
van deze cel een geliefd instrument maakt voor in vitro testen. Relatieve allergene potentie is 
onderzocht door cytokinen dosis-respons relaties in een muize KC cellijn HEL30 (hoofdstuk 
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8) en een humane KC cellijn HaCaT (hoofdstuk 9) vast te stellen. Deze werden vervolgens 
geanalyseerd, waarna EC3 waarden zijn berekend. Vervolgens zijn deze gebruikt voor 
classificatie van de verschillende allergenen. De ranking zoals wij deze vonden in de muis 
(HEL30) kwam overeen met de classificatie zoals wij deze reeds vonden in vivo (LLNA). 
Bovendien zagen we dat de classificatie in vitro in beide species sterk overeen kwamen.  
De bovengenoemde in silico (hoofdstuk 7) en in vitro (hoofdstuk 8 en 9) 
benaderingen kunnen worden gezien als mogelijke methoden om de allergene potentie van 
stoffen te voorspellen, die mogelijk zullen leiden tot een vermindering van het 
proefdiergebruik. Desalniettemin is validatie van deze methoden noodzakelijk (testen van 
meerdere allergenen, niet-allergenen en irriterende verbindingen). Over het algemeen zijn de 
afwezigheid van biotransformatie in gekweekte cellen, mogelijk niet-specifieke 
immunologische effecten van teststoffen en de afwezigheid van externe invloeden (zoals andere 
celtypen of neuro-endocrine interacties) belangrijke tekortkomingen van in vitro methoden. 
Daarentegen hebben in vitro assays ook een aantal belangrijke voordelen vergeleken met in 
vivo assays:  ze besparen dieren (en daardoor) geld en tijd. Bovendien kan een bredere 
concentratie-range worden bekeken. 
 Met de benadering zoals deze beschreven staat in dit proefschrift, zijn we nu in staat 
om de allergene potentie van sensibiliserende verbindingen in de LLNA op een nauwkeurig(er) 
en betrouwbaar(der) vast te stellen. Dit resulteert in een betere inschatting van het minimale 
aantal proefdieren nodig voor een experiment, wat uiteindelijk zal leiden tot een vermindering 
van het proefdiergebruik. Daarnaast verschaft deze predictieve methode ons cruciale informatie 
over de (mogelijke) threshold van een allergeen. Het 90%-betrouwbaarheidsinterval geeft 
informatie over de kwaliteit van een bepaalde dataset, waarbij de onderste 5%-grens voorspelt 
dat onder de betreffende concentratie (EC3) er een 5% kans bestaat op een positieve respons 
(sensibilisatie) en kan daarom worden gezien als een threshold. Thresholds in mensen kunnen 
niet direct worden afgeleid van dierexperimenten. Daarom hebben we getracht een in vitro 
model te ontwikkelen waarbij de productie van cytokinen door muize- en humane huidcellen 
(keratinocyten) als indicatie voor allergene potentie is gebruikt. Deze in vitro benadering 
verschaft ons enig inzicht in de onderlinge verschillen in gevoeligheid tussen mens en muis, 
belangrijk voor de vertaling van LLNA data (muis) naar een risicoschatting in de mens. De 
GPMT en de LLNA worden gebruikt voor de identificatie van sensibilisrende stoffen wat leidt 
tot labelling. Als het mogelijk is om thresholds bij mensen vast te stellen, zal dit uiteindelijk 
leiden tot een beslissing om sommige zwakke allergenen niet te labelen als zijnde allergeen. 
Cytokinen als “tool”  voor de vaststelling van allergene potentie lijken veelbelovend en is één 
van de vele mogelijke in vitro benaderingen. Momenteel is een relatief nieuw en dynamische 
technologie binnen de toxicologie de “toxicogenomics”, waarvan veel wordt verwacht in de 
toekomst. Risico-identificatie en -schatting zullen door de toepassing van dit type technieken 
worden verbeterd, wat onherroepelijk zal leiden tot meer inzicht in de werking van allergenen, 
ontwikkeling van nieuwe biomarkers voor blootstelling/effect en identificatie van gevoelige 
subpopulaties. 
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ABBREVATIONS 
 
ANOVA analysis of variance 
BENZ benzocaine  
BSA bovine serum albumin 
CHS contact hypersensitivity 
DEA diethylamine  
DMEM Dulbecco’s modified eagle’s medium 
DNCB dinitrochlorobenzene 
DTH delayed-type hypersensitivity 
EC3 estimated concentration in % required for SI=3 
ELISA enzyme-linked immunosorbent assay  
FCS foetal calf serum 
HaCaT human keratinocyte cell line 
HEL30 murine keratinocyte cell line 
HCA hexylcinnamic aldehyde 
GPMT guinea pig maximization test 
ICAM intercellular adhesion molecule 
ICE IL-1β coverting enzyme 
IL interleukin 
KC keratinocytes 
LC Langerhans cells 
LLNA local lymph node assay 
LN lymph node 
MBT mercaptobenzothiazole 
MBTS dibenzothiazyldisulfide 
MHC major histocompatibility complex 
min minutes 
n number 
NHEK normal human epidermal keratinocytes 
NK natural killer 
OXA oxazolone 
PA phtalic anhydride 
PROAST possible risk obtained from animal studies 
PSV predicted sensitizing value 
PTD dipentamethylenethiuramdisulfide 
PTT dipentamethylenethiuramtetrasulfide 
QSAR quantitative structure-activity relationship 
SI stimulation index 
TBTD tetrabutylthiuramdisulfide 
TDI toluene diisocyanate 
TETD tetraethylthiuramdisulfide 
Th T helper 
TMA trimellitic anhydride 
TMTD tetramethylthiuramdisulfide 
TMTM tetramethylthiurammonosulfide 
TS5 estimated concentration in % required for a total skin score of 5 
ZDBC zinc dibutyldithiocarbamate 
ZDEC zinc diethyldithiocarbamate  
ZDMC zinc dimethyldithiocarbamate 
ZMBT zinc mercaptobenzothiazole 
ZPC zinc pentamethylenedithiocarbamate 
 130    
   131   
LIST OF PUBLICATIONS 
 
Wendela A. Kappers, François M. M. van Och,  Els M. de Groene, G. Jean Horbach. (2000) 
Comparison of three different in vitro mutation assays used for the investigation of cytochrome 
P450-mediated mutagenicity of nitro-polycyclic aromatic hydrocarbons. Mutation Research 
466 (2), 143-159. 
 
François M. M. van Och, Wout Slob, Wim H. de Jong, Rob J. Vandebriel, Henk van Loveren. 
(2000) A quantitative method for assessing the sensitizing potency of low molecular weight 
chemicals using a local lymph node assay: employment of a regression method that includes 
determination of the uncertainty margins. Toxicology 146 (1), 49-59. 
 
François M. M. van Och, Rob J. Vandebriel, Menk K. Prinsen, Wim H. de Jong, Wout Slob, 
Henk van Loveren. (2001) Comparison of dose-responses of contact allergens using the guinea 
pig maximization test and the local lymph node assay. Toxicology 167 (3), 207-215. 
 
Wim H. de Jong, François M. M. van Och, Constance F. Den Hartog Jager, Sander W. 
Spiekstra, Rob J. Vandebriel, Henk van Loveren. (2002) Ranking of allergenic potency of latex 
chemicals in a modified local lymph node assay. Toxicological Sciences 66 (2), 226-232. 
 
François M. M. van Och, Henk van Loveren, Wim H. de Jong, Rob J. Vandebriel. Cytokine 
production induced by low molecular weight chemicals as a function of the stimulation index in 
a modified local lymph node assay: an approach to discriminate contact sensitizers from 
respiratory sensitizers. Toxicology and Applied Pharmacology. In press. 
 
François M. M. van Och, Rob J. Vandebriel, Wim H. de Jong, Henk van Loveren. Effect of 
exposure duration on identification of allergens in a modified local lymph node assay. 
Toxicology. In press. 
 
François M. M. van Och, Henk van Loveren, Josien C. van Wolfswinkel, Anja C. A. 
Machielsen, Rob J. Vandebriel. Assessment of potency of allergenic activity of low molecular 
weight compounds based on IL-1 and IL-18 production by a murine keratinocyte cell line. 
Submitted for publication.  
 
François M. M. van Och, Josien C. van Wolfswinkel, Katsushisa Takumi, Cees A. van Walree, 
Henk van Loveren, Rob J. Vandebriel. Modelling physico-chemical properties of low 
molecular weight chemicals for prediction of allergenic potency. Manuscript in preparation. 
 
François M. M. Van Och, Henk Van Loveren, Almar Kuipers, Anja J. C. Machielsen, Rob J. 
Vandebriel. Cytokine responses in human keratinocytes by exposure to low molecular weight 
chemicals: predictive value and a tool for extrapolation. Manuscript in preparation. 
 
 132    
CURRICULUM VITAE 
 
De auteur van dit proefschrift werd op 3 april 1971 geboren te Eindhoven. In 1991 behaalde 
hij het VWO-diploma aan het Sint-Joris college te Eindhoven, na in 1989 reeds het HAVO-
diploma te hebben behaald. In het daaropvolgende jaar werd de dienstplicht vervuld waarin hij 
als ambulance-chauffeur werkzaam was op de Willem George Frederik kazerne te Harderwijk. 
In 1992 begon hij met de studie Biologie aan de Universiteit Utrecht (UU). Tijdens deze studie 
liep hij stages bij de vakgroep Moleculaire Biochemische Toxicologie op het toenmalige 
Research Instituut voor Toxicologie (nu Institute for Risk Assessment Sciences) o.l.v. Dr. 
W.A. Kappers en Dr. G.J. Horbach, en de vakgroep Pathologie in het Academisch Ziekenhuis 
Utrecht (nu Universitair Medisch Centrum Utrecht) o.l.v. Dr. P. Joling en Dr. R.A. de Weger. 
Na het behalen van het doctoraal examen in januari 1998, begon hij in februari 1998 aan zijn 
promotiestudie bij de vakgroep Pathologie aan de Faculteit Diergeneeskunde van de UU in 
samenwerking met het Laboratorium Pathologie en Immunobiologie van het Rijksinstituut 
voor Volksgezondheid en Milieu (RIVM) te Bilthoven. Het promotieonderzoek, waarvan de 
resultaten beschreven staan in dit proefschrift, is uitgevoerd onder begeleiding van Dr. R.J. 
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